[{
    "name": "18F-FDG PET\/CT",
    "jumpto": "ENAS5079_5.4.1.0"
}, {
    "name": "5-alpha-reductase inhibitors (HF)",
    "jumpto": "ENAS5195_12.14.0.0"
}, {
    "name": "6-minute walk test (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "AAD (AFib)",
    "jumpto": "ENAS5194_10.1.1.0"
}, {
    "name": "AAD for the long term maintenance of sinus rhythm (AFib)",
    "jumpto": "ENAS5194_10.3.0.0"
}, {
    "name": "AADs for cardioversion (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "AADs, contra-indications in sinus rhythm (AFib)",
    "jumpto": "ENAS5194_10.5.0.0"
}, {
    "name": "AADs, oral drugs for sinus rhythm (AFib)",
    "jumpto": "ENAS5194_10.5.0.0"
}, {
    "name": "AADs, warning signs for discontinuation (AFib)",
    "jumpto": "ENAS5194_10.5.0.0"
}, {
    "name": "abciximab, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "abciximab, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "abciximab, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "abdominal angina",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "abdominal aortic aneurysm (AAA)",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "abdominal aortic aneurysm, asymptomatic patients",
    "jumpto": "ENAS264_9.3.3.0"
}, {
    "name": "abdominal aortic aneurysm, genetics",
    "jumpto": "ENAS264_10.2.8.0"
}, {
    "name": "abdominal aortic aneurysm, overview",
    "jumpto": "ENAS264_9.3.1.0"
}, {
    "name": "abdominal aortic aneurysm, screening",
    "jumpto": "ENAS264_9.3.2.0"
}, {
    "name": "abdominal aortic aneurysm, symptomatic patients",
    "jumpto": "ENAS264_9.3.4.0"
}, {
    "name": "Abiciximab, glycoprotein IIb\/IIIa inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.2.0"
}, {
    "name": "ablation, pregnancy",
    "jumpto": "ENAS255_10.3.0.0"
}, {
    "name": "Aborted cardiac arrest (ACA)",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Aborted cardiac arrest, definition",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Abscess, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Abscess, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "accelerated idioventricular rhythm",
    "jumpto": "ENAS250_7.1.3.0"
}, {
    "name": "ACE inhibitor, pregnancy",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "ACE-I (HF)",
    "jumpto": "ENAS5195_7.0.0.0"
}, {
    "name": "ACE-inhibitors, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.3.0.0"
}, {
    "name": "ACE-inhibitors, risk reduction in non-cardiac surgery18.8.2.5.1",
    "jumpto": "ENAS261_7.3.0.0"
}, {
    "name": "acenocoumarol",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "ACS and undergoing PCI, dyslipidaemias",
    "jumpto": "ENAS5197_11.6.0.0"
}, {
    "name": "active bleeding in anticoagulated pts. (AFib)",
    "jumpto": "ENAS5194_8.10.2.0"
}, {
    "name": "acute aortic dissection, clinical presentation",
    "jumpto": "ENAS264_8.2.1.0"
}, {
    "name": "Acute aortic dissection, diagnostic work-up",
    "jumpto": "ENAS264_8.2.5.1"
}, {
    "name": "acute aortic dissection, imaging",
    "jumpto": "ENAS264_8.2.3.0"
}, {
    "name": "acute aortic dissection, laboratory tests",
    "jumpto": "ENAS264_8.2.2.0"
}, {
    "name": "acute aortic dissection, treatment",
    "jumpto": "ENAS264_8.2.5.4"
}, {
    "name": "acute aortic dissection, various imaging modalities",
    "jumpto": "ENAS264_8.2.4.0"
}, {
    "name": "Acute aortic syndrome, a priori probability",
    "jumpto": "ENAS264_8.2.5.2"
}, {
    "name": "acute aortic syndrome, diagnostic approach",
    "jumpto": "ENAS264_8.2.5.3"
}, {
    "name": "acute heart failure, overview",
    "jumpto": "ENAS5195_13.1.0.0"
}, {
    "name": "acute heart failure, oxygen therapy (HF)",
    "jumpto": "ENAS5195_13.7.0.0"
}, {
    "name": "acute heart failure, ventilatory support (HF)",
    "jumpto": "ENAS5195_13.7.0.0"
}, {
    "name": "acute HF patients, clinical profiles",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "acute HF, factors triggering",
    "jumpto": "ENAS5195_13.2.0.0"
}, {
    "name": "Acute HR control of AF (interactive algorithm)",
    "jumpto": "interactive_0000558"
}, {
    "name": "acute myocardial infarction, pacing",
    "jumpto": "ENAS259_6.1.0.0"
}, {
    "name": "Acute pericarditis, anti-inflammatory therapy",
    "jumpto": "ENAS5082_3.2.6.0"
}, {
    "name": "Acute pericarditis, clinical diagnosis",
    "jumpto": "ENAS5082_3.2.2.0"
}, {
    "name": "Acute pericarditis, clinical management",
    "jumpto": "ENAS5082_3.2.3.0"
}, {
    "name": "Acute pericarditis, daignostic criteria",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Acute pericarditis, definition",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Acute pericarditis, first-line therapy",
    "jumpto": "ENAS5082_3.2.7.0"
}, {
    "name": "Acute pericarditis, high risk cases",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute pericarditis, hospital admission",
    "jumpto": "ENAS5082_3.2.5.0"
}, {
    "name": "Acute pericarditis, low risk cases",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute pericarditis, management",
    "jumpto": "ENAS5082_3.2.5.0"
}, {
    "name": "Acute pericarditis, moderate risk cases",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute pericarditis, non-high risk cases",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute pericarditis, outpatient management",
    "jumpto": "ENAS5082_3.2.5.0"
}, {
    "name": "Acute pericarditis, predictors of prognosis",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute pericarditis, prognosis",
    "jumpto": "ENAS5082_3.2.8.0"
}, {
    "name": "Acute pericarditis, treatment",
    "jumpto": "ENAS5082_3.2.7.0"
}, {
    "name": "Acute pericarditis, triage",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Acute thoracic aortic syndrome, classification",
    "jumpto": "ENAS264_8.1.0.0"
}, {
    "name": "Acute thoracic aortic syndrome, definition",
    "jumpto": "ENAS264_8.1.0.0"
}, {
    "name": "Acute vasoreactivity test",
    "jumpto": "ENAS5081_6.2.5.0"
}, {
    "name": "adaptive servo-ventilation (HF)",
    "jumpto": "ENAS5195_12.13.2.0"
}, {
    "name": "Adenosine, in vasoreactivity testing",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "AF after surgery",
    "jumpto": "ENAS5194_11.5.0.0"
}, {
    "name": "AF and newly diagnosed HF, management",
    "jumpto": "ENAS5194_6.2.0.0"
}, {
    "name": "AF and pregnacny",
    "jumpto": "ENAS5194_11.4.0.0"
}, {
    "name": "AF and SHD",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "AF and sports",
    "jumpto": "ENAS5194_11.3.0.0"
}, {
    "name": "AF in athletes",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "AF in obese patients, mgmt.",
    "jumpto": "ENAS5194_6.3.0.0"
}, {
    "name": "AF in the elderly patients",
    "jumpto": "ENAS5194_11.1.0.0"
}, {
    "name": "AF with kidney diseases, mgmt.",
    "jumpto": "ENAS5194_6.3.0.0"
}, {
    "name": "AF with MS or prosthetic valves",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "AF with respiratory diseases, mgmt.",
    "jumpto": "ENAS5194_6.3.0.0"
}, {
    "name": "AF with VHD, mgmt.",
    "jumpto": "ENAS5194_6.3.0.0"
}, {
    "name": "AF, acute and chronic management",
    "jumpto": "ENAS5194_7.2.0.0"
}, {
    "name": "AF, acute heart rate control",
    "jumpto": "ENAS5194_9.2.0.0"
}, {
    "name": "AF, classification",
    "jumpto": "ENAS5194_5.1.0.0"
}, {
    "name": "AF, clinical types",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "AF, diagnosis",
    "jumpto": "ENAS5194_4.1.0.0"
}, {
    "name": "AF, epidemiology",
    "jumpto": "ENAS5194_3.0.0.0"
}, {
    "name": "AF, integrated management",
    "jumpto": "ENAS5194_7.1.0.0"
}, {
    "name": "AF, long-term heart rate control",
    "jumpto": "ENAS5194_9.3.0.0"
}, {
    "name": "AF, patterns",
    "jumpto": "ENAS5194_5.2.0.0"
}, {
    "name": "AF, prediction of stroke and bleeding risk",
    "jumpto": "ENAS5194_8.5.0.0"
}, {
    "name": "AF, risk factors detection and management",
    "jumpto": "ENAS5194_6.1.0.0"
}, {
    "name": "AF, screening",
    "jumpto": "ENAS5194_4.3.0.0"
}, {
    "name": "AF, specialized service",
    "jumpto": "ENAS5194_7.3.0.0"
}, {
    "name": "AF, stroke prevention",
    "jumpto": "ENAS5194_8.3.0.0"
}, {
    "name": "aging aorta",
    "jumpto": "ENAS264_5.0.0.0"
}, {
    "name": "AHF, pharmacotherapy (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "AHRE, mgmt. (AFib)",
    "jumpto": "ENAS5194_4.2.0.0"
}, {
    "name": "alcohol abuse, population-based approach (CVD prev)",
    "jumpto": "ENAS5196_14.4.0.0"
}, {
    "name": "alcohol consumption, PAD",
    "jumpto": "ENAS256_4.2.0.0"
}, {
    "name": "algorithm, management of AHF",
    "jumpto": "ENAS5195_13.8.1.0"
}, {
    "name": "Allergic granulomatosis",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "alpha-adrenoceptor antagonists (HF)",
    "jumpto": "ENAS5195_12.11.0.0"
}, {
    "name": "alpha-methyldopa, pregnancy",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "alteplase, STEMI",
    "jumpto": "ENAS250_5.5.7.0"
}, {
    "name": "Ambrisentan + sildenafil, PAH sequential combination therapy",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Ambrisentan + tadalafil, PAH combination therapy",
    "jumpto": "ENAS5081_6.2.3.3"
}, {
    "name": "Ambrisentan added to sildenafil, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Ambrisentan, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Ambulatory ECG, non-invasive VA screening",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "Amiodarone (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "Amiodarone (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "amiodarone (HF)",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "Amiodarone (VA and SCD)",
    "jumpto": "ENAS5083_6.1.3.0"
}, {
    "name": "Amiodarone, SVT therapy",
    "jumpto": "ENAS5083_7.4.1.0"
}, {
    "name": "amlodipine (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "Amoxicillin, dental procedure prophylaxis",
    "jumpto": "ENAS5079_3.2.0.0"
}, {
    "name": "Ampicillin, dental procedure prophylaxis",
    "jumpto": "ENAS5079_3.2.0.0"
}, {
    "name": "Amyloidosis, cardiac",
    "jumpto": "ENAS5083_8.4.1.0"
}, {
    "name": "anaemia (HF)",
    "jumpto": "ENAS5195_12.12.0.0"
}, {
    "name": "Anaemia correction, PAH supportive therapy",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "Anakinra, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.4.0"
}, {
    "name": "aneasthesia, in non-cardiac surgery",
    "jumpto": "ENAS261_10.0.0.0"
}, {
    "name": "anemia, hemolytic",
    "jumpto": "ENAS248_11.2.10.0"
}, {
    "name": "aneurysms-osteoarthritis syndrome",
    "jumpto": "ENAS264_10.2.6.0"
}, {
    "name": "angina and coronary artery disease (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "angina pectoris, epidemiology [SCAD]",
    "jumpto": "ENAS258_5.0.0.0"
}, {
    "name": "angina, abdominal",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "angina, classification [SCAD]",
    "jumpto": "ENAS258_7.2.0.0"
}, {
    "name": "angina, microvascular: treatment [SCAD]",
    "jumpto": "ENAS258_8.4.5.0"
}, {
    "name": "angina, vasospastic [SCAD]",
    "jumpto": "ENAS258_7.8.2.0"
}, {
    "name": "angiography, cardiac arrest",
    "jumpto": "ENAS250_5.3.0.0"
}, {
    "name": "angiography, coronary [CVD Preg]",
    "jumpto": "ENAS255_4.5.0.0"
}, {
    "name": "angiography, coronary [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "angiography, coronary [VHD]",
    "jumpto": "ENAS248_5.1.7.0"
}, {
    "name": "angiotensin receptor blocker, HF in STEMI",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "angiotensin receptor blocker, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "angiotensin receptor blocker, STEMI",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "angiotensin receptor blockers (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "angiotensin receptor neprilysin inhibitor (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "Angiotensin-2 receptor antagonists (PH)",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "Angiotensin-converting enzyme inhibitors (PH)",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "ankle-brachial index, CLI",
    "jumpto": "ENAS256_5.6.9.0"
}, {
    "name": "ankle-brachial index, measurement",
    "jumpto": "ENAS256_5.6.2.0"
}, {
    "name": "ankle-brachial index, PAD diagnosis",
    "jumpto": "ENAS256_4.5.0.0"
}, {
    "name": "anomalous pulmonary venous drainage",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "anthracyclines prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.3.1.0"
}, {
    "name": "anthracyclines, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.2"
}, {
    "name": "Anti-arrhythmic surgery",
    "jumpto": "ENAS5083_5.4.2.0"
}, {
    "name": "Anti-thrombotic therapy (IE)",
    "jumpto": "ENAS5079_12.0.0.0"
}, {
    "name": "anti-Xa activity",
    "jumpto": "ENAS248_11.2.6.0"
}, {
    "name": "antiarrhythmic drugs, pregnancy",
    "jumpto": "ENAS255_10.1.0.0"
}, {
    "name": "Antibiotic prophylaxis in IE, summary",
    "jumpto": "ENAS5079_3.7.0.0"
}, {
    "name": "antibiotic therapy, VHD",
    "jumpto": "ENAS248_11.2.5.0"
}, {
    "name": "Anticoag. after ICH (interactive algorithm)",
    "jumpto": "interactive_0000554"
}, {
    "name": "Anticoag. after stroke or TIA (interactive algorithm)",
    "jumpto": "interactive_0000553"
}, {
    "name": "anticoagulation after ICH (AFib)",
    "jumpto": "ENAS5194_8.9.3.0"
}, {
    "name": "anticoagulation after stroke or TIA (AFib)",
    "jumpto": "ENAS5194_8.9.2.0"
}, {
    "name": "anticoagulation, mechanical prosthesis",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "anticoagulation, mitral stenosis",
    "jumpto": "ENAS248_9.3.0.0"
}, {
    "name": "anticoagulation, native VHD",
    "jumpto": "ENAS248_5.2.0.0"
}, {
    "name": "anticoagulation, pregnancy",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "anticoagulation, VHD surgery",
    "jumpto": "ENAS248_11.2.2.0"
}, {
    "name": "antihypertensive drugs, possible combinations",
    "jumpto": "ENAS260_7.2.2.0"
}, {
    "name": "antiplatelet therapy (CVD prev)",
    "jumpto": "ENAS5196_12.4.0.0"
}, {
    "name": "Antiplatelet therapy in NSTE-ACS, perioperative mgmt.",
    "jumpto": "ENAS5080_5.5.3.0"
}, {
    "name": "antiplatelet therapy, diabetes mellitus [DM]",
    "jumpto": "ENAS257_8.5.0.0"
}, {
    "name": "antiplatelet therapy, myocardial revascularization",
    "jumpto": "ENAS265_20.7.0.0"
}, {
    "name": "antiplatelt agents\/anticoagulants, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.5.0.0"
}, {
    "name": "Antithromb. therapy after ACS (interactive algorithm)",
    "jumpto": "interactive_0000556"
}, {
    "name": "Antithromb. therapy after PCI (interactive algorithm)",
    "jumpto": "interactive_0000557"
}, {
    "name": "antithrombotic drugs, CAD",
    "jumpto": "ENAS256_5.1.3.0"
}, {
    "name": "antithrombotic drugs, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "antithrombotic drugs, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "antithrombotic therapy after ACS (AFib)",
    "jumpto": "ENAS5194_8.11.2.0"
}, {
    "name": "antithrombotic therapy after PCI (AFib)",
    "jumpto": "ENAS5194_8.11.3.0"
}, {
    "name": "antithrombotic treatments for PCI, NSTE-ACS",
    "jumpto": "ENAS265_20.2.0.0"
}, {
    "name": "antithrombotic treatments for PCI, pts. under DAPT",
    "jumpto": "ENAS265_20.5.0.0"
}, {
    "name": "antithrombotic treatments for PCI, pts. with CKD",
    "jumpto": "ENAS265_20.6.0.0"
}, {
    "name": "antithrombotic treatments for PCI, SCAD",
    "jumpto": "ENAS265_20.1.0.0"
}, {
    "name": "antithrombotic treatments for PCI, STEMI",
    "jumpto": "ENAS265_20.3.0.0"
}, {
    "name": "anxiety, STEMI",
    "jumpto": "ENAS250_5.2.0.0"
}, {
    "name": "aorta, 3D-reconstruction",
    "jumpto": "ENAS264_6.3.6.0"
}, {
    "name": "aorta, aging",
    "jumpto": "ENAS264_5.0.0.0"
}, {
    "name": "aorta, calcified",
    "jumpto": "ENAS264_11.4.0.0"
}, {
    "name": "aorta, clinical examination",
    "jumpto": "ENAS264_6.1.0.0"
}, {
    "name": "aorta, coarctation",
    "jumpto": "ENAS264_10.4.0.0"
}, {
    "name": "aorta, comparison of imaging methods",
    "jumpto": "ENAS264_6.3.2.0"
}, {
    "name": "aorta, coral reef",
    "jumpto": "ENAS264_11.5.0.0"
}, {
    "name": "aorta, cross-sectional\/long-axis US of abd. aorta",
    "jumpto": "ENAS264_6.3.5.0"
}, {
    "name": "aorta, Ehlers-Danlos syndrome type IV or vascular type",
    "jumpto": "ENAS264_10.2.3.0"
}, {
    "name": "aorta, genetic diseases",
    "jumpto": "ENAS264_10.1.0.0"
}, {
    "name": "aorta, imaging methods",
    "jumpto": "ENAS264_6.3.1.0"
}, {
    "name": "aorta, laboratory testing",
    "jumpto": "ENAS264_6.2.0.0"
}, {
    "name": "aorta, Loeys-Dietz syndrome",
    "jumpto": "ENAS264_10.2.4.0"
}, {
    "name": "aorta, long-axis and cross-sectional TOE",
    "jumpto": "ENAS264_6.3.4.0"
}, {
    "name": "aorta, Marfan syndrome",
    "jumpto": "ENAS264_10.2.2.0"
}, {
    "name": "aorta, mobile aortic thrombosis",
    "jumpto": "ENAS264_11.2.0.0"
}, {
    "name": "aorta, non-syndromic familia TAAD",
    "jumpto": "ENAS264_10.2.7.0"
}, {
    "name": "aorta, parasternal and suprasternal TTE",
    "jumpto": "ENAS264_6.3.3.0"
}, {
    "name": "aorta, segments",
    "jumpto": "ENAS264_5.0.0.0"
}, {
    "name": "aorta, thromboembolic disease",
    "jumpto": "ENAS264_11.1.0.0"
}, {
    "name": "aorta, Turner syndrome",
    "jumpto": "ENAS264_10.2.1.0"
}, {
    "name": "aortic aneurysms, overview",
    "jumpto": "ENAS264_9.1.0.0"
}, {
    "name": "aortic dilatation",
    "jumpto": "ENAS248_6.4.0.0"
}, {
    "name": "aortic disease, pregnancy",
    "jumpto": "ENAS255_6.2.0.0"
}, {
    "name": "aortic disease, pregnancy: surgery",
    "jumpto": "ENAS255_6.3.0.0"
}, {
    "name": "aortic diseases, arch debranching",
    "jumpto": "ENAS264_7.3.4.0"
}, {
    "name": "aortic diseases, endovascular therapy",
    "jumpto": "ENAS264_7.2.0.0"
}, {
    "name": "aortic diseases, follow-up after thoracic intervention",
    "jumpto": "ENAS264_14.3.0.0"
}, {
    "name": "aortic diseases, left heart bypass",
    "jumpto": "ENAS264_7.3.5.0"
}, {
    "name": "aortic diseases, long-term follow-up",
    "jumpto": "ENAS264_14.1.0.0"
}, {
    "name": "aortic diseases, medical therapy",
    "jumpto": "ENAS264_7.1.0.0"
}, {
    "name": "aortic diseases, overview",
    "jumpto": "ENAS264_4.0.0.0"
}, {
    "name": "aortic diseases, surgery",
    "jumpto": "ENAS264_7.3.1.0"
}, {
    "name": "aortic diseases, with bicuspid aortic valve",
    "jumpto": "ENAS264_10.3.0.0"
}, {
    "name": "aortic dissection, pregnancy",
    "jumpto": "ENAS255_6.1.0.0"
}, {
    "name": "Aortic dissection; Renal dysfunction and associated cardiac disease",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "aortic pseudoaneurysm",
    "jumpto": "ENAS264_8.5.0.0"
}, {
    "name": "aortic root surgery",
    "jumpto": "ENAS264_7.3.2.0"
}, {
    "name": "aortic stenosis, mgmt.",
    "jumpto": "ENAS248_7.4.0.0"
}, {
    "name": "aortic stenosis, moderate",
    "jumpto": "ENAS248_7.1.0.0"
}, {
    "name": "aortic stenosis, pregnancy",
    "jumpto": "ENAS255_7.2.0.0"
}, {
    "name": "aortic stenosis, severe",
    "jumpto": "ENAS248_12.1.0.0"
}, {
    "name": "aortic stenosis, surgery",
    "jumpto": "ENAS248_7.1.0.0"
}, {
    "name": "aortic stiffness",
    "jumpto": "ENAS264_6.4.0.0"
}, {
    "name": "aortic tumours",
    "jumpto": "ENAS264_13.0.0.0"
}, {
    "name": "aortic valve calcification",
    "jumpto": "ENAS248_7.1.0.0"
}, {
    "name": "aortic valve regurgitation",
    "jumpto": "ENAS248_6.2.0.0"
}, {
    "name": "aortic valve replacement",
    "jumpto": "ENAS248_7.1.0.0"
}, {
    "name": "aortitis",
    "jumpto": "ENAS264_12.0.0.0"
}, {
    "name": "aortoiliac lesions",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "aortoiliac occlusive disease",
    "jumpto": "ENAS256_5.5.1.0"
}, {
    "name": "applied diagnostic measurements (HF)",
    "jumpto": "ENAS5195_13.6.0.0"
}, {
    "name": "arrhythmia, cardiac [CVD Preg]",
    "jumpto": "ENAS255_10.1.0.0"
}, {
    "name": "arrhythmia, cardiac [VHD]",
    "jumpto": "ENAS248_5.2.0.0"
}, {
    "name": "arrhythmia, mgmt. in DM",
    "jumpto": "ENAS257_11.1.0.0"
}, {
    "name": "Arrhythmia, not related to peripartum cardiomyopathy",
    "jumpto": "ENAS5083_13.3.1.0"
}, {
    "name": "Arrhythmia, related to peripartum cardiomyopathy",
    "jumpto": "ENAS5083_13.3.2.0"
}, {
    "name": "arrhythmias, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.1"
}, {
    "name": "arrhythmias, overview (HF)",
    "jumpto": "ENAS5195_11.1.0.0"
}, {
    "name": "Arrhythmic risk in pregnancy, management",
    "jumpto": "ENAS5083_13.3.1.0"
}, {
    "name": "Arrhythmic risk, during pregnancy",
    "jumpto": "ENAS5083_13.3.1.0"
}, {
    "name": "Arrhythmic risk, in neuromuscular disorders",
    "jumpto": "ENAS5083_13.2.1.0"
}, {
    "name": "Arrhythmic risk, in psychiatric patients",
    "jumpto": "ENAS5083_13.1.0.0"
}, {
    "name": "Arrhythmogenic RV cardiomyopathy (ARVC)",
    "jumpto": "ENAS5083_8.3.0.0"
}, {
    "name": "Arterial hypertension in non-cardiac surgery",
    "jumpto": "ENAS261_8.2.0.0"
}, {
    "name": "arterial hypertension key points, cardiotoxicity",
    "jumpto": "ENAS5193_3.5.3.0"
}, {
    "name": "arterial hypertension mgmt., cardiotoxicity",
    "jumpto": "ENAS5193_3.5.2.0"
}, {
    "name": "arterial hypertension, cardiotoxicity",
    "jumpto": "ENAS5193_3.5.1.0"
}, {
    "name": "arterial thrombosis, cardiotoxicity",
    "jumpto": "ENAS5193_3.6.1.2"
}, {
    "name": "Arterial tortuosity syndrome",
    "jumpto": "ENAS264_10.2.5.0"
}, {
    "name": "ARVC, prevention of SCD",
    "jumpto": "ENAS5083_8.3.0.0"
}, {
    "name": "ascending aortic and aortic arch surgery",
    "jumpto": "ENAS264_7.3.3.0"
}, {
    "name": "Ascites (PH)",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "Aspergillus spp (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "Aspirin (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "Aspirin after ACS (AFib)",
    "jumpto": "ENAS5194_8.11.2.0"
}, {
    "name": "Aspirin after PCI (AFib)",
    "jumpto": "ENAS5194_8.11.3.0"
}, {
    "name": "Aspirin, acute pericarditis",
    "jumpto": "ENAS5082_3.2.5.0"
}, {
    "name": "Aspirin, anti-inflammatory therapy (Pericard.)",
    "jumpto": "ENAS5082_3.2.6.0"
}, {
    "name": "aspirin, dosage in STEMI",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "aspirin, fibrinolysis",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "Aspirin, in paediatric pericardial diseases",
    "jumpto": "ENAS5082_6.1.2.0"
}, {
    "name": "Aspirin, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.2.0"
}, {
    "name": "aspirin, pre-eclampsia",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "aspirin, use in CKD",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "aspirin, valve replacement",
    "jumpto": "ENAS248_11.2.2.0"
}, {
    "name": "associated carotid\/PAD in revascularization",
    "jumpto": "ENAS265_15.0.0.0"
}, {
    "name": "atherosclerotic aortic occlusion",
    "jumpto": "ENAS264_11.3.0.0"
}, {
    "name": "atherosclerotic lesions, brachiocephalic trunk",
    "jumpto": "ENAS256_5.3.0.0"
}, {
    "name": "atherosclerotic lesions, subclavian artery",
    "jumpto": "ENAS256_5.3.0.0"
}, {
    "name": "Atherosclerotic plaque rupture, type 1 M",
    "jumpto": "ENAS5080_2.0.0.0"
}, {
    "name": "atherosclerotic risk, VHD",
    "jumpto": "ENAS248_7.5.0.0"
}, {
    "name": "Atrial arrhythmias in CHD (GUCH) (Afib)",
    "jumpto": "ENAS5194_11.6.0.0"
}, {
    "name": "atrial dilatation",
    "jumpto": "ENAS248_8.1.1.0"
}, {
    "name": "atrial fibrillation (CVD prev)",
    "jumpto": "ENAS5196_13.1.0.0"
}, {
    "name": "atrial fibrillation heart team",
    "jumpto": "ENAS5194_10.8.0.0"
}, {
    "name": "Atrial fibrillation, antithrombotic strategies",
    "jumpto": "ENAS5080_5.4.2.0"
}, {
    "name": "atrial fibrillation, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.2.2"
}, {
    "name": "atrial fibrillation, mgmt. in DM",
    "jumpto": "ENAS257_11.2.0.0"
}, {
    "name": "atrial fibrillation, mgmt. in STEMI",
    "jumpto": "ENAS250_7.1.2.0"
}, {
    "name": "atrial fibrillation, primary MR",
    "jumpto": "ENAS248_8.1.1.0"
}, {
    "name": "atrial flutter, management",
    "jumpto": "ENAS5194_11.7.0.0"
}, {
    "name": "atrial high rate episode, mgmt. (AFib)",
    "jumpto": "ENAS5194_4.2.0.0"
}, {
    "name": "atrial septal defect, pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "atrial septal defect, risk assessment",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "atrioventricular block, indication for pacing [Pacing]",
    "jumpto": "ENAS259_4.3.1.0"
}, {
    "name": "atrioventricular block, pregnancy",
    "jumpto": "ENAS255_10.5.0.0"
}, {
    "name": "atrioventricular junction ablation, indications",
    "jumpto": "ENAS259_5.3.2.0"
}, {
    "name": "atypical angina, definition [SCAD]",
    "jumpto": "ENAS258_7.2.0.0"
}, {
    "name": "autoimmune disease (CVD prev)",
    "jumpto": "ENAS5196_9.10.3.0"
}, {
    "name": "autonomic dysfunction, cardiotoxicity",
    "jumpto": "ENAS5193_3.9.3.0"
}, {
    "name": "AV block, pacing mode",
    "jumpto": "ENAS259_4.2.3.0"
}, {
    "name": "Azathioprine, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.4.0"
}, {
    "name": "balloon angioplasty, STEMI",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "Balloon pulmonary angioplasty (BPA)",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "balloon valvulotomy [CVD Preg]",
    "jumpto": "ENAS255_5.4.0.0"
}, {
    "name": "balloon valvulotomy [VHD]",
    "jumpto": "ENAS248_7.2.0.0"
}, {
    "name": "Bartonella henselea (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "Bartonella Quintana (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "baseline nyquist limit",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "Basic lab (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "BCR-ABL kinase, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.6"
}, {
    "name": "behaviour change (CVD prev)",
    "jumpto": "ENAS5196_11.1.0.0"
}, {
    "name": "Behcet syndrome",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "benefit, CVD prevention",
    "jumpto": "ENAS5196_9.1.0.0"
}, {
    "name": "Beraprost, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Beraprost, Prostanoids",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "beta-blocker (HF)",
    "jumpto": "ENAS5195_7.0.0.0"
}, {
    "name": "Beta-blockers (PH)",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "beta-blockers, aortic regurg.",
    "jumpto": "ENAS248_6.3.0.0"
}, {
    "name": "beta-blockers, pregnancy",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "beta-blockers, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.1.0.0"
}, {
    "name": "bicommissural calcification",
    "jumpto": "ENAS248_9.1.0.0"
}, {
    "name": "bicuspid aortic valve, pregnancy",
    "jumpto": "ENAS255_6.2.0.0"
}, {
    "name": "bicuspid aortic valve, regurg.",
    "jumpto": "ENAS248_6.4.0.0"
}, {
    "name": "bile acid sequestrants, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.2.0.0"
}, {
    "name": "biomarkers (CVD prev)",
    "jumpto": "ENAS5196_9.8.0.0"
}, {
    "name": "biomarkers, MI",
    "jumpto": "ENAS247_4.1.0.0"
}, {
    "name": "biomarkers, MI definition",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "bioprosthetic valve [CVD Preg]",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "bioprosthetic valve [VHD]",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "Bisoprolo (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "Bivalirudin (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "bivalirudin, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Bivalirudin, dosing (NSTE-ACS)",
    "jumpto": "ENAS5080_5.3.1.0"
}, {
    "name": "bivalirudin, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "bivalirudin, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "Bleeding risk factors in anticoag. pts. (AFib)",
    "jumpto": "ENAS5194_8.4.0.0"
}, {
    "name": "Blood culture, positive for IE",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "Blood cultures in IE",
    "jumpto": "ENAS5079_5.3.1.0"
}, {
    "name": "Blood gas analysis (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "blood pressure (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "blue toe syndrome",
    "jumpto": "ENAS256_5.6.3.0"
}, {
    "name": "body weight (CVD prev)",
    "jumpto": "ENAS5196_11.5.0.0"
}, {
    "name": "body weight (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "Borg dyspnoea score (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "Bosentan + i.v.epoprostenol, PAH combination therapy",
    "jumpto": "ENAS5081_6.2.3.3"
}, {
    "name": "Bosentan + sildenafil + i.v. epoprostenol, PAH combination therapy",
    "jumpto": "ENAS5081_6.2.3.3"
}, {
    "name": "Bosentan added to epoprostenol, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Bosentan added to sildenafil, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Bosentan, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "brachiocephalic trunk",
    "jumpto": "ENAS256_5.3.0.0"
}, {
    "name": "bradyarrhythmia, classification [Pacing]",
    "jumpto": "ENAS259_4.1.2.0"
}, {
    "name": "bradyarrhythmia, clinical presentation [Pacing]",
    "jumpto": "ENAS259_4.1.2.0"
}, {
    "name": "bradyarrhythmia, diagnosis [Pacing]",
    "jumpto": "ENAS259_4.1.3.0"
}, {
    "name": "bradyarrhythmia, ECG monitoring [Pacing]",
    "jumpto": "ENAS259_4.1.3.0"
}, {
    "name": "bradyarrhythmia, epidemiology [Pacing]",
    "jumpto": "ENAS259_4.1.1.0"
}, {
    "name": "Bradyarrhythmia, in sleep apnea",
    "jumpto": "ENAS5083_13.4.0.0"
}, {
    "name": "bradyarrhythmia, symptoms",
    "jumpto": "ENAS259_4.1.3.0"
}, {
    "name": "bradyarrhythmic syncope, diagnosis",
    "jumpto": "ENAS259_4.1.3.0"
}, {
    "name": "bradycardia and atrioventricular block, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.2.3"
}, {
    "name": "bradycardia, intermittent (documented)",
    "jumpto": "ENAS259_4.3.1.0"
}, {
    "name": "bradycardia, management (HF)",
    "jumpto": "ENAS5195_11.6.0.0"
}, {
    "name": "bradycardia, persistent",
    "jumpto": "ENAS259_4.2.1.0"
}, {
    "name": "bradycardia, symptoms",
    "jumpto": "ENAS259_4.1.3.0"
}, {
    "name": "breastfeeding",
    "jumpto": "ENAS255_11.6.0.0"
}, {
    "name": "breathlessness, STEMI",
    "jumpto": "ENAS250_5.2.0.0"
}, {
    "name": "Brucella spp (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "Brugada syndrome, diagnosis",
    "jumpto": "ENAS5083_9.4.1.0"
}, {
    "name": "Brugada syndrome, risk stratification and management",
    "jumpto": "ENAS5083_9.4.2.0"
}, {
    "name": "bundle branch block, clinical perspectives",
    "jumpto": "ENAS259_4.4.1.0"
}, {
    "name": "bundle branch block, indications for cardiac pacing",
    "jumpto": "ENAS259_4.4.1.0"
}, {
    "name": "bundle branch block, therapeutic algorithm",
    "jumpto": "ENAS259_4.4.1.0"
}, {
    "name": "Bundle branch re-entrant tachycardia",
    "jumpto": "ENAS5083_7.4.3.0"
}, {
    "name": "Bundle-branch re-entrant tachycardia (VA and SCD)",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "bypass graft, autologous",
    "jumpto": "ENAS256_5.6.7.0"
}, {
    "name": "bypass graft, coronary artery [PAD]",
    "jumpto": "ENAS256_5.7.3.0"
}, {
    "name": "bypass graft, coronary artery [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "bypass graft, coronary artery [VHD]",
    "jumpto": "ENAS248_5.1.7.0"
}, {
    "name": "bypass graft, tabulation in clinical trials",
    "jumpto": "ENAS247_11.0.0.0"
}, {
    "name": "CABG (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "cachexia and sarcopenia (HF)",
    "jumpto": "ENAS5195_12.3.0.0"
}, {
    "name": "calcified aorta",
    "jumpto": "ENAS264_11.4.0.0"
}, {
    "name": "calcium channel blockers, mitral stenosis",
    "jumpto": "ENAS248_9.3.0.0"
}, {
    "name": "cancer (HF)",
    "jumpto": "ENAS5195_12.4.0.0"
}, {
    "name": "cancer patients, long-term surveillance",
    "jumpto": "ENAS5193_5.1.0.0"
}, {
    "name": "cancer treated patients (CVD prev)",
    "jumpto": "ENAS5196_9.10.2.0"
}, {
    "name": "cancer treatment, heart failure",
    "jumpto": "ENAS5193_3.1.1.1"
}, {
    "name": "cancer treatment, LV dysfunction",
    "jumpto": "ENAS5193_3.1.1.1"
}, {
    "name": "cancer, pulmonary embolism",
    "jumpto": "ENAS262_10.2.0.0"
}, {
    "name": "cancer, thromboembolic events, prevention",
    "jumpto": "ENAS5193_4.2.0.0"
}, {
    "name": "Cangrelor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "Cangrelor, P2Y12 inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.1.0"
}, {
    "name": "captopril renal scintigraphy",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "cardiac arrest",
    "jumpto": "ENAS250_5.3.0.0"
}, {
    "name": "cardiac death [STEMI]",
    "jumpto": "ENAS250_4.1.0.0"
}, {
    "name": "cardiac death [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "cardiac imaging, overview (HF)",
    "jumpto": "ENAS5195_6.1.0.0"
}, {
    "name": "cardiac imaging, suspected or established heart failure",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "Cardiac magnetic resonance (PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "cardiac magnetic resonance, CMR (HF)",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "cardiac resynchronization therapy (CRT)",
    "jumpto": "ENAS259_5.1.0.0"
}, {
    "name": "cardiac resynchronization therapy (HF)",
    "jumpto": "ENAS5195_9.2.0.0"
}, {
    "name": "cardiac resynchronization therapy, implantation rate of devices",
    "jumpto": "ENAS259_5.1.0.0"
}, {
    "name": "cardiac risk stratification, PAD",
    "jumpto": "ENAS256_5.7.6.0"
}, {
    "name": "cardiac surgery, pacing [Pacing]",
    "jumpto": "ENAS259_6.2.0.0"
}, {
    "name": "Cardiac tamponade (Pericard.)",
    "jumpto": "ENAS5082_3.6.2.0"
}, {
    "name": "Cardiac tamponade, causes",
    "jumpto": "ENAS5082_3.7.2.0"
}, {
    "name": "Cardiac tamponade, definition",
    "jumpto": "ENAS5082_3.7.1.0"
}, {
    "name": "Cardiac tamponade, treatment",
    "jumpto": "ENAS5082_3.7.3.0"
}, {
    "name": "cardiac transplantation, pregnancy",
    "jumpto": "ENAS255_9.2.0.0"
}, {
    "name": "cardiogenic shock (STEMI)",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "cardiogenic shock, management (HF)",
    "jumpto": "ENAS5195_13.8.4.0"
}, {
    "name": "Cardiomyocyte injury, biomarker",
    "jumpto": "ENAS5080_3.1.0.0"
}, {
    "name": "Cardiomyopathy, Chagas\u2019",
    "jumpto": "ENAS5083_8.4.3.0"
}, {
    "name": "cardiomyopathy, dilated (CVD Preg)",
    "jumpto": "ENAS255_9.3.0.0"
}, {
    "name": "Cardiomyopathy, dilated (VA and SCD)",
    "jumpto": "ENAS5083_8.1.1.0"
}, {
    "name": "cardiomyopathy, hypertrophic [CVD Preg]",
    "jumpto": "ENAS255_9.4.0.0"
}, {
    "name": "cardiomyopathy, hypertrophic, pacing therapy [Pacing]",
    "jumpto": "ENAS259_6.4.0.0"
}, {
    "name": "cardiomyopathy, idiopathic",
    "jumpto": "ENAS248_8.2.1.0"
}, {
    "name": "Cardiomyopathy, infiltrative (VA and SCD)",
    "jumpto": "ENAS5083_8.4.1.0"
}, {
    "name": "cardiomyopathy, peripartum",
    "jumpto": "ENAS255_9.2.0.0"
}, {
    "name": "Cardiomyopathy, restrictive (VA and SCD)",
    "jumpto": "ENAS5083_8.4.2.0"
}, {
    "name": "cardiomyopathy, tachycardia-induced",
    "jumpto": "ENAS255_10.2.0.0"
}, {
    "name": "cardioprotective interventions, non-pharmacological",
    "jumpto": "ENAS5193_4.1.6.0"
}, {
    "name": "cardiopulmonary exercise testing (HF)",
    "jumpto": "ENAS5195_6.3.0.0"
}, {
    "name": "Cardiopulmonary exercise testing (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "Cardiopulmonary exercise testing (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "cardiotixicity, future perspective",
    "jumpto": "ENAS5193_6.0.0.0"
}, {
    "name": "cardiotoxic cytotoxics (HF)",
    "jumpto": "ENAS5195_12.4.0.0"
}, {
    "name": "cardiotoxicity, anthracyclines",
    "jumpto": "ENAS5193_3.1.1.2"
}, {
    "name": "cardiotoxicity, anthracyclines prevention",
    "jumpto": "ENAS5193_4.3.1.0"
}, {
    "name": "cardiotoxicity, arrhythmias",
    "jumpto": "ENAS5193_3.4.1.1"
}, {
    "name": "cardiotoxicity, arterial hypertension",
    "jumpto": "ENAS5193_3.5.1.0"
}, {
    "name": "cardiotoxicity, arterial hypertension key points",
    "jumpto": "ENAS5193_3.5.3.0"
}, {
    "name": "cardiotoxicity, arterial hypertension mgmt.",
    "jumpto": "ENAS5193_3.5.2.0"
}, {
    "name": "cardiotoxicity, arterial thrombosis",
    "jumpto": "ENAS5193_3.6.1.2"
}, {
    "name": "cardiotoxicity, atrial fibrillation",
    "jumpto": "ENAS5193_3.4.2.2"
}, {
    "name": "cardiotoxicity, autonomic dysfunction",
    "jumpto": "ENAS5193_3.9.3.0"
}, {
    "name": "cardiotoxicity, BCR-ABL kinase",
    "jumpto": "ENAS5193_3.1.1.6"
}, {
    "name": "cardiotoxicity, bradycardia and atrioventricular block",
    "jumpto": "ENAS5193_3.4.2.3"
}, {
    "name": "cardiotoxicity, chemotherapies",
    "jumpto": "ENAS5193_3.1.1.3"
}, {
    "name": "cardiotoxicity, conduction defects",
    "jumpto": "ENAS5193_3.4.1.5"
}, {
    "name": "cardiotoxicity, CV management anthracyclines",
    "jumpto": "ENAS5193_3.1.2.2"
}, {
    "name": "cardiotoxicity, CV management anti-HER2",
    "jumpto": "ENAS5193_3.1.2.3"
}, {
    "name": "cardiotoxicity, CV management VEGF inhibitors",
    "jumpto": "ENAS5193_3.1.2.4"
}, {
    "name": "cardiotoxicity, CV mgmt. anthracyclines",
    "jumpto": "ENAS5193_3.1.2.2"
}, {
    "name": "cardiotoxicity, CV mgmt. anti-HER2",
    "jumpto": "ENAS5193_3.1.2.3"
}, {
    "name": "cardiotoxicity, CV mgmt. VEGF inhibitors",
    "jumpto": "ENAS5193_3.1.2.4"
}, {
    "name": "cardiotoxicity, CVD",
    "jumpto": "ENAS5193_3.2.1.1"
}, {
    "name": "cardiotoxicity, diagnostic tools",
    "jumpto": "ENAS5193_3.1.2.6"
}, {
    "name": "cardiotoxicity, early detection strategies",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "cardiotoxicity, elderly patients",
    "jumpto": "ENAS5193_3.10.2.0"
}, {
    "name": "cardiotoxicity, fluoropyrimidines",
    "jumpto": "ENAS5193_3.2.1.2"
}, {
    "name": "cardiotoxicity, global longitudinal strain reduction",
    "jumpto": "ENAS5193_4.1.4.0"
}, {
    "name": "cardiotoxicity, heart failure",
    "jumpto": "ENAS5193_4.1.5.0"
}, {
    "name": "cardiotoxicity, HER-2 targeted therapy prevention",
    "jumpto": "ENAS5193_4.3.2.0"
}, {
    "name": "cardiotoxicity, immunotherapies",
    "jumpto": "ENAS5193_3.1.1.4"
}, {
    "name": "cardiotoxicity, key points",
    "jumpto": "ENAS5193_3.1.3.0"
}, {
    "name": "cardiotoxicity, LVEF reduction",
    "jumpto": "ENAS5193_4.1.3.0"
}, {
    "name": "cardiotoxicity, mgmt. of patients treated with anthracyclines",
    "jumpto": "ENAS5193_3.1.2.2"
}, {
    "name": "cardiotoxicity, mgmt. of patients treated with anti-HER2",
    "jumpto": "ENAS5193_3.1.2.3"
}, {
    "name": "cardiotoxicity, mgmt. of patients treated with VEGF inhibitors",
    "jumpto": "ENAS5193_3.1.2.4"
}, {
    "name": "cardiotoxicity, paediatric population",
    "jumpto": "ENAS5193_3.10.1.0"
}, {
    "name": "cardiotoxicity, peripheral vascular disease",
    "jumpto": "ENAS5193_3.7.1.1"
}, {
    "name": "cardiotoxicity, peripheral vascular disease mgmt.",
    "jumpto": "ENAS5193_3.7.2.0"
}, {
    "name": "cardiotoxicity, pleural effusion",
    "jumpto": "ENAS5193_3.9.2.0"
}, {
    "name": "cardiotoxicity, pregnant women",
    "jumpto": "ENAS5193_3.10.3.0"
}, {
    "name": "cardiotoxicity, prevention",
    "jumpto": "ENAS5193_4.1.1.0"
}, {
    "name": "cardiotoxicity, proteasome inhibitors",
    "jumpto": "ENAS5193_3.1.1.7"
}, {
    "name": "cardiotoxicity, pulmonary hypertension",
    "jumpto": "ENAS5193_3.8.1.0"
}, {
    "name": "cardiotoxicity, pulmonary hypertension mgmt.",
    "jumpto": "ENAS5193_3.8.2.0"
}, {
    "name": "cardiotoxicity, pyrimidine analogues prevention",
    "jumpto": "ENAS5193_4.3.3.0"
}, {
    "name": "cardiotoxicity, QT prolongation",
    "jumpto": "ENAS5193_3.4.1.2"
}, {
    "name": "cardiotoxicity, QT prolongation, risk factors",
    "jumpto": "ENAS5193_3.4.2.1"
}, {
    "name": "cardiotoxicity, radiotherapy",
    "jumpto": "ENAS5193_3.1.1.8"
}, {
    "name": "cardiotoxicity, radiotherapy prevention",
    "jumpto": "ENAS5193_4.3.5.0"
}, {
    "name": "cardiotoxicity, radiotherapy, key points",
    "jumpto": "ENAS5193_3.2.3.0"
}, {
    "name": "cardiotoxicity, radiotherapy, mgmt.",
    "jumpto": "ENAS5193_3.2.2.0"
}, {
    "name": "cardiotoxicity, risk factors",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "cardiotoxicity, risk stratification",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "cardiotoxicity, screening",
    "jumpto": "ENAS5193_3.1.2.5"
}, {
    "name": "cardiotoxicity, screening",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "cardiotoxicity, sinus node dysfunction",
    "jumpto": "ENAS5193_3.4.1.5"
}, {
    "name": "cardiotoxicity, stroke",
    "jumpto": "ENAS5193_3.7.1.2"
}, {
    "name": "cardiotoxicity, stroke mgmt.",
    "jumpto": "ENAS5193_3.7.2.0"
}, {
    "name": "cardiotoxicity, supraventricular arrhythmia",
    "jumpto": "ENAS5193_3.4.1.3"
}, {
    "name": "cardiotoxicity, targeted therapies",
    "jumpto": "ENAS5193_3.1.1.4"
}, {
    "name": "cardiotoxicity, thrombembolic disease",
    "jumpto": "ENAS5193_3.6.1.1"
}, {
    "name": "cardiotoxicity, thrombembolic disease mgmt.",
    "jumpto": "ENAS5193_3.6.2.0"
}, {
    "name": "cardiotoxicity, treatment options",
    "jumpto": "ENAS5193_4.1.1.0"
}, {
    "name": "cardiotoxicity, troponin elevation",
    "jumpto": "ENAS5193_4.1.2.0"
}, {
    "name": "cardiotoxicity, valvular disease",
    "jumpto": "ENAS5193_3.3.1.0"
}, {
    "name": "cardiotoxicity, VEGF inhibitors",
    "jumpto": "ENAS5193_3.1.1.5"
}, {
    "name": "cardiotoxicity, VEGF inhibitors prevention",
    "jumpto": "ENAS5193_4.3.4.0"
}, {
    "name": "cardiotoxicity, venous thrombosis",
    "jumpto": "ENAS5193_3.6.1.3"
}, {
    "name": "cardiotoxicity, ventricular arrhythmias",
    "jumpto": "ENAS5193_3.4.1.4"
}, {
    "name": "cardiotoxicity, VHD mgmt.",
    "jumpto": "ENAS5193_3.3.2.0"
}, {
    "name": "cardiovascular continuum [DM]",
    "jumpto": "ENAS257_6.0.0.0"
}, {
    "name": "cardiovascular disease in diabetes mellitus",
    "jumpto": "ENAS257_4.1.0.0"
}, {
    "name": "cardiovascular disease, asymptomatic [HTN]",
    "jumpto": "ENAS260_5.8.0.0"
}, {
    "name": "cardiovascular risk assessment [HTN]",
    "jumpto": "ENAS260_4.4.1.0"
}, {
    "name": "cardioversion, STEMI",
    "jumpto": "ENAS250_7.1.2.0"
}, {
    "name": "Cardioverter defibrillator, public access",
    "jumpto": "ENAS5083_5.2.4.0"
}, {
    "name": "Cardioverter defibrillator, subcutaneous",
    "jumpto": "ENAS5083_5.2.2.0"
}, {
    "name": "Cardioverter defibrillator, wearable",
    "jumpto": "ENAS5083_5.2.3.0"
}, {
    "name": "carotid artery disease [DM]",
    "jumpto": "ENAS257_12.3.0.0"
}, {
    "name": "carotid artery disease [PAD]",
    "jumpto": "ENAS256_5.1.1.0"
}, {
    "name": "carotid artery disease, extra cranial",
    "jumpto": "ENAS257_12.3.0.0"
}, {
    "name": "carotid artery disease, mgmt.",
    "jumpto": "ENAS256_5.1.4.0"
}, {
    "name": "carotid artery disease, symptomatic",
    "jumpto": "ENAS256_5.1.5.0"
}, {
    "name": "carotid artery disease, treatment",
    "jumpto": "ENAS256_5.1.3.0"
}, {
    "name": "carotid artery stenosis, multisite",
    "jumpto": "ENAS256_5.7.2.0"
}, {
    "name": "carotid artery stenosis, not scheduled for CABG",
    "jumpto": "ENAS256_5.7.2.0"
}, {
    "name": "carotid artery stenosis, revascularization",
    "jumpto": "ENAS256_5.7.3.0"
}, {
    "name": "carotid artery stenosis, scheduled for CABG",
    "jumpto": "ENAS256_5.7.3.0"
}, {
    "name": "carotid endarterectomy",
    "jumpto": "ENAS256_5.1.5.0"
}, {
    "name": "carotid plaques",
    "jumpto": "ENAS256_5.1.2.0"
}, {
    "name": "Carvedilol (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "catheter ablation (HF)",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "Catheter ablation, complications (AFib)",
    "jumpto": "ENAS5194_10.4.0.0"
}, {
    "name": "CCB in DPAH",
    "jumpto": "ENAS5081_6.2.3.1"
}, {
    "name": "CCB in HPAH",
    "jumpto": "ENAS5081_6.2.3.1"
}, {
    "name": "CCB therapy in PAH",
    "jumpto": "ENAS5081_6.2.3.1"
}, {
    "name": "CCB therapy in PAH, contraindication",
    "jumpto": "ENAS5081_6.2.3.1"
}, {
    "name": "CCBs in IPAH",
    "jumpto": "ENAS5081_6.2.3.1"
}, {
    "name": "CCBs, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.4.0.0"
}, {
    "name": "CDRIE, diagnosis",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "CDRIE, mode of device removal",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "CDRIE, principles of treatment",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "CDRIE, prophylaxis",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "CDRIE, reimplantation",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "central nervous system (HF)",
    "jumpto": "ENAS5195_12.5.0.0"
}, {
    "name": "cerebrovascular disease (CVD prev)",
    "jumpto": "ENAS5196_13.4.0.0"
}, {
    "name": "cerebrovascular disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.6.0.0"
}, {
    "name": "CHA2DS2-VASc score (AFib)",
    "jumpto": "ENAS5194_8.2.0.0"
}, {
    "name": "CHA2DS2-VASc score (interactive score)",
    "jumpto": "interactive_0000566"
}, {
    "name": "CHAMP (HF)",
    "jumpto": "ENAS5195_13.5.0.0"
}, {
    "name": "charateristics and components, multidisciplinary team management",
    "jumpto": "ENAS5195_15.1.1.0"
}, {
    "name": "chemotherapies, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.3"
}, {
    "name": "chest pain, pre-test clinical probabilities",
    "jumpto": "ENAS258_7.3.4.0"
}, {
    "name": "chest radiograph [CVD Preg]",
    "jumpto": "ENAS255_4.5.0.0"
}, {
    "name": "chest X-ray [SCAD]",
    "jumpto": "ENAS258_7.3.2.0"
}, {
    "name": "children, dyslipidaemias",
    "jumpto": "ENAS5197_11.2.0.0"
}, {
    "name": "cholesterol absorption inhibitors, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.3.0.0"
}, {
    "name": "chronic aortic dissection",
    "jumpto": "ENAS264_14.2.0.0"
}, {
    "name": "chronic heart failure (CVD prev)",
    "jumpto": "ENAS5196_13.3.0.0"
}, {
    "name": "Chronic heart failure in non-cardiac surgery",
    "jumpto": "ENAS261_8.1.0.0"
}, {
    "name": "chronic kidney disease, asymptomatic [HTN]",
    "jumpto": "ENAS260_5.8.0.0"
}, {
    "name": "chronic kidney disease, dyslipidaemias",
    "jumpto": "ENAS5197_11.8.0.0"
}, {
    "name": "Chronic pericarditis, definition",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Chronic thromboembolic pulmonary hypertension (CTEPH)",
    "jumpto": "ENAS5081_10.1.0.0"
}, {
    "name": "chronic thromboembolic pulmonary hypertension, diagnosis",
    "jumpto": "ENAS262_9.1.0.0"
}, {
    "name": "chronic thromboembolic pulmonary hypertension, treatment",
    "jumpto": "ENAS262_9.2.0.0"
}, {
    "name": "Churg-Strauss syndrome (Pericard.)",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Chylopericardium",
    "jumpto": "ENAS5082_5.8.2.0"
}, {
    "name": "Chylopericardium, diagnosis",
    "jumpto": "ENAS5082_5.8.2.0"
}, {
    "name": "Chylothorax",
    "jumpto": "ENAS5082_5.8.2.0"
}, {
    "name": "cinefluoroscopy, baseline assessment VHD",
    "jumpto": "ENAS248_11.2.1.0"
}, {
    "name": "cinefluoroscopy, prosthetic thrombosis",
    "jumpto": "ENAS248_11.2.9.0"
}, {
    "name": "circulating and urinary biomarkers (CVD prev)",
    "jumpto": "ENAS5196_9.8.0.0"
}, {
    "name": "CKD, antithrombotic agents",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "CKMB [UDMI]",
    "jumpto": "ENAS247_4.1.0.0"
}, {
    "name": "classes of recommendation (CVD prev)",
    "jumpto": "ENAS5196_2.0.0.0"
}, {
    "name": "Classes of recommendations (PH)",
    "jumpto": "ENAS5081_2.0.0.0"
}, {
    "name": "Classes of recommendations (VA and SCD)",
    "jumpto": "ENAS5083_2.0.0.0"
}, {
    "name": "classification (HF)",
    "jumpto": "ENAS5195_4.0.0.0"
}, {
    "name": "classification, AF",
    "jumpto": "ENAS5194_5.1.0.0"
}, {
    "name": "claudication, intermittent",
    "jumpto": "ENAS256_5.6.3.0"
}, {
    "name": "claudication, intermittent: mgmt.",
    "jumpto": "ENAS256_5.6.8.0"
}, {
    "name": "Clindamycin, dental procedure prophylaxis",
    "jumpto": "ENAS5079_3.2.0.0"
}, {
    "name": "clinical monitoring, AHF",
    "jumpto": "ENAS5195_13.8.6.0"
}, {
    "name": "clinical monitoring, hospitalized patients (HF)",
    "jumpto": "ENAS5195_13.8.6.0"
}, {
    "name": "Clinical predictors, major (Pericard.)",
    "jumpto": "ENAS5082_4.2.2.0"
}, {
    "name": "Clinical predictors, minor (Pericard.)",
    "jumpto": "ENAS5082_4.2.2.0"
}, {
    "name": "clinical profiles, acute HF patients",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "Clinical signs of right heart failure (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "Clopidogrel (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "clopidogrel, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "clopidogrel, fibrinolysis",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "Clopidogrel, P2Y12 inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.1.0"
}, {
    "name": "clopidogrel, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "co-morbidities, overview (HF)",
    "jumpto": "ENAS5195_12.1.0.0"
}, {
    "name": "coaptation defect",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "coarctation of aorta",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "coarctation of the aorta",
    "jumpto": "ENAS264_10.4.0.0"
}, {
    "name": "Colchicine, anti-inflammatory therapy (Pericard.)",
    "jumpto": "ENAS5082_3.2.6.0"
}, {
    "name": "Colchicine, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.2.0"
}, {
    "name": "combination therapy with OAC and antiplatelets (AFib)",
    "jumpto": "ENAS5194_8.11.4.0"
}, {
    "name": "Combined post-capillary PH",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "Combined pulmonary fibrosis and emphysema (CPEE)",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Complicated infective endocarditis",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "computed tomography angiography , PAD",
    "jumpto": "ENAS256_4.5.0.0"
}, {
    "name": "computed tomography angiography [SCAD]",
    "jumpto": "ENAS258_7.3.8.0"
}, {
    "name": "computed tomography angiography, CAD",
    "jumpto": "ENAS256_5.1.2.0"
}, {
    "name": "computed tomography angiography, RAS",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "computed tomography angiography, STEMI",
    "jumpto": "ENAS250_6.2.0.0"
}, {
    "name": "computed tomography, multi-sliced (VHD)",
    "jumpto": "ENAS248_5.1.6.0"
}, {
    "name": "conductance disturbance, overview (HF)",
    "jumpto": "ENAS5195_11.1.0.0"
}, {
    "name": "conduction defects, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.5"
}, {
    "name": "congenital heart disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.9.0.0"
}, {
    "name": "congenital heart disease, indications for pacing",
    "jumpto": "ENAS259_6.3.1.0"
}, {
    "name": "Constrictive pericardial syndromes",
    "jumpto": "ENAS5082_3.8.5.0"
}, {
    "name": "Constrictive pericarditis, chronic constriction",
    "jumpto": "ENAS5082_3.8.5.0"
}, {
    "name": "Constrictive pericarditis, diagnosis",
    "jumpto": "ENAS5082_3.8.3.0"
}, {
    "name": "Constrictive pericarditis, differential diagnoses",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "Constrictive pericarditis, effusive",
    "jumpto": "ENAS5082_3.8.5.0"
}, {
    "name": "Constrictive pericarditis, overview",
    "jumpto": "ENAS5082_3.8.1.0"
}, {
    "name": "Constrictive pericarditis, therapy",
    "jumpto": "ENAS5082_3.8.6.0"
}, {
    "name": "Constrictive pericarditis, therapy overview",
    "jumpto": "ENAS5082_3.8.4.0"
}, {
    "name": "Constrictive pericarditis, transient constriction",
    "jumpto": "ENAS5082_3.8.5.0"
}, {
    "name": "Constrictive pericarditis, tuberculor",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "Constrictive tuberculous pericarditis, management",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "Continuous rhythm monitoring (NSTE-ACS)",
    "jumpto": "ENAS5080_4.3.3.0"
}, {
    "name": "contraception, cardiovascular disease",
    "jumpto": "ENAS255_4.10.0.0"
}, {
    "name": "contraception, coronary artery disease",
    "jumpto": "ENAS255_4.10.0.0"
}, {
    "name": "Cool extremities (PH)",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "coral reef aorta",
    "jumpto": "ENAS264_11.5.0.0"
}, {
    "name": "coronary angiography, invasive [SCAD]",
    "jumpto": "ENAS258_7.4.0.0"
}, {
    "name": "Coronary angiography, VA screening",
    "jumpto": "ENAS5083_4.3.2.0"
}, {
    "name": "coronary artery disease, commonly used tests [SCAD]",
    "jumpto": "ENAS258_7.3.4.0"
}, {
    "name": "coronary artery disease, LEAD",
    "jumpto": "ENAS256_5.7.5.0"
}, {
    "name": "coronary artery disease, mgmt. [DM]",
    "jumpto": "ENAS257_9.1.0.0"
}, {
    "name": "coronary artery disease, PAD",
    "jumpto": "ENAS256_5.7.6.0"
}, {
    "name": "coronary artery disease, RAS",
    "jumpto": "ENAS256_5.7.4.0"
}, {
    "name": "coronary artery disease, STEMI",
    "jumpto": "ENAS250_4.2.0.0"
}, {
    "name": "coronary artery disease, VHD",
    "jumpto": "ENAS248_5.2.0.0"
}, {
    "name": "Coronary care unit (NSTE-ACS)",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "coronary care unit, logistics",
    "jumpto": "ENAS250_6.1.0.0"
}, {
    "name": "coronary disease (CVD prev)",
    "jumpto": "ENAS5196_13.2.0.0"
}, {
    "name": "coronary embolism, MI Type 2",
    "jumpto": "ENAS247_5.2.0.0"
}, {
    "name": "coronary endothelial dysfunction",
    "jumpto": "ENAS247_5.2.0.0"
}, {
    "name": "coronary microvascular disease [SCAD]",
    "jumpto": "ENAS258_7.8.1.0"
}, {
    "name": "coronary ostium obstruction",
    "jumpto": "ENAS248_7.3.0.0"
}, {
    "name": "coronary revascularization [DM]",
    "jumpto": "ENAS257_9.2.0.0"
}, {
    "name": "Coronary stenting, anticoagulation (NSTE-ACS)",
    "jumpto": "ENAS5080_5.4.4.0"
}, {
    "name": "Coronary stenting, antiplatelet treatment (NSTE-ACS)",
    "jumpto": "ENAS5080_5.4.4.0"
}, {
    "name": "Coronary stenting, medically-managed patients (NSTE-ACS)",
    "jumpto": "ENAS5080_5.4.4.0"
}, {
    "name": "Coronary stenting, vascular access (NSTE-ACS)",
    "jumpto": "ENAS5080_5.4.4.0"
}, {
    "name": "Correction of CHD with PAH",
    "jumpto": "ENAS5081_7.2.0.0"
}, {
    "name": "corticosteroids (HF)",
    "jumpto": "ENAS5195_12.15.0.0"
}, {
    "name": "cost-effectiveness of CVD prevention, key messages (Dyslip)",
    "jumpto": "ENAS5197_3.2.0.0"
}, {
    "name": "cost-effectiveness, CVD prevention",
    "jumpto": "ENAS5196_8.0.0.0"
}, {
    "name": "COX-2 inhibitors (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "Coxiella burnettii (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "CPET (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "CPVT, diagnosis",
    "jumpto": "ENAS5083_9.5.1.0"
}, {
    "name": "CPVT, risk stratification and management",
    "jumpto": "ENAS5083_9.5.2.0"
}, {
    "name": "criteria for discharge (HF)",
    "jumpto": "ENAS5195_13.9.0.0"
}, {
    "name": "Critical illness, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "CRT (HF)",
    "jumpto": "ENAS5195_9.2.0.0"
}, {
    "name": "CRT and defibrillator vs. CRT and pacemaker",
    "jumpto": "ENAS259_5.5.2.0"
}, {
    "name": "CRT in primary prevention of SCD",
    "jumpto": "ENAS5083_7.2.1.0"
}, {
    "name": "CRT, complications",
    "jumpto": "ENAS259_7.1.0.0"
}, {
    "name": "CRT, in atrial fibrillation [Pacing]",
    "jumpto": "ENAS259_5.3.1.0"
}, {
    "name": "CRT, in permanent atrial fibrillation, indications",
    "jumpto": "ENAS259_5.3.3.0"
}, {
    "name": "CRT, indications for upgrade",
    "jumpto": "ENAS259_5.4.1.0"
}, {
    "name": "CRT, indications in patients with sinus rhythm",
    "jumpto": "ENAS259_5.2.2.0"
}, {
    "name": "CRT, patient with sinus rhythm, summary",
    "jumpto": "ENAS259_5.2.4.0"
}, {
    "name": "CRT, patients with sinus rhythm, choice of pacing",
    "jumpto": "ENAS259_5.2.3.0"
}, {
    "name": "CRT, patients with sinus rhythm, clinical perspective",
    "jumpto": "ENAS259_5.2.3.0"
}, {
    "name": "CRT, sinus rhythm [Pacing]",
    "jumpto": "ENAS259_5.2.1.0"
}, {
    "name": "CRUSADE risk score (NSTE-ACS)",
    "jumpto": "ENAS5080_4.1.0.0"
}, {
    "name": "CTEPH diagnostic algorithm",
    "jumpto": "ENAS5081_10.1.0.0"
}, {
    "name": "CTEPH strategy",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "CTEPH, clinical classification",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "CTEPH, treatment algorithm",
    "jumpto": "ENAS5081_10.2.0.0"
}, {
    "name": "CV complications, cardiotoxicity",
    "jumpto": "ENAS5193_3.9.1.0"
}, {
    "name": "CV event, relationship with BP",
    "jumpto": "ENAS260_4.1.0.0"
}, {
    "name": "CV risk assessment: in DM",
    "jumpto": "ENAS257_7.0.0.0"
}, {
    "name": "CV risk, CKD [HTN]",
    "jumpto": "ENAS260_4.4.3.0"
}, {
    "name": "CV risk, diabetes [HTN]",
    "jumpto": "ENAS260_4.4.3.0"
}, {
    "name": "CV risk, dyslipidaemia [HTN]",
    "jumpto": "ENAS260_4.4.3.0"
}, {
    "name": "CV risk, maternal",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "CV risk: risk stratification factors [HTN]",
    "jumpto": "ENAS260_4.4.3.0"
}, {
    "name": "CVD definition and rationale",
    "jumpto": "ENAS5197_3.1.0.0"
}, {
    "name": "CVD prevention, acute hospital admission",
    "jumpto": "ENAS5196_15.2.0.0"
}, {
    "name": "CVD prevention, benfit",
    "jumpto": "ENAS5196_9.1.0.0"
}, {
    "name": "CVD prevention, cost-effectiveness",
    "jumpto": "ENAS5196_8.0.0.0"
}, {
    "name": "CVD prevention, monitoring preventive activities",
    "jumpto": "ENAS5196_15.4.0.0"
}, {
    "name": "CVD prevention, performance measurements",
    "jumpto": "ENAS5196_15.5.0.0"
}, {
    "name": "CVD prevention, primary care",
    "jumpto": "ENAS5196_15.1.0.0"
}, {
    "name": "CVD prevention, relevance",
    "jumpto": "ENAS5196_7.0.0.0"
}, {
    "name": "CVD prevention, specialized programmes",
    "jumpto": "ENAS5196_15.3.0.0"
}, {
    "name": "CVD prevention, total CV risk assessment",
    "jumpto": "ENAS5196_9.2.0.0"
}, {
    "name": "CVD, cardiotoxicity",
    "jumpto": "ENAS5193_3.2.1.1"
}, {
    "name": "CVD, genetic testing",
    "jumpto": "ENAS255_4.3.0.0"
}, {
    "name": "cyanotic heart disease",
    "jumpto": "ENAS255_5.1.0.0"
}, {
    "name": "Deep hypothermia circulatory arrest, CTEPH",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "deep vein thrombosis, pregnancy",
    "jumpto": "ENAS255_12.3.0.0"
}, {
    "name": "definition (CVD prev)",
    "jumpto": "ENAS5196_4.0.0.0"
}, {
    "name": "definition (HF)",
    "jumpto": "ENAS5195_4.0.0.0"
}, {
    "name": "definition and rationale CVD",
    "jumpto": "ENAS5197_3.1.0.0"
}, {
    "name": "definition of HFmrEF",
    "jumpto": "ENAS5195_4.0.0.0"
}, {
    "name": "definition of HFpEF",
    "jumpto": "ENAS5195_4.0.0.0"
}, {
    "name": "definition of HFrEF",
    "jumpto": "ENAS5195_4.0.0.0"
}, {
    "name": "Delayed tamponade",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "delivery, vaginal",
    "jumpto": "ENAS255_4.7.0.0"
}, {
    "name": "Device therapy in VA, ICD implantation",
    "jumpto": "ENAS5083_5.2.1.0"
}, {
    "name": "Device therapy in VA, public access defibrillator",
    "jumpto": "ENAS5083_5.2.4.0"
}, {
    "name": "Device therapy in VA, subcut. cardioverter defibrillator",
    "jumpto": "ENAS5083_5.2.2.0"
}, {
    "name": "Device therapy in VA, wearable cardioverter defibrillator",
    "jumpto": "ENAS5083_5.2.3.0"
}, {
    "name": "diabetes (HF)",
    "jumpto": "ENAS5195_12.6.0.0"
}, {
    "name": "diabetes mellitus (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "diabetes mellitus, antiplatelet therapy",
    "jumpto": "ENAS257_8.5.0.0"
}, {
    "name": "diabetes mellitus, BP control",
    "jumpto": "ENAS257_8.3.0.0"
}, {
    "name": "diabetes mellitus, cardiovascular disease",
    "jumpto": "ENAS257_4.1.0.0"
}, {
    "name": "diabetes mellitus, cardiovascular risk assessment",
    "jumpto": "ENAS257_7.0.0.0"
}, {
    "name": "diabetes mellitus, coronary revascularization",
    "jumpto": "ENAS257_9.2.0.0"
}, {
    "name": "diabetes mellitus, diagnostic criteria",
    "jumpto": "ENAS257_5.2.0.0"
}, {
    "name": "diabetes mellitus, dyslipidaemia mgmt.",
    "jumpto": "ENAS257_8.4.0.0"
}, {
    "name": "diabetes mellitus, FINDRISC [DM]",
    "jumpto": "ENAS257_5.3.2.0"
}, {
    "name": "diabetes mellitus, glycaemic control recommendations",
    "jumpto": "ENAS257_8.2.1.0"
}, {
    "name": "diabetes mellitus, glycaemic targets",
    "jumpto": "ENAS257_8.2.2.0"
}, {
    "name": "diabetes mellitus, lifestyle modifications",
    "jumpto": "ENAS257_8.1.1.0"
}, {
    "name": "diabetes mellitus, microvascular disease mgmt.",
    "jumpto": "ENAS257_13.1.0.0"
}, {
    "name": "diabetes mellitus, multifactorial risk mgmt.",
    "jumpto": "ENAS257_8.6.0.0"
}, {
    "name": "diabetes mellitus, patient-centred care",
    "jumpto": "ENAS257_14.0.0.0"
}, {
    "name": "diabetes mellitus, pharmacological treatment",
    "jumpto": "ENAS257_8.2.3.0"
}, {
    "name": "diabetes mellitus, prevention of T2DM",
    "jumpto": "ENAS257_5.4.0.0"
}, {
    "name": "diabetes mellitus, risk scores: overview",
    "jumpto": "ENAS257_5.3.1.0"
}, {
    "name": "diabetes mellitus, sudden cardiac death",
    "jumpto": "ENAS257_11.3.0.0"
}, {
    "name": "diabetes type 1 (CVD prev)",
    "jumpto": "ENAS5196_12.2.1.0"
}, {
    "name": "diabetes type 2 (CVD prev)",
    "jumpto": "ENAS5196_12.1.0.0"
}, {
    "name": "diabetes, dyslipidaemias",
    "jumpto": "ENAS5197_11.5.0.0"
}, {
    "name": "diagnosis of AF",
    "jumpto": "ENAS5194_4.1.0.0"
}, {
    "name": "diagnosis of heart failure",
    "jumpto": "ENAS5195_5.2.0.0"
}, {
    "name": "Diagnosis of IE, role of echocardiography",
    "jumpto": "ENAS5079_5.2.1.0"
}, {
    "name": "Diagnosis of non-acute HF (interactive algorithm)",
    "jumpto": "interactive_0000595"
}, {
    "name": "Diagnostic criteria for FH (interactive score)",
    "jumpto": "interactive_0000278"
}, {
    "name": "diagnostic evaluation of HTN, laboratory investigations",
    "jumpto": "ENAS260_5.6.0.0"
}, {
    "name": "diagnostic evaluation of HTN, medical history",
    "jumpto": "ENAS260_5.3.0.0"
}, {
    "name": "diagnostic evaluation of HTN, summary",
    "jumpto": "ENAS260_5.5.0.0"
}, {
    "name": "diagnostic tests, recommendations (HF)",
    "jumpto": "ENAS5195_6.3.0.0"
}, {
    "name": "diagnostic tools, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.6"
}, {
    "name": "diagnostic workup (HF)",
    "jumpto": "ENAS5195_13.4.0.0"
}, {
    "name": "Dialted cardiomyopathy, definition",
    "jumpto": "ENAS5083_8.1.1.0"
}, {
    "name": "Diastolic murmur, of pulmonary regurgitation",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "Diastolic pressure gradient (DPG)",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "diet (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "diet in CVD prevention (Dyslip)",
    "jumpto": "ENAS5197_7.5.0.0"
}, {
    "name": "diet, population-based approach (CVD prev)",
    "jumpto": "ENAS5196_14.1.0.0"
}, {
    "name": "dietary supplements (Dyslip)",
    "jumpto": "ENAS5197_7.4.0.0"
}, {
    "name": "digital subtraction angiography, RAS",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "Digitoxin (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "Digoxin (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "digoxin, pregnancy",
    "jumpto": "ENAS255_10.1.0.0"
}, {
    "name": "Dilated cardiomyopathy, management",
    "jumpto": "ENAS5083_8.1.2.0"
}, {
    "name": "Dilated cardiomyopathy, prevention of SCD",
    "jumpto": "ENAS5083_8.1.2.0"
}, {
    "name": "Dilated cardiomyopathy, risk stratification",
    "jumpto": "ENAS5083_8.1.2.0"
}, {
    "name": "Diltiazem (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "diltiazem (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "Dip and plateau sign",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "disorders of glucose metabolism, diagnosis",
    "jumpto": "ENAS257_5.1.0.0"
}, {
    "name": "diuretics, mitral stenosis",
    "jumpto": "ENAS248_9.3.0.0"
}, {
    "name": "Diuretics, PAH supportive therapy",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "diuretics, pregnancy",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "DM and coronary artery disease: treatment targets",
    "jumpto": "ENAS257_4.2.0.0"
}, {
    "name": "DM with CAD: treatment targets",
    "jumpto": "ENAS257_4.2.0.0"
}, {
    "name": "dobutamine (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "dogoxin (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "door to balloon time",
    "jumpto": "ENAS250_5.5.2.0"
}, {
    "name": "dopamine (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "dopamine [CVD Preg]",
    "jumpto": "ENAS255_9.2.0.0"
}, {
    "name": "doppler velocimetry",
    "jumpto": "ENAS255_4.5.0.0"
}, {
    "name": "Doppler velocities (HF)",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "dronedarone (HF)",
    "jumpto": "ENAS5195_11.3.0.0"
}, {
    "name": "Drug monotherapy, group I PAH",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Drugs approved for PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Drugs approved for PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "dual therapy after ACS (AFib)",
    "jumpto": "ENAS5194_8.11.2.0"
}, {
    "name": "dual therapy after PCI (AFib)",
    "jumpto": "ENAS5194_8.11.3.0"
}, {
    "name": "Duke criteria (IE)",
    "jumpto": "ENAS5079_5.4.1.0"
}, {
    "name": "duplex ultrasonography, carotid artery",
    "jumpto": "ENAS256_5.1.2.0"
}, {
    "name": "duplex ultrasonography, mesenteric artery",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "duplex ultrasonography, renal artery",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "dyslipidaemia, diet in CVD prevention",
    "jumpto": "ENAS5197_7.5.0.0"
}, {
    "name": "dyslipidaemias, ACS and undergoing PCI",
    "jumpto": "ENAS5197_11.6.0.0"
}, {
    "name": "dyslipidaemias, bile acid sequestrants, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.2.0.0"
}, {
    "name": "dyslipidaemias, children",
    "jumpto": "ENAS5197_11.2.0.0"
}, {
    "name": "dyslipidaemias, cholesterol absorption inhibitors, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.3.0.0"
}, {
    "name": "dyslipidaemias, chronic kidney disease",
    "jumpto": "ENAS5197_11.8.0.0"
}, {
    "name": "dyslipidaemias, diabetes",
    "jumpto": "ENAS5197_11.5.0.0"
}, {
    "name": "dyslipidaemias, dietary supplements",
    "jumpto": "ENAS5197_7.4.0.0"
}, {
    "name": "dyslipidaemias, familial",
    "jumpto": "ENAS5197_11.1.0.0"
}, {
    "name": "dyslipidaemias, HDL-cholesterol",
    "jumpto": "ENAS5197_10.0.0.0"
}, {
    "name": "dyslipidaemias, heart failure",
    "jumpto": "ENAS5197_11.7.0.0"
}, {
    "name": "dyslipidaemias, HIV patients",
    "jumpto": "ENAS5197_11.12.0.0"
}, {
    "name": "dyslipidaemias, Illustration of the risk age concept",
    "jumpto": "ENAS5197_4.1.5.0"
}, {
    "name": "dyslipidaemias, key messages",
    "jumpto": "ENAS5197_4.2.2.0"
}, {
    "name": "dyslipidaemias, lifestyle changes LDL",
    "jumpto": "ENAS5197_7.2.0.0"
}, {
    "name": "dyslipidaemias, lifestyle changes lipids",
    "jumpto": "ENAS5197_7.1.0.0"
}, {
    "name": "dyslipidaemias, mental disorders",
    "jumpto": "ENAS5197_11.13.0.0"
}, {
    "name": "dyslipidaemias, monitoring lipids\/enzymes",
    "jumpto": "ENAS5197_12.1.0.0"
}, {
    "name": "dyslipidaemias, muscular symptoms",
    "jumpto": "ENAS5197_12.2.0.0"
}, {
    "name": "dyslipidaemias, nicotinic acid, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.5.0.0"
}, {
    "name": "dyslipidaemias, older persons",
    "jumpto": "ENAS5197_11.4.0.0"
}, {
    "name": "dyslipidaemias, overweight",
    "jumpto": "ENAS5197_7.3.0.0"
}, {
    "name": "dyslipidaemias, PCSK9 inhibitors, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.4.0.0"
}, {
    "name": "dyslipidaemias, peripheral arterial disease",
    "jumpto": "ENAS5197_11.10.0.0"
}, {
    "name": "dyslipidaemias, pharmacological treatment, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.6.0.0"
}, {
    "name": "dyslipidaemias, relative risk chart for CV mortality",
    "jumpto": "ENAS5197_4.1.4.0"
}, {
    "name": "dyslipidaemias, risk based intervention strategies",
    "jumpto": "ENAS5197_4.2.3.0"
}, {
    "name": "dyslipidaemias, risk charts qualifiers",
    "jumpto": "ENAS5197_4.1.9.0"
}, {
    "name": "dyslipidaemias, risk estimation",
    "jumpto": "ENAS5197_4.2.4.0"
}, {
    "name": "dyslipidaemias, risk estimation charts",
    "jumpto": "ENAS5197_4.1.8.0"
}, {
    "name": "dyslipidaemias, SCORE high risk chart",
    "jumpto": "ENAS5197_4.1.2.0"
}, {
    "name": "dyslipidaemias, SCORE low risk chart",
    "jumpto": "ENAS5197_4.1.3.0"
}, {
    "name": "dyslipidaemias, statin, hypercholesterolaemia",
    "jumpto": "ENAS5197_8.1.0.0"
}, {
    "name": "dyslipidaemias, stroke",
    "jumpto": "ENAS5197_11.11.0.0"
}, {
    "name": "dyslipidaemias, transplantation",
    "jumpto": "ENAS5197_11.9.0.0"
}, {
    "name": "dyslipidaemias, triglycerides",
    "jumpto": "ENAS5197_9.2.0.0"
}, {
    "name": "dyslipidaemias, tx goals LDL-cholesterol",
    "jumpto": "ENAS5197_6.2.0.0"
}, {
    "name": "dyslipidaemias, tx goals secondary targets",
    "jumpto": "ENAS5197_6.3.0.0"
}, {
    "name": "dyslipidaemias, tx targets",
    "jumpto": "ENAS5197_6.1.0.0"
}, {
    "name": "dyslipidaemias, valvular diseases",
    "jumpto": "ENAS5197_11.7.0.0"
}, {
    "name": "dyslipidaemias, women",
    "jumpto": "ENAS5197_11.3.0.0"
}, {
    "name": "Early after MI",
    "jumpto": "ENAS5083_6.2.1.0"
}, {
    "name": "early detection strategies, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "Early diagnostic pulmonary regurgitation velocity",
    "jumpto": "ENAS5081_5.4.0.0"
}, {
    "name": "Early diastolic pulmonary regurgitation velocity",
    "jumpto": "ENAS5081_5.6.0.0"
}, {
    "name": "Early invasive strategy, PCI in NSTE-ACS",
    "jumpto": "ENAS5080_5.5.2.0"
}, {
    "name": "Ebsteins anomaly, pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "ECG (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "ECHO (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "Echocardiography (VA and SCD)",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "echocardiography [SCAD]",
    "jumpto": "ENAS258_7.3.2.0"
}, {
    "name": "echocardiography [STEMI]",
    "jumpto": "ENAS250_6.2.0.0"
}, {
    "name": "echocardiography [VHD]",
    "jumpto": "ENAS248_5.1.2.0"
}, {
    "name": "Echocardiography in iE, indications",
    "jumpto": "ENAS5079_5.2.2.0"
}, {
    "name": "Echocardiography in IE, recommendations",
    "jumpto": "ENAS5079_5.2.3.0"
}, {
    "name": "echocardiography, 3D [VHD]",
    "jumpto": "ENAS248_5.1.4.0"
}, {
    "name": "Echocardiography, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "edge-to-edge procedure",
    "jumpto": "ENAS248_8.2.1.0"
}, {
    "name": "effective regurgitant orifice area",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "Ehlers-Danlos syndrome, pregnancy",
    "jumpto": "ENAS255_6.2.0.0"
}, {
    "name": "Eisenmenger syndrome, pregnancy",
    "jumpto": "ENAS255_5.1.0.0"
}, {
    "name": "Eisenmenger's syndrome (PH)",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "elderly (CVD prev)",
    "jumpto": "ENAS5196_10.2.0.0"
}, {
    "name": "elderly patients, cardiotoxicity",
    "jumpto": "ENAS5193_3.10.2.0"
}, {
    "name": "elective non-cardiac surgery, VHD",
    "jumpto": "ENAS248_12.2.0.0"
}, {
    "name": "Elective surgery (PH)",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "electrical cardioversion (HF)",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "electro-anatomic mapping",
    "jumpto": "ENAS255_10.3.0.0"
}, {
    "name": "electrocardiography (ECG) [SCAD]",
    "jumpto": "ENAS258_7.3.2.0"
}, {
    "name": "electrocardiography, definition of MI",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "electrocardiography, detection of MI",
    "jumpto": "ENAS247_6.1.0.0"
}, {
    "name": "electrocardiography, diagnostic pitfalls",
    "jumpto": "ENAS247_8.0.0.0"
}, {
    "name": "electrocardiography, monitoring [STEMI]",
    "jumpto": "ENAS250_5.1.0.0"
}, {
    "name": "electrocardiography, prosthetic valves",
    "jumpto": "ENAS248_11.2.1.0"
}, {
    "name": "Electrophysiological study, VA screening",
    "jumpto": "ENAS5083_4.3.2.0"
}, {
    "name": "embolic protection device",
    "jumpto": "ENAS256_5.1.3.0"
}, {
    "name": "embryopathy",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "emergency medical system",
    "jumpto": "ENAS250_5.4.4.0"
}, {
    "name": "Emerin",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Emery-Dreifuss muscular dystrophy",
    "jumpto": "ENAS5083_13.2.1.0"
}, {
    "name": "empagliflozin (HF)",
    "jumpto": "ENAS5195_7.0.0.0"
}, {
    "name": "end-diastolic velocity",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "Endocarditis team, characteristics",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "Endocarditis team, role",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "endocarditis, prophylaxis [CVD Preg]",
    "jumpto": "ENAS255_4.8.0.0"
}, {
    "name": "endocarditis, prophylaxis [VHD]",
    "jumpto": "ENAS248_5.1.7.0"
}, {
    "name": "endomyocardial biopsy, EMB (HF)",
    "jumpto": "ENAS5195_6.3.0.0"
}, {
    "name": "enoxaparin, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Enoxaparin, dosing (NSTE-ACS)",
    "jumpto": "ENAS5080_5.3.1.0"
}, {
    "name": "enoxaparin, fibrinolysis",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "enoxaparin, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "enoxaparin, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "Enterococcus spp., infective endocarditis",
    "jumpto": "ENAS5079_7.4.0.0"
}, {
    "name": "environment, population-based approach (CVD prev)",
    "jumpto": "ENAS5196_14.5.0.0"
}, {
    "name": "Epicardial access",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "epidemiology, AF",
    "jumpto": "ENAS5194_3.0.0.0"
}, {
    "name": "eplerenone, HF",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "eplerenone, STEMI",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "Epoprostenol in vasoreactivity testing",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "Epoprostenol, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Epoprostenol, Prostanoids",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "eptifibatide, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Eptifibatide, glycoprotein IIb\/IIIa inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.2.0"
}, {
    "name": "eptifibatide, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "eptifibatide, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "ERA + PDE-5i, PAH therapy",
    "jumpto": "ENAS5081_6.2.3.3"
}, {
    "name": "erectile dysfunction (CVD prev)",
    "jumpto": "ENAS5196_9.10.5.0"
}, {
    "name": "erectile dysfunction (HF)",
    "jumpto": "ENAS5195_12.7.0.0"
}, {
    "name": "EROA",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "erythropoietin, hemolytic anemia",
    "jumpto": "ENAS248_11.2.10.0"
}, {
    "name": "ESC 2015 modified criteria, major (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "ESC 2015 modified criteria, minor (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "Esmolol (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "Ethambutol, in tubercular pericarditis",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "ethnic minorities (CVD prev)",
    "jumpto": "ENAS5196_10.4.0.0"
}, {
    "name": "EuroSCORE",
    "jumpto": "ENAS248_5.1.7.0"
}, {
    "name": "euvolaemic",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "evaluation of lipid and apolipoprotein parameters (Dyslip)",
    "jumpto": "ENAS5197_5.1.0.0"
}, {
    "name": "exercise (HF)",
    "jumpto": "ENAS5195_15.1.2.0"
}, {
    "name": "Exercise restriction, , acute pericarditis therapy",
    "jumpto": "ENAS5082_3.2.7.0"
}, {
    "name": "Exercise stress testing (VA and SCD)",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "Expert center (PH)",
    "jumpto": "ENAS5081_11.0.0.0"
}, {
    "name": "Expert center (PH)",
    "jumpto": "ENAS5081_10.1.0.0"
}, {
    "name": "Expert Center (PH)",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "Expert Center, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Expert center, PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "Extended lab (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "extra cranial CAD, mgmt. algorithm [DM]",
    "jumpto": "ENAS257_12.3.0.0"
}, {
    "name": "factors modifying SCORE risks (Dyslip)",
    "jumpto": "ENAS5197_4.1.10.0"
}, {
    "name": "factors triggering, acute HF",
    "jumpto": "ENAS5195_13.2.0.0"
}, {
    "name": "false negatives, ECG pitfalls",
    "jumpto": "ENAS247_8.0.0.0"
}, {
    "name": "false positives, ECG pitfalls",
    "jumpto": "ENAS247_8.0.0.0"
}, {
    "name": "familial dyslipidaemias",
    "jumpto": "ENAS5197_11.1.0.0"
}, {
    "name": "family history\/(epi)genetics (CVD prev)",
    "jumpto": "ENAS5196_9.6.0.0"
}, {
    "name": "fasting (Dyslip)",
    "jumpto": "ENAS5197_5.3.0.0"
}, {
    "name": "felodipine (HF)",
    "jumpto": "ENAS5195_12.11.0.0"
}, {
    "name": "female-specific conditions (CVD prev)",
    "jumpto": "ENAS5196_10.3.0.0"
}, {
    "name": "fetal biophysical profile testing",
    "jumpto": "ENAS255_4.5.0.0"
}, {
    "name": "fibrin-specific agents, STEMI",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "fibrinolysis, contraindications",
    "jumpto": "ENAS250_5.5.5.0"
}, {
    "name": "fibrinolysis, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.7.0"
}, {
    "name": "fibrinolysis, STEMI",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "fibrinolysis, valve thrombosis",
    "jumpto": "ENAS248_11.2.7.0"
}, {
    "name": "first-degree atrioventricular block, pacing",
    "jumpto": "ENAS259_6.7.0.0"
}, {
    "name": "Fistula, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Fistula, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Flecainide (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "fluoropyrimidines, cardiotoxicity",
    "jumpto": "ENAS5193_3.2.1.2"
}, {
    "name": "FMC to needle time",
    "jumpto": "ENAS250_5.5.2.0"
}, {
    "name": "Focal AF",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "follow-up after intervention for AAA (after open surgery)",
    "jumpto": "ENAS264_14.4.2.0"
}, {
    "name": "follow-up after intervention for AAA (endovascular repair)",
    "jumpto": "ENAS264_14.4.1.0"
}, {
    "name": "Fondaparinux (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "fondaparinux, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Fondaparinux, dosing (NSTE-ACS)",
    "jumpto": "ENAS5080_5.3.1.0"
}, {
    "name": "fondaparinux, fibrinolysis",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "fondaparinux, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "fondaparinux, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "Fontaine classification",
    "jumpto": "ENAS256_5.6.1.0"
}, {
    "name": "Fontan circulation, pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "Fontan circulation, risk assessment",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "fractional flow reserve [SCAD]",
    "jumpto": "ENAS258_9.2.0.0"
}, {
    "name": "Fukutin-related protein",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "gastrointestinal haemorrhage (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "gastrointestinal tonometry",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "gastropathy, ischaemic",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "General diagnositic work-up (Pericard.)",
    "jumpto": "ENAS5082_4.2.3.0"
}, {
    "name": "genetic testing, recommendations",
    "jumpto": "ENAS5195_6.4.0.0"
}, {
    "name": "global longitudinal strain reduction, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.4.0"
}, {
    "name": "glycaemic continuum",
    "jumpto": "ENAS257_6.0.0.0"
}, {
    "name": "goal of management (HF)",
    "jumpto": "ENAS5195_15.1.3.0"
}, {
    "name": "goals of treatment, AHF",
    "jumpto": "ENAS5195_13.10.0.0"
}, {
    "name": "gout and arthritis (HF)",
    "jumpto": "ENAS5195_12.8.0.0"
}, {
    "name": "GP IIb\/IIIa inhibitor, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "Group 2 PH, key factors",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "Group 3 PAH, hemodynamic classification",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Haemodynamics (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "HAS-BLED score (interactive score)",
    "jumpto": "interactive_0000284"
}, {
    "name": "HbA1c, PAD",
    "jumpto": "ENAS256_4.6.0.0"
}, {
    "name": "HDL-cholesterol and CVD risk (Dyslip)",
    "jumpto": "ENAS5197_10.0.0.0"
}, {
    "name": "health impact pyramid, dyslipidaemias (Dyslip)",
    "jumpto": "ENAS5197_3.2.0.0"
}, {
    "name": "Healthcare associated endocarditis",
    "jumpto": "ENAS5079_7.5.0.0"
}, {
    "name": "Heart failure following NSTE-ACS, mgmt.",
    "jumpto": "ENAS5080_5.6.5.0"
}, {
    "name": "heart failure, cancer treatment",
    "jumpto": "ENAS5193_3.1.1.1"
}, {
    "name": "heart failure, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.5.0"
}, {
    "name": "Heart failure, clinical perspectives of pacemaker therapy [Pacing]",
    "jumpto": "ENAS259_5.4.2.0"
}, {
    "name": "heart failure, CRT [Pacing]",
    "jumpto": "ENAS259_5.1.0.0"
}, {
    "name": "heart failure, dyslipidaemias",
    "jumpto": "ENAS5197_11.7.0.0"
}, {
    "name": "Heart failure, indications for pacemaker [Pacing]",
    "jumpto": "ENAS259_5.4.1.0"
}, {
    "name": "heart failure, mgmt. in DM",
    "jumpto": "ENAS257_10.0.0.0"
}, {
    "name": "heart team, AF",
    "jumpto": "ENAS5194_10.8.0.0"
}, {
    "name": "heart team, VHD",
    "jumpto": "ENAS248_5.1.1.0"
}, {
    "name": "heart transplantation, indications and contra-indications (HF)",
    "jumpto": "ENAS5195_14.4.2.0"
}, {
    "name": "heart transplantation, introduction",
    "jumpto": "ENAS5195_14.4.1.0"
}, {
    "name": "heart transplantation, overview (HF)",
    "jumpto": "ENAS5195_14.1.0.0"
}, {
    "name": "heart transplantation, pacing [Pacing]",
    "jumpto": "ENAS259_6.2.0.0"
}, {
    "name": "Heart transplantation, PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "hemodynamic disturbances, STEMI",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "Hemopericardia",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "Hemopericardium",
    "jumpto": "ENAS5082_5.6.0.0"
}, {
    "name": "Hemoperitoneum",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "hepatojugular reflux (HF)",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "Hepatomegaly (PH)",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "HER-2 targeted therapy prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.3.2.0"
}, {
    "name": "Heritable PAH, BMPR2 mutation",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "Heritable PAH, other mutations",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "HF treatment",
    "jumpto": "ENAS5195_12.13.1.0"
}, {
    "name": "HFmrEF, treatment",
    "jumpto": "ENAS5195_10.0.0.0"
}, {
    "name": "HFpEF, treatment",
    "jumpto": "ENAS5195_10.0.0.0"
}, {
    "name": "HFrEF, therapeutic algorithm",
    "jumpto": "ENAS5195_8.2.0.0"
}, {
    "name": "hibernation of myocardium",
    "jumpto": "ENAS250_6.3.0.0"
}, {
    "name": "High risk, PAH",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "High-risk patients, clinical predictors (Pericard.)",
    "jumpto": "ENAS5082_4.2.2.0"
}, {
    "name": "High-sensitivity cardiac troponin assay, implications (NSTE-ACS)",
    "jumpto": "ENAS5080_3.2.0.0"
}, {
    "name": "High-sensitivity troponin 0h\/1h rule-in NSTEMI algorithm",
    "jumpto": "ENAS5080_3.5.3.0"
}, {
    "name": "High-sensitivity troponin 0h\/1h rule-out NSTEMI algorithm",
    "jumpto": "ENAS5080_3.5.3.0"
}, {
    "name": "High-sensitivity troponin 0h\/3h rule-out NSTEMI algorithm",
    "jumpto": "ENAS5080_3.5.2.0"
}, {
    "name": "High-sensitivity troponin negative predictive value of MI",
    "jumpto": "ENAS5080_3.5.1.0"
}, {
    "name": "High-sensitivity troponin positive predictive value of MI",
    "jumpto": "ENAS5080_3.5.1.0"
}, {
    "name": "High-sensitivity troponin rule-in NSTEMI algorithm, overview",
    "jumpto": "ENAS5080_3.5.1.0"
}, {
    "name": "High-sensitivity troponin rule-out NSTEMI algorithm, overview",
    "jumpto": "ENAS5080_3.5.1.0"
}, {
    "name": "HIV patients, dyslipidaemias",
    "jumpto": "ENAS5197_11.12.0.0"
}, {
    "name": "holodiastolic flow",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "hormonal derangements (HF)",
    "jumpto": "ENAS5195_13.2.0.0"
}, {
    "name": "Horton disease",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "how to use the risk estimation charts, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.8.0"
}, {
    "name": "HTN, diagnostic evaluation",
    "jumpto": "ENAS260_5.1.0.0"
}, {
    "name": "hydatidiform mole",
    "jumpto": "ENAS255_11.2.0.0"
}, {
    "name": "hydralazine (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "Hydropericardium",
    "jumpto": "ENAS5082_6.2.1.0"
}, {
    "name": "hypercholesterolaemia, pharmacological treatment",
    "jumpto": "ENAS5197_8.6.0.0"
}, {
    "name": "hyperglycaemia [STEMI]",
    "jumpto": "ENAS250_5.6.0.0"
}, {
    "name": "hyperglycaemia, mgmt.",
    "jumpto": "ENAS257_8.2.3.0"
}, {
    "name": "hyperkalaemia (HF)",
    "jumpto": "ENAS5195_12.9.0.0"
}, {
    "name": "hyperkalaemia (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "hyperlipidaemia (HF)",
    "jumpto": "ENAS5195_12.10.0.0"
}, {
    "name": "hypertension (CVD prev)",
    "jumpto": "ENAS5196_12.3.2.0"
}, {
    "name": "hypertension (HF)",
    "jumpto": "ENAS5195_12.11.0.0"
}, {
    "name": "hypertension thresholds (CVD prev)",
    "jumpto": "ENAS5196_12.3.3.0"
}, {
    "name": "hypertension treatment, follow-up",
    "jumpto": "ENAS260_10.0.0.0"
}, {
    "name": "hypertension treatment, improving adherence",
    "jumpto": "ENAS260_10.0.0.0"
}, {
    "name": "hypertension treatment, monotherapy vs. drug combination strategy",
    "jumpto": "ENAS260_7.2.2.0"
}, {
    "name": "hypertension treatment, patients with arteriosclerosis",
    "jumpto": "ENAS260_8.10.0.0"
}, {
    "name": "hypertension treatment, patients with atherosclerosis",
    "jumpto": "ENAS260_8.10.0.0"
}, {
    "name": "hypertension treatment, patients with cerebrovascular disease",
    "jumpto": "ENAS260_8.8.0.0"
}, {
    "name": "hypertension treatment, patients with DM",
    "jumpto": "ENAS260_8.5.0.0"
}, {
    "name": "hypertension treatment, patients with heart disease",
    "jumpto": "ENAS260_8.9.0.0"
}, {
    "name": "hypertension treatment, patients with nephropathy",
    "jumpto": "ENAS260_8.7.0.0"
}, {
    "name": "hypertension treatment, patients with OSA",
    "jumpto": "ENAS260_8.6.0.0"
}, {
    "name": "hypertension treatment, patients with PAD",
    "jumpto": "ENAS260_8.10.0.0"
}, {
    "name": "hypertension treatment, summary of strategies",
    "jumpto": "ENAS260_7.2.3.0"
}, {
    "name": "hypertension treatment, the elderly",
    "jumpto": "ENAS260_8.2.0.0"
}, {
    "name": "hypertension treatment, white-coat and masked hypertension",
    "jumpto": "ENAS260_8.1.0.0"
}, {
    "name": "hypertension treatment, women",
    "jumpto": "ENAS260_8.4.0.0"
}, {
    "name": "hypertension treatment, young adults",
    "jumpto": "ENAS260_8.3.0.0"
}, {
    "name": "hypertension treatment: choice of antihypertensive drugs",
    "jumpto": "ENAS260_7.2.1.0"
}, {
    "name": "hypertension, blood pressure measurement",
    "jumpto": "ENAS260_5.2.1.0"
}, {
    "name": "hypertension, classification [HTN]",
    "jumpto": "ENAS260_4.2.0.0"
}, {
    "name": "hypertension, CV risk stratification",
    "jumpto": "ENAS260_4.4.2.0"
}, {
    "name": "hypertension, definition [CVD Preg]",
    "jumpto": "ENAS255_11.2.0.0"
}, {
    "name": "hypertension, definition [HTN]",
    "jumpto": "ENAS260_4.2.0.0"
}, {
    "name": "hypertension, diagnostic summary",
    "jumpto": "ENAS260_5.5.0.0"
}, {
    "name": "hypertension, family history",
    "jumpto": "ENAS260_5.3.0.0"
}, {
    "name": "hypertension, genetics",
    "jumpto": "ENAS260_5.7.0.0"
}, {
    "name": "hypertension, gestational",
    "jumpto": "ENAS255_11.2.0.0"
}, {
    "name": "hypertension, indications for antihypertensive drug treatment",
    "jumpto": "ENAS260_6.2.0.0"
}, {
    "name": "hypertension, indications for initiation of lifestyle changes",
    "jumpto": "ENAS260_6.2.0.0"
}, {
    "name": "hypertension, initiation of antihypertensive drug treatment",
    "jumpto": "ENAS260_6.3.0.0"
}, {
    "name": "hypertension, laboratory investigations",
    "jumpto": "ENAS260_5.6.0.0"
}, {
    "name": "hypertension, lifestyle changes",
    "jumpto": "ENAS260_7.1.0.0"
}, {
    "name": "hypertension, malignant",
    "jumpto": "ENAS260_8.12.0.0"
}, {
    "name": "hypertension, medical history",
    "jumpto": "ENAS260_5.3.0.0"
}, {
    "name": "hypertension, new aspects",
    "jumpto": "ENAS260_3.2.0.0"
}, {
    "name": "hypertension, organ damage signs",
    "jumpto": "ENAS260_5.4.0.0"
}, {
    "name": "hypertension, physical examination",
    "jumpto": "ENAS260_5.4.0.0"
}, {
    "name": "hypertension, pregnancy",
    "jumpto": "ENAS255_11.1.0.0"
}, {
    "name": "hypertension, pregnancy: mgmt.",
    "jumpto": "ENAS255_11.3.0.0"
}, {
    "name": "hypertension, pregnancy: prognosis",
    "jumpto": "ENAS255_11.7.0.0"
}, {
    "name": "hypertension, prevalence [HTN]",
    "jumpto": "ENAS260_4.3.0.0"
}, {
    "name": "hypertension, prevention: lifestyle changes",
    "jumpto": "ENAS260_7.1.0.0"
}, {
    "name": "hypertension, renovascular",
    "jumpto": "ENAS260_8.13.0.0"
}, {
    "name": "hypertension, resistant",
    "jumpto": "ENAS260_8.11.0.0"
}, {
    "name": "hypertension, secondary",
    "jumpto": "ENAS260_5.9.0.0"
}, {
    "name": "hypertension, total cardiovascular risk [HTN]",
    "jumpto": "ENAS260_4.4.1.0"
}, {
    "name": "hypertension, treatment approach",
    "jumpto": "ENAS260_6.1.0.0"
}, {
    "name": "hypertension, treatment goals",
    "jumpto": "ENAS260_6.4.0.0"
}, {
    "name": "hypertension, treatment of risk factors",
    "jumpto": "ENAS260_9.0.0.0"
}, {
    "name": "Hypertensive emergencies, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "hypertriglyceridaemia, causes (Dyslip)",
    "jumpto": "ENAS5197_9.1.0.0"
}, {
    "name": "Hypertrophic cardiomyopathy (VA and SCD)",
    "jumpto": "ENAS5083_8.2.1.0"
}, {
    "name": "Hypertrophic cardiomyopathy, introduction",
    "jumpto": "ENAS5083_8.2.1.0"
}, {
    "name": "hypertrophic cardiomyopathy, pacing",
    "jumpto": "ENAS259_6.4.0.0"
}, {
    "name": "Hypertrophic cardiomyopathy, prevention of SCD",
    "jumpto": "ENAS5083_8.2.2.0"
}, {
    "name": "hyperuricemia (HF)",
    "jumpto": "ENAS5195_12.8.0.0"
}, {
    "name": "hypokalaemia (HF)",
    "jumpto": "ENAS5195_12.9.0.0"
}, {
    "name": "hypoperfusion (HF)",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "IAS bowing to right, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "iatrogenic aortic dissection",
    "jumpto": "ENAS264_8.8.0.0"
}, {
    "name": "Ibuprofen, anti-inflammatory therapy (Pericard.)",
    "jumpto": "ENAS5082_3.2.6.0"
}, {
    "name": "Ibuprofen, in paediatric pericardial diseases",
    "jumpto": "ENAS5082_6.1.2.0"
}, {
    "name": "Ibuprofen, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.2.0"
}, {
    "name": "Ibutilide (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "ICD (HF)",
    "jumpto": "ENAS5195_9.1.0.0"
}, {
    "name": "ICD implantation, in children",
    "jumpto": "ENAS5083_10.3.0.0"
}, {
    "name": "ICD placement after MI (VA and SCD)",
    "jumpto": "ENAS5083_6.2.2.0"
}, {
    "name": "ICD treatment, psychosocial impact",
    "jumpto": "ENAS5083_5.5.0.0"
}, {
    "name": "Idiopathic ventricular fibrillation, treatment",
    "jumpto": "ENAS5083_11.3.0.0"
}, {
    "name": "Idiopathic VF, definition",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Idiopathic VT, prevention",
    "jumpto": "ENAS5083_11.2.0.0"
}, {
    "name": "Idioventricular rhythm (VA and SCD)",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "IE treatment, acute severe cases\/patients",
    "jumpto": "ENAS5079_7.5.0.0"
}, {
    "name": "IE treatment, anti-thrombotic therapy",
    "jumpto": "ENAS5079_12.0.0.0"
}, {
    "name": "IE treatment, beta-lactam allergic patients",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "IE treatment, Enterococcus spp.",
    "jumpto": "ENAS5079_7.4.0.0"
}, {
    "name": "IE treatment, MRSA",
    "jumpto": "ENAS5079_7.3.0.0"
}, {
    "name": "IE treatment, MSSA",
    "jumpto": "ENAS5079_7.3.0.0"
}, {
    "name": "IE treatment, native valves",
    "jumpto": "ENAS5079_7.3.0.0"
}, {
    "name": "IE treatment, oral Streptococci",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "IE treatment, penicillin resistant strains",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "IE treatment, penicillin-susceptible strains",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "IE treatment, prosthetic valves",
    "jumpto": "ENAS5079_7.3.0.0"
}, {
    "name": "IE treatment, Streptococcus bovis",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "If-channel inhibitor (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "Iloprost + bosentan, PAH sequential combination therapy",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Iloprost inhaled added to bosentan, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Iloprost, in vasoreactivity testing",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "Iloprost, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Iloprost, Prostanoids",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Imaging (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "Imaging, positive for IE",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "Immediate invasive strategy, PCI in NSTE-ACS",
    "jumpto": "ENAS5080_5.5.2.0"
}, {
    "name": "Immunization of PAH patients",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "immunotherapies, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.4"
}, {
    "name": "implantable cardioverter defibrillator [CVD Preg]",
    "jumpto": "ENAS255_10.4.0.0"
}, {
    "name": "implantable cardioverter defibrillator [VHD]",
    "jumpto": "ENAS248_8.2.2.0"
}, {
    "name": "implantable cardioverter defibrillator, in CRT patients [Pacing]",
    "jumpto": "ENAS259_5.5.1.0"
}, {
    "name": "implantable cardioverter-defibrillator (HF)",
    "jumpto": "ENAS5195_9.1.0.0"
}, {
    "name": "implantation of LVAD (HF)",
    "jumpto": "ENAS5195_14.2.0.0"
}, {
    "name": "implantation of MCS (HF)",
    "jumpto": "ENAS5195_14.3.0.0"
}, {
    "name": "implementing healthy lifestyles, suggestions (Dyslip)",
    "jumpto": "ENAS5197_3.2.0.0"
}, {
    "name": "importance of co-morbidities (HF)",
    "jumpto": "ENAS5195_12.1.0.0"
}, {
    "name": "Incessant pericarditis, definition",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "indications and contra-indications, heart transplantation (HF)",
    "jumpto": "ENAS5195_14.4.2.0"
}, {
    "name": "individuals <50 years of age (CVD prev)",
    "jumpto": "ENAS5196_10.1.0.0"
}, {
    "name": "Indomethacin, in paediatric pericardial diseases",
    "jumpto": "ENAS5082_6.1.2.0"
}, {
    "name": "Indomethacin, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.2.0"
}, {
    "name": "Infective endocarditis, anti-thrombotic therapy",
    "jumpto": "ENAS5079_12.0.0.0"
}, {
    "name": "Infective endocarditis, antimicrobial therapy",
    "jumpto": "ENAS5079_7.1.0.0"
}, {
    "name": "Infective endocarditis, cardiac device-related",
    "jumpto": "ENAS5079_10.0.0.0"
}, {
    "name": "Infective endocarditis, complicated",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "Infective endocarditis, diagnosis",
    "jumpto": "ENAS5079_5.1.0.0"
}, {
    "name": "Infective endocarditis, diagnostic algorithm",
    "jumpto": "ENAS5079_5.5.0.0"
}, {
    "name": "Infective endocarditis, indications for surgery",
    "jumpto": "ENAS5079_8.2.0.0"
}, {
    "name": "Infective endocarditis, introduction",
    "jumpto": "ENAS5079_2.0.0.0"
}, {
    "name": "Infective endocarditis, left-sided",
    "jumpto": "ENAS5079_8.1.0.0"
}, {
    "name": "Infective endocarditis, microbio. diagnosis algorithm",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "Infective endocarditis, microbiological diagnosis",
    "jumpto": "ENAS5079_5.3.1.0"
}, {
    "name": "Infective endocarditis, neurological complications",
    "jumpto": "ENAS5079_9.0.0.0"
}, {
    "name": "Infective endocarditis, non-complicated",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "Infective endocarditis, non-specific preventive measures",
    "jumpto": "ENAS5079_3.4.0.0"
}, {
    "name": "Infective endocarditis, predictors of poor outcome",
    "jumpto": "ENAS5079_6.2.0.0"
}, {
    "name": "Infective endocarditis, principles of prevention",
    "jumpto": "ENAS5079_3.1.0.0"
}, {
    "name": "Infective endocarditis, right-sided",
    "jumpto": "ENAS5079_11.0.0.0"
}, {
    "name": "Infective endocarditis, role of antibiotic prophylaxis",
    "jumpto": "ENAS5079_3.1.0.0"
}, {
    "name": "influenza (CVD prev)",
    "jumpto": "ENAS5196_9.10.1.0"
}, {
    "name": "Inherited arrhythmogenic disease",
    "jumpto": "ENAS5083_4.3.4.0"
}, {
    "name": "Inherited cardiomyopathies and channelopathies (AFib)",
    "jumpto": "ENAS5194_11.2.0.0"
}, {
    "name": "Inherited primary arrhythmia syndrome",
    "jumpto": "ENAS5083_9.1.0.0"
}, {
    "name": "Initial Management of AHF (interactive algorithm)",
    "jumpto": "interactive_0000593"
}, {
    "name": "initial management, patient with AHF",
    "jumpto": "ENAS5195_13.5.0.0"
}, {
    "name": "inotropic agents, aortic regurg.",
    "jumpto": "ENAS248_6.3.0.0"
}, {
    "name": "inotropic agents, STEMI",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "Intermediate care unit (NSTE-ACS)",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "Intermediate risk, PAH",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "intermittent bradycardia, choice of pacing mode",
    "jumpto": "ENAS259_4.3.2.0"
}, {
    "name": "intermittent bradycardia, clinical perspective",
    "jumpto": "ENAS259_4.3.2.0"
}, {
    "name": "intermittent bradycardia, indications for pacing",
    "jumpto": "ENAS259_4.3.1.0"
}, {
    "name": "intervention strategies, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.3.0"
}, {
    "name": "Intervention strategy (interactive calculator)",
    "jumpto": "interactive_0000279"
}, {
    "name": "intervention, time interval (STEMI)",
    "jumpto": "ENAS250_5.4.2.0"
}, {
    "name": "Interventional BPA, CTEPH",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "Interventional therapy of VA, catheter ablation",
    "jumpto": "ENAS5083_5.4.1.0"
}, {
    "name": "Interventricular septum flattening (PH)",
    "jumpto": "ENAS5081_5.4.0.0"
}, {
    "name": "Interventricular septum flattening (PH)",
    "jumpto": "ENAS5081_5.6.0.0"
}, {
    "name": "intra-aortic balloon pump [PAD]",
    "jumpto": "ENAS256_5.6.11.0"
}, {
    "name": "intra-aortic balloon pump [STEMI]",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "intracoronary vasodilators, STEMI",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "intracranial haemorrhage (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "intramural haematoma",
    "jumpto": "ENAS264_8.3.0.0"
}, {
    "name": "intravascular ultrasound [SCAD]",
    "jumpto": "ENAS258_9.2.0.0"
}, {
    "name": "intravenous FCM (HF)",
    "jumpto": "ENAS5195_12.13.1.0"
}, {
    "name": "intravenous heparin (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "intravenous loop diuretics (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "introduction (CVD prev)",
    "jumpto": "ENAS5196_3.0.0.0"
}, {
    "name": "Introduction (VA and SCD)",
    "jumpto": "ENAS5083_3.0.0.0"
}, {
    "name": "introduction, heart transplantation",
    "jumpto": "ENAS5195_14.4.1.0"
}, {
    "name": "Invasive EPS",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "Invasive strategy, PCI in NSTE-ACS",
    "jumpto": "ENAS5080_5.5.2.0"
}, {
    "name": "iron deficiency (HF)",
    "jumpto": "ENAS5195_12.12.0.0"
}, {
    "name": "ischaemia, diagnosis [SCAD]",
    "jumpto": "ENAS258_7.1.0.0"
}, {
    "name": "ischaemia, mesenteric",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "ischaemia, splanchnic",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "ischaemic gastropathy",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "Isolated post-capillary PH",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "Isoniazid, in tubercular pericarditis",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "Isoproterenol, Brugada syndrome",
    "jumpto": "ENAS5083_9.4.2.0"
}, {
    "name": "isosorbide dinitrate (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "isradipine, pregnancy",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "ivabradine (HF)",
    "jumpto": "ENAS5195_8.2.0.0"
}, {
    "name": "Ivabradine (PH)",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "IVIG, in recurrent pericarditis",
    "jumpto": "ENAS5082_3.3.4.0"
}, {
    "name": "jugular venous dilatation (HF)",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "Jugular venous pressure, elevated (PH)",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "Kearns-Sayre syndrome",
    "jumpto": "ENAS5083_13.2.1.0"
}, {
    "name": "Kerley B lines, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "key messages, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.2.0"
}, {
    "name": "kidney dysfunction (HF)",
    "jumpto": "ENAS5195_12.14.0.0"
}, {
    "name": "killip class",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "Kussumal sign (Pericard.)",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "LAA exclusion (AFib)",
    "jumpto": "ENAS5194_8.8.0.0"
}, {
    "name": "LAA occlusion (AFib)",
    "jumpto": "ENAS5194_8.8.0.0"
}, {
    "name": "labetalol, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "laboratory lipid and apolipoprotein parameters (Dyslip)",
    "jumpto": "ENAS5197_5.1.0.0"
}, {
    "name": "lactation",
    "jumpto": "ENAS255_11.6.0.0"
}, {
    "name": "Lamin A\/C",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "late gadolinium enhancement, LGT (HF)",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "leads, ECG",
    "jumpto": "ENAS247_6.1.0.0"
}, {
    "name": "left bundle branch block (HF)",
    "jumpto": "ENAS5195_9.2.0.0"
}, {
    "name": "left bundle branch block [Pacing]",
    "jumpto": "ENAS259_5.2.1.0"
}, {
    "name": "left bundle branch block [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "Left cardiac sympathetic denervation",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "Left heart failure, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "Left ventricular assist devices (LVAD), PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "left ventricular dysfunction [STEMI]",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "left ventricular dysfunction [VHD]",
    "jumpto": "ENAS248_8.1.1.0"
}, {
    "name": "left ventricular end-diastolic diameter",
    "jumpto": "ENAS248_6.1.0.0"
}, {
    "name": "left ventricular enlargement",
    "jumpto": "ENAS248_8.2.1.0"
}, {
    "name": "left ventricular outflow tract obstruction",
    "jumpto": "ENAS255_9.5.0.0"
}, {
    "name": "Left-sided valve IE, introduction",
    "jumpto": "ENAS5079_8.1.0.0"
}, {
    "name": "Legionella Pneumophila (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "lethal ventricular arrhythmias (HF)",
    "jumpto": "ENAS5195_9.1.0.0"
}, {
    "name": "levels of evidence (CVD prev)",
    "jumpto": "ENAS5196_2.0.0.0"
}, {
    "name": "Levels of evidence (PH)",
    "jumpto": "ENAS5081_2.0.0.0"
}, {
    "name": "Levels of evidence (VA and SCD)",
    "jumpto": "ENAS5083_2.0.0.0"
}, {
    "name": "levosimendan (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "levosimendan [CVD Preg]",
    "jumpto": "ENAS255_9.2.0.0"
}, {
    "name": "Lidocaine (VA and SCD)",
    "jumpto": "ENAS5083_6.1.3.0"
}, {
    "name": "lifestyle [STEMI]",
    "jumpto": "ENAS250_6.4.1.0"
}, {
    "name": "lifestyle changes strategy (Dyslip)",
    "jumpto": "ENAS5197_13.1.0.0"
}, {
    "name": "lifestyle changes\/LDL (Dyslip)",
    "jumpto": "ENAS5197_7.2.0.0"
}, {
    "name": "lifestyle changes\/lipids (Dyslip)",
    "jumpto": "ENAS5197_7.1.0.0"
}, {
    "name": "limb ischaemia, acute: categories",
    "jumpto": "ENAS256_5.6.11.0"
}, {
    "name": "limb ischaemia, acute: treatment",
    "jumpto": "ENAS256_5.6.11.0"
}, {
    "name": "limb ischaemia, critical",
    "jumpto": "ENAS256_5.6.9.0"
}, {
    "name": "limb ischaemia, critical: mgmt.",
    "jumpto": "ENAS256_5.6.10.0"
}, {
    "name": "limb ischaemia, limb salvage",
    "jumpto": "ENAS256_5.6.10.0"
}, {
    "name": "limb ischaemia, revascularization",
    "jumpto": "ENAS256_5.6.10.0"
}, {
    "name": "limb schaemia, acute: decision making",
    "jumpto": "ENAS256_5.6.12.0"
}, {
    "name": "Limb-girdle muscular dystrophy",
    "jumpto": "ENAS5083_13.2.1.0"
}, {
    "name": "lipid analyses before Tx (Dyslip)",
    "jumpto": "ENAS5197_5.2.0.0"
}, {
    "name": "lipid and lipoprotein analyses (Dyslip)",
    "jumpto": "ENAS5197_5.4.0.0"
}, {
    "name": "lipid control (CVD prev)",
    "jumpto": "ENAS5196_11.6.1.0"
}, {
    "name": "lipid intervention (CVD prev)",
    "jumpto": "ENAS5196_11.6.2.0"
}, {
    "name": "lipids (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "liver function tests (HF)",
    "jumpto": "ENAS5195_6.3.0.0"
}, {
    "name": "Liver transplantation (PH)",
    "jumpto": "ENAS5081_7.4.0.0"
}, {
    "name": "LMWH (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "Loeys-Dietz syndrome",
    "jumpto": "ENAS264_10.2.4.0"
}, {
    "name": "Long QT syndrome, diagnosis",
    "jumpto": "ENAS5083_9.2.1.0"
}, {
    "name": "long QT syndrome, pacing therapy,",
    "jumpto": "ENAS259_6.5.0.0"
}, {
    "name": "Long term oxygen therapy, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "long-QT syndrome, pregnancy",
    "jumpto": "ENAS255_4.3.0.0"
}, {
    "name": "Long-term HR control of AF (interactive algorithm)",
    "jumpto": "interactive_0000559"
}, {
    "name": "long-term rhythm control, AF",
    "jumpto": "ENAS5194_10.2.2.0"
}, {
    "name": "long-term surveillance, cancer patients",
    "jumpto": "ENAS5193_5.1.0.0"
}, {
    "name": "long-term surveillance, myocardial dysfunction",
    "jumpto": "ENAS5193_5.2.0.0"
}, {
    "name": "long-term surveillance, valvular disease",
    "jumpto": "ENAS5193_5.4.0.0"
}, {
    "name": "long-term surveillance, vascular disease",
    "jumpto": "ENAS5193_5.3.0.0"
}, {
    "name": "low molecular weight heparin, LMWH (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "low molecular weight heparin, pregnancy",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "low molecular weight heparin, valve replacement",
    "jumpto": "ENAS248_11.2.6.0"
}, {
    "name": "Low risk, PAH",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "lower extremity artery disease, exercise",
    "jumpto": "ENAS256_5.6.4.0"
}, {
    "name": "lower extremity artery disease, non-surgical",
    "jumpto": "ENAS256_5.7.7.0"
}, {
    "name": "lower extremity artery disease, pharmacotherapy",
    "jumpto": "ENAS256_5.6.4.0"
}, {
    "name": "lower extremity artery disease, staging",
    "jumpto": "ENAS256_5.6.1.0"
}, {
    "name": "lower extremity artery disease, surgical",
    "jumpto": "ENAS256_5.6.7.0"
}, {
    "name": "lower extremity artery disease, treadmill",
    "jumpto": "ENAS256_5.6.4.0"
}, {
    "name": "lower-extremity artery disease",
    "jumpto": "ENAS256_4.1.0.0"
}, {
    "name": "LQTS, risk stratification and management",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "lumbar epidural analgesia",
    "jumpto": "ENAS255_4.7.0.0"
}, {
    "name": "lumbar sympathectomy",
    "jumpto": "ENAS256_5.6.7.0"
}, {
    "name": "lung disease (HF)",
    "jumpto": "ENAS5195_12.15.0.0"
}, {
    "name": "Lung transplantation (PH)",
    "jumpto": "ENAS5081_11.0.0.0"
}, {
    "name": "Lung transplantation (PH)",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "Lung transplantation, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "LV dysfunction assessment, after dishcharge (VA and SCD)",
    "jumpto": "ENAS5083_6.2.2.0"
}, {
    "name": "LV dysfunction assessment, before dishcharge (VA and SCD)",
    "jumpto": "ENAS5083_6.2.2.0"
}, {
    "name": "LV dysfunction, cancer treatment",
    "jumpto": "ENAS5193_3.1.1.1"
}, {
    "name": "LV dysfunction, use of drugs",
    "jumpto": "ENAS5083_7.1.0.0"
}, {
    "name": "LV dysfunctiuon, ICD implant",
    "jumpto": "ENAS5083_7.1.0.0"
}, {
    "name": "LVEF reduction, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.3.0"
}, {
    "name": "Macitentan added to sildenafil, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Macitentan, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "magnesium sulfate, pregnancy",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "magnet resonance imaging, implanted cardiac devices",
    "jumpto": "ENAS259_8.3.0.0"
}, {
    "name": "magnetic resonance angiography, CAD",
    "jumpto": "ENAS256_5.1.2.0"
}, {
    "name": "magnetic resonance angiography, PAD",
    "jumpto": "ENAS256_4.5.0.0"
}, {
    "name": "magnetic resonance angiography, RAS",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "magnetic resonance imaging, pregnancy",
    "jumpto": "ENAS255_4.4.0.0"
}, {
    "name": "magnetic resonance, cardiac (VHD)",
    "jumpto": "ENAS248_5.1.6.0"
}, {
    "name": "major new key messages (CVD prev)",
    "jumpto": "ENAS5196_6.0.0.0"
}, {
    "name": "malignant hypertension, treatment",
    "jumpto": "ENAS260_8.12.0.0"
}, {
    "name": "Management of AHF (interactive algorithm)",
    "jumpto": "interactive_0000596"
}, {
    "name": "management of AHF, algorithm",
    "jumpto": "ENAS5195_13.8.1.0"
}, {
    "name": "management of AHRE (AFib)",
    "jumpto": "ENAS5194_4.2.0.0"
}, {
    "name": "management of atrial flutter",
    "jumpto": "ENAS5194_11.7.0.0"
}, {
    "name": "management of bleeding, AF",
    "jumpto": "ENAS5194_8.10.3.0"
}, {
    "name": "Management strategy, summary (NSTE-ACS)",
    "jumpto": "ENAS5080_6.1.0.0"
}, {
    "name": "management, bradycardia (HF)",
    "jumpto": "ENAS5195_11.6.0.0"
}, {
    "name": "management, cardiogenic shock (HF)",
    "jumpto": "ENAS5195_13.8.4.0"
}, {
    "name": "management, ventricular tachycardia (HF)",
    "jumpto": "ENAS5195_11.5.0.0"
}, {
    "name": "Marfan syndrome [CVD Preg]",
    "jumpto": "ENAS255_4.3.0.0"
}, {
    "name": "Marfan syndrome [VHD]",
    "jumpto": "ENAS248_6.1.0.0"
}, {
    "name": "markers of organ damage [HTN]",
    "jumpto": "ENAS260_5.8.0.0"
}, {
    "name": "maternal heart rate",
    "jumpto": "ENAS255_4.7.0.0"
}, {
    "name": "maternal risk, cardiovascular",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "maternal risk, high",
    "jumpto": "ENAS255_5.1.0.0"
}, {
    "name": "maternal risk, moderate",
    "jumpto": "ENAS255_5.2.0.0"
}, {
    "name": "maximum jet velocity",
    "jumpto": "ENAS248_5.1.2.0"
}, {
    "name": "mechanical circulatory support, overview (HF)",
    "jumpto": "ENAS5195_14.1.0.0"
}, {
    "name": "Medical assessment and determination of functional class (PH)",
    "jumpto": "ENAS5081_6.1.1.0"
}, {
    "name": "medication adherence (CVD prev)",
    "jumpto": "ENAS5196_12.5.0.0"
}, {
    "name": "medication strategy (Dyslip)",
    "jumpto": "ENAS5197_13.2.0.0"
}, {
    "name": "mEHRA scale (interactive score)",
    "jumpto": "interactive_0000564"
}, {
    "name": "mEHRA symptom scale (AFib)",
    "jumpto": "ENAS5194_5.4.0.0"
}, {
    "name": "mental disorders, dyslipidaemias",
    "jumpto": "ENAS5197_11.13.0.0"
}, {
    "name": "mesenteric artery disease",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "metabolic derangements (HF)",
    "jumpto": "ENAS5195_13.2.0.0"
}, {
    "name": "Metabolic syndrome, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "metformin (HF)",
    "jumpto": "ENAS5195_12.6.0.0"
}, {
    "name": "methyldopa, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "Metoprolol (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "Mgmt. of active bleeding (interactive algorithm)",
    "jumpto": "interactive_0000555"
}, {
    "name": "Mgmt. of AHRE (interactive algorithm)",
    "jumpto": "interactive_0000551"
}, {
    "name": "mgmt. of arrhythmia [DM]",
    "jumpto": "ENAS257_11.1.0.0"
}, {
    "name": "microvascular disease, treatment targets [DM]",
    "jumpto": "ENAS257_13.2.0.0"
}, {
    "name": "Microvolt T-wave alternans",
    "jumpto": "ENAS5083_6.2.1.0"
}, {
    "name": "Mid systolic notching, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "mineralocorticoid receptor antagonist, MRA (HF)",
    "jumpto": "ENAS5195_8.3.0.0"
}, {
    "name": "mitral regurgitation, functional",
    "jumpto": "ENAS248_8.2.1.0"
}, {
    "name": "mitral regurgitation, mgmt.",
    "jumpto": "ENAS248_8.1.2.0"
}, {
    "name": "mitral regurgitation, primary",
    "jumpto": "ENAS248_8.1.1.0"
}, {
    "name": "mitral regurgitation, STEMI",
    "jumpto": "ENAS250_7.2.0.0"
}, {
    "name": "mitral regurgitation, therapy",
    "jumpto": "ENAS248_8.1.3.0"
}, {
    "name": "mitral stenosis, intervention",
    "jumpto": "ENAS248_9.1.0.0"
}, {
    "name": "mitral stenosis, mgmt.",
    "jumpto": "ENAS248_9.2.0.0"
}, {
    "name": "mitral stenosis, pregnancy",
    "jumpto": "ENAS255_7.1.0.0"
}, {
    "name": "mobilization, mgmt. of VTE",
    "jumpto": "ENAS255_12.4.0.0"
}, {
    "name": "modified EHRA symptom scale (AFib)",
    "jumpto": "ENAS5194_5.4.0.0"
}, {
    "name": "Modifiers of calculated total CV risk",
    "jumpto": "ENAS5196_9.5.0.0"
}, {
    "name": "monitoring and follow-up, older adult (HF)",
    "jumpto": "ENAS5195_15.1.4.0"
}, {
    "name": "Monitoring lipids\/enzymes (Dyslip)",
    "jumpto": "ENAS5197_12.1.0.0"
}, {
    "name": "monitoring of patients (HF)",
    "jumpto": "ENAS5195_15.1.2.0"
}, {
    "name": "Monitoring, NSTE-ACS",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "monogenic AF",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "monotherapy after ACS (AFib)",
    "jumpto": "ENAS5194_8.11.2.0"
}, {
    "name": "monotherapy after PCI (AFib)",
    "jumpto": "ENAS5194_8.11.3.0"
}, {
    "name": "morphine (HF)",
    "jumpto": "ENAS5195_15.2.0.0"
}, {
    "name": "moxonidine (HF)",
    "jumpto": "ENAS5195_12.11.0.0"
}, {
    "name": "MR antagonist (HF)",
    "jumpto": "ENAS5195_8.2.0.0"
}, {
    "name": "Multi-detector computed tomography (MDCT)(NSTE-ACS)",
    "jumpto": "ENAS5080_3.6.0.0"
}, {
    "name": "multidisciplinary management (HF)",
    "jumpto": "ENAS5195_15.1.2.0"
}, {
    "name": "multidisciplinary team management, charateristics and components",
    "jumpto": "ENAS5195_15.1.1.0"
}, {
    "name": "multisite artery disease",
    "jumpto": "ENAS256_5.7.1.0"
}, {
    "name": "muscular dystrophies, pacing therapy",
    "jumpto": "ENAS259_6.5.0.0"
}, {
    "name": "muscular symptoms (Dyslip)",
    "jumpto": "ENAS5197_12.2.0.0"
}, {
    "name": "Muscular symptoms during statin treatment (interactive algorithm)",
    "jumpto": "interactive_0000594"
}, {
    "name": "Mycoplasma spp (IE)",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "myocardial infarction, assoc. with CABG",
    "jumpto": "ENAS247_5.7.0.0"
}, {
    "name": "myocardial infarction, assoc. with PCI",
    "jumpto": "ENAS247_5.5.0.0"
}, {
    "name": "myocardial infarction, definition [STEMI]",
    "jumpto": "ENAS250_4.1.0.0"
}, {
    "name": "myocardial infarction, definition [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "myocardial infarction, illustration",
    "jumpto": "ENAS247_4.3.0.0"
}, {
    "name": "myocardial infarction, recurrent",
    "jumpto": "ENAS247_10.0.0.0"
}, {
    "name": "myocardial infarction, silent",
    "jumpto": "ENAS247_10.0.0.0"
}, {
    "name": "myocardial infarction, stent-thrombosis",
    "jumpto": "ENAS247_5.6.0.0"
}, {
    "name": "myocardial infarction, Type 1",
    "jumpto": "ENAS247_5.1.0.0"
}, {
    "name": "myocardial infarction, Type 1\/Type 2",
    "jumpto": "ENAS247_5.3.0.0"
}, {
    "name": "myocardial infarction, Type 2",
    "jumpto": "ENAS247_5.2.0.0"
}, {
    "name": "myocardial infarction, Type 3",
    "jumpto": "ENAS247_5.4.0.0"
}, {
    "name": "myocardial infarction, Type 4a",
    "jumpto": "ENAS247_5.5.0.0"
}, {
    "name": "myocardial infarction, Type 4b",
    "jumpto": "ENAS247_5.6.0.0"
}, {
    "name": "myocardial infarction, Type 5",
    "jumpto": "ENAS247_5.7.0.0"
}, {
    "name": "myocardial ischaemia, atypical ECG",
    "jumpto": "ENAS250_5.1.0.0"
}, {
    "name": "myocardial ischaemia, definition of MI",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "myocardial ischaemia, pathology of MI",
    "jumpto": "ENAS247_3.0.0.0"
}, {
    "name": "myocardial ischaemia, primary",
    "jumpto": "ENAS247_4.2.0.0"
}, {
    "name": "myocardial necrosis",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "myocardial perfusion scintigraphy [SCAD]",
    "jumpto": "ENAS258_7.3.7.0"
}, {
    "name": "myocardial revascularization (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "myocardial revascularization [STEMI]",
    "jumpto": "ENAS250_6.3.0.0"
}, {
    "name": "myocardial revascularization, antiplatelet therapy",
    "jumpto": "ENAS265_20.7.0.0"
}, {
    "name": "myocardial revascularization, arrhythmias",
    "jumpto": "ENAS265_17.0.0.0"
}, {
    "name": "myocardial revascularization, CABG",
    "jumpto": "ENAS265_18.0.0.0"
}, {
    "name": "myocardial revascularization, follow up",
    "jumpto": "ENAS265_22.1.0.0"
}, {
    "name": "myocardial revascularization, functional testing",
    "jumpto": "ENAS265_7.0.0.0"
}, {
    "name": "myocardial revascularization, imaging",
    "jumpto": "ENAS265_7.0.0.0"
}, {
    "name": "myocardial revascularization, patient information",
    "jumpto": "ENAS265_6.0.0.0"
}, {
    "name": "myocardial revascularization, procedural aspects of PCI",
    "jumpto": "ENAS265_19.0.0.0"
}, {
    "name": "myocardial revascularization, risk models for outcome",
    "jumpto": "ENAS265_5.2.0.0"
}, {
    "name": "myocardial revascularization, secondary prevention",
    "jumpto": "ENAS265_22.1.0.0"
}, {
    "name": "myocardial revascularization, trials overview",
    "jumpto": "ENAS265_4.0.0.0"
}, {
    "name": "myocardial revascularization, volume-outcome",
    "jumpto": "ENAS265_21.0.0.0"
}, {
    "name": "myocardial viability",
    "jumpto": "ENAS250_6.3.0.0"
}, {
    "name": "Myocarditis, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "myocyte necrosis",
    "jumpto": "ENAS247_5.1.0.0"
}, {
    "name": "Myopathy, Becker",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, Duchenne",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, Emery-Dreifuss",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, facioscapulohumeral",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, limb girdle type 2C-2F",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, limb girdle type 2I",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, limb-girdle type IB",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, myotonic type 1",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopathy, myotonic type 2",
    "jumpto": "ENAS5083_13.2.2.0"
}, {
    "name": "Myopericarditis",
    "jumpto": "ENAS5082_3.5.0.0"
}, {
    "name": "N-3 PUFA (HF)",
    "jumpto": "ENAS5195_8.4.0.0"
}, {
    "name": "Naproxen, in paediatric pericardial diseases",
    "jumpto": "ENAS5082_6.1.2.0"
}, {
    "name": "NASCET criteria",
    "jumpto": "ENAS256_5.1.2.0"
}, {
    "name": "natriuretic peptides, aortic stenosis",
    "jumpto": "ENAS248_7.6.0.0"
}, {
    "name": "natriuretic peptides, patient evaluation",
    "jumpto": "ENAS248_5.1.6.0"
}, {
    "name": "Nebivolol (Afib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "New York Heart Association [VHD]",
    "jumpto": "ENAS248_9.1.0.0"
}, {
    "name": "nicorandil (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "nicotinic acid, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.5.0.0"
}, {
    "name": "nifedipine, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "NIHSS scores and OAC (AFib)",
    "jumpto": "ENAS5194_8.9.2.0"
}, {
    "name": "Nitric oxide, in vasoreactivity testing",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "nitroglycerine, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "NOACs in AF",
    "jumpto": "ENAS5194_8.6.0.0"
}, {
    "name": "non-acute onset HF, diagnosis",
    "jumpto": "ENAS5195_5.2.0.0"
}, {
    "name": "non-antiarrhythmic drugs, antiarrhythmic effects (AFib)",
    "jumpto": "ENAS5194_10.3.0.0"
}, {
    "name": "non-cardiac surgery, cardiovascular complications",
    "jumpto": "ENAS261_3.0.0.0"
}, {
    "name": "non-cardiac surgery, type",
    "jumpto": "ENAS261_5.0.0.0"
}, {
    "name": "Non-complicated infective endocarditis",
    "jumpto": "ENAS5079_4.1.0.0"
}, {
    "name": "Non-invasive imaging (NSTE-ACS)",
    "jumpto": "ENAS5080_3.6.0.0"
}, {
    "name": "Non-ST-elevation ACS, definitions (NSTE-ACS)",
    "jumpto": "ENAS5080_2.0.0.0"
}, {
    "name": "NSAID, acute pericarditis",
    "jumpto": "ENAS5082_3.2.5.0"
}, {
    "name": "NSAIDs (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "NSTE-ACS management, initial evaluation",
    "jumpto": "ENAS5080_6.1.0.0"
}, {
    "name": "NSTE-ACS management, pathway",
    "jumpto": "ENAS5080_6.1.0.0"
}, {
    "name": "NSTE-ACS with acute heart failure, mgmt.",
    "jumpto": "ENAS5080_5.6.4.0"
}, {
    "name": "NSTE-ACS, anticoagulation recommendations",
    "jumpto": "ENAS5080_5.3.2.0"
}, {
    "name": "NSTE-ACS, antiplatelet treatment. general treatment recommendations",
    "jumpto": "ENAS5080_5.2.6.0"
}, {
    "name": "NSTE-ACS, antithrombotic drugs",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "NSTE-ACS, antithrombotic strategies",
    "jumpto": "ENAS5080_5.4.2.0"
}, {
    "name": "NSTE-ACS, antithrombotic treatment summary",
    "jumpto": "ENAS5080_6.3.0.0"
}, {
    "name": "NSTE-ACS, bleeding management",
    "jumpto": "ENAS5080_5.4.5.0"
}, {
    "name": "NSTE-ACS, blood transfusion recommendations",
    "jumpto": "ENAS5080_5.4.5.0"
}, {
    "name": "NSTE-ACS, cardiac troponin assay",
    "jumpto": "ENAS5080_3.2.0.0"
}, {
    "name": "NSTE-ACS, chronic oral anticoagulation",
    "jumpto": "ENAS5080_5.4.3.0"
}, {
    "name": "NSTE-ACS, diagnosis",
    "jumpto": "ENAS5080_3.1.0.0"
}, {
    "name": "NSTE-ACS, diagnosis validation",
    "jumpto": "ENAS5080_6.2.0.0"
}, {
    "name": "NSTE-ACS, differential diagnoses",
    "jumpto": "ENAS5080_3.7.1.0"
}, {
    "name": "NSTE-ACS, hospital discharge",
    "jumpto": "ENAS5080_6.6.0.0"
}, {
    "name": "NSTE-ACS, in diabetic patients",
    "jumpto": "ENAS5080_5.6.2.0"
}, {
    "name": "NSTE-ACS, in elderly patients",
    "jumpto": "ENAS5080_5.6.1.0"
}, {
    "name": "NSTE-ACS, in patients with chronic kidney disease",
    "jumpto": "ENAS5080_5.6.3.0"
}, {
    "name": "NSTE-ACS, intravenous antiplatelet therapy",
    "jumpto": "ENAS5080_5.2.4.0"
}, {
    "name": "NSTE-ACS, invasive strategy summary",
    "jumpto": "ENAS5080_6.4.0.0"
}, {
    "name": "NSTE-ACS, long-term P2Y12 inhibition",
    "jumpto": "ENAS5080_5.2.5.0"
}, {
    "name": "NSTE-ACS, mgmt. of Afib",
    "jumpto": "ENAS5080_5.6.6.0"
}, {
    "name": "NSTE-ACS, oral platelet therapy",
    "jumpto": "ENAS5080_5.2.3.0"
}, {
    "name": "NSTE-ACS, patients requiring CABG",
    "jumpto": "ENAS5080_5.5.3.0"
}, {
    "name": "NSTE-ACS, platelet inhibition",
    "jumpto": "ENAS5080_5.2.3.0"
}, {
    "name": "NSTE-ACS, post-discharge management",
    "jumpto": "ENAS5080_6.6.0.0"
}, {
    "name": "NSTE-ACS, revascularisation modalities",
    "jumpto": "ENAS5080_6.5.0.0"
}, {
    "name": "NSTE-ACS, risk assessment",
    "jumpto": "ENAS5080_6.2.0.0"
}, {
    "name": "NSTE-ACS, risk assessment",
    "jumpto": "ENAS5080_4.1.0.0"
}, {
    "name": "NSTE-ACS, thrombocytopenia mgmt.",
    "jumpto": "ENAS5080_5.6.7.0"
}, {
    "name": "NSTE-ACS, treatment strategy",
    "jumpto": "ENAS5080_5.5.1.0"
}, {
    "name": "NSTE-ACS, treatment timing",
    "jumpto": "ENAS5080_5.5.1.0"
}, {
    "name": "NSTE-ACS, with acute heart failure",
    "jumpto": "ENAS5080_5.6.4.0"
}, {
    "name": "NSTEMI, intermediate risk of cardiac arrhythmia",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "NSTEMI, low risk for cardiac arrhythmia",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "NT-proBNP plasma levels (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "ntithrombotic treatments for PCI, patients with OAC",
    "jumpto": "ENAS265_20.4.0.0"
}, {
    "name": "nutrition (CVD prev)",
    "jumpto": "ENAS5196_11.5.0.0"
}, {
    "name": "nyquist limit",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "obesity (HF)",
    "jumpto": "ENAS5195_12.16.0.0"
}, {
    "name": "obesity [PAD]",
    "jumpto": "ENAS256_4.2.0.0"
}, {
    "name": "obesity, physical examination [HTN]",
    "jumpto": "ENAS260_5.4.0.0"
}, {
    "name": "obstructive sleep apnoea syndrome (CVD prev)",
    "jumpto": "ENAS5196_9.10.4.0"
}, {
    "name": "occlusion, femoral artery",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "occlusion, iliac artery",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "office blood pressure",
    "jumpto": "ENAS260_5.2.1.0"
}, {
    "name": "older adult, monitoring and follow-up (HF)",
    "jumpto": "ENAS5195_15.1.4.0"
}, {
    "name": "older persons, dyslipidaemias",
    "jumpto": "ENAS5197_11.4.0.0"
}, {
    "name": "opioids [STEMI]",
    "jumpto": "ENAS250_5.2.0.0"
}, {
    "name": "optical coherence tomography [SCAD]",
    "jumpto": "ENAS258_9.2.0.0"
}, {
    "name": "Optimized volume status",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "Oral anticoagulant, PAH supportive therapy",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "oral disease-modifying therapies (HF)",
    "jumpto": "ENAS5195_13.8.5.0"
}, {
    "name": "organ damage, asymptomatic [HTN]",
    "jumpto": "ENAS260_5.8.0.0"
}, {
    "name": "orthopnoea (HF)",
    "jumpto": "ENAS5195_13.3.0.0"
}, {
    "name": "Osler\u2019s nodes (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "other co-morbidities, treatment recommendations (HF)",
    "jumpto": "ENAS5195_12.13.1.0"
}, {
    "name": "other co-morbidities, treatments not recommended (HF)",
    "jumpto": "ENAS5195_12.13.2.0"
}, {
    "name": "out-of-office blood pressure measurement, clinical indications",
    "jumpto": "ENAS260_5.2.3.0"
}, {
    "name": "out-of-office blood pressure, monitoring",
    "jumpto": "ENAS260_5.2.2.0"
}, {
    "name": "Overdrive pacing",
    "jumpto": "ENAS5083_6.1.3.0"
}, {
    "name": "overt heart failure, prevention",
    "jumpto": "ENAS5195_7.0.0.0"
}, {
    "name": "overview, acute heart failure",
    "jumpto": "ENAS5195_13.1.0.0"
}, {
    "name": "overview, arrhythmias (HF)",
    "jumpto": "ENAS5195_11.1.0.0"
}, {
    "name": "overview, cardiac imaging (HF)",
    "jumpto": "ENAS5195_6.1.0.0"
}, {
    "name": "overview, co-morbidities (HF)",
    "jumpto": "ENAS5195_12.1.0.0"
}, {
    "name": "overview, conductance disturbance (HF)",
    "jumpto": "ENAS5195_11.1.0.0"
}, {
    "name": "overview, heart transplantation (HF)",
    "jumpto": "ENAS5195_14.1.0.0"
}, {
    "name": "overview, mechanical circulatory support (HF)",
    "jumpto": "ENAS5195_14.1.0.0"
}, {
    "name": "overview,treatment of HFrEF",
    "jumpto": "ENAS5195_8.1.0.0"
}, {
    "name": "overweight (Dyslip)",
    "jumpto": "ENAS5197_7.3.0.0"
}, {
    "name": "oxygen therapy, acute heart failure (HF)",
    "jumpto": "ENAS5195_13.7.0.0"
}, {
    "name": "Oxygen therapy, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Oxygen, PAH supportive therapy",
    "jumpto": "ENAS5081_6.2.2.2"
}, {
    "name": "oxygen, STEMI",
    "jumpto": "ENAS250_5.2.0.0"
}, {
    "name": "P2Y12 inhibitors, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "P2Y12 inhibitors, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "P2Y12 inhibitors, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "pacemaker, implantation rate",
    "jumpto": "ENAS259_4.1.1.0"
}, {
    "name": "pacemaker, indication [Pacing]",
    "jumpto": "ENAS259_4.1.2.0"
}, {
    "name": "pacemaker, pregnancy",
    "jumpto": "ENAS255_10.5.0.0"
}, {
    "name": "pacemaker, type [Pacing]",
    "jumpto": "ENAS259_4.1.2.0"
}, {
    "name": "pacing mode, children",
    "jumpto": "ENAS259_6.3.2.0"
}, {
    "name": "pacing therapy, children",
    "jumpto": "ENAS259_6.3.1.0"
}, {
    "name": "pacing therapy, emergency transvenous",
    "jumpto": "ENAS259_8.4.0.0"
}, {
    "name": "pacing therapy, first-degree atrioventricular block",
    "jumpto": "ENAS259_6.7.0.0"
}, {
    "name": "pacing therapy, hematomas\/infections",
    "jumpto": "ENAS259_7.2.0.0"
}, {
    "name": "pacing therapy, pregnancy",
    "jumpto": "ENAS259_6.6.0.0"
}, {
    "name": "pacing therapy, reimplantation",
    "jumpto": "ENAS259_8.2.0.0"
}, {
    "name": "pacing, complications",
    "jumpto": "ENAS259_7.1.0.0"
}, {
    "name": "Paediatric pericardial diseases, therapy",
    "jumpto": "ENAS5082_6.1.3.0"
}, {
    "name": "paediatric population, cardiotoxicity",
    "jumpto": "ENAS5193_3.10.1.0"
}, {
    "name": "PAH mgmt., according to echo probability",
    "jumpto": "ENAS5081_5.5.0.0"
}, {
    "name": "PAH treatment, general measures",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "PAH with CHD, clinical classification",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "PAH, associated with adult CHD",
    "jumpto": "ENAS5081_7.2.0.0"
}, {
    "name": "PAH, associated with congenital heart disease",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, associated with CTD",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, associated with HIV infection",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, associated with portal hypertension",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, associated with schistosomiasis",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, balloon atrial septostomy",
    "jumpto": "ENAS5081_6.2.4.0"
}, {
    "name": "PAH, clinical response to therapy",
    "jumpto": "ENAS5081_6.1.3.0"
}, {
    "name": "PAH, definition",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "PAH, drug and toxins induced",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, evaluation of severity",
    "jumpto": "ENAS5081_6.1.3.0"
}, {
    "name": "PAH, group 3",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "PAH, heritable",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, ICU mgmt. efficacy",
    "jumpto": "ENAS5081_6.2.4.0"
}, {
    "name": "PAH, idiopathic",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, initial drug combination therapy",
    "jumpto": "ENAS5081_6.2.3.3"
}, {
    "name": "PAH, inotropic support",
    "jumpto": "ENAS5081_6.2.4.0"
}, {
    "name": "PAH, lung transplantation",
    "jumpto": "ENAS5081_6.2.4.0"
}, {
    "name": "PAH, other pulmonary artery obstructions",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PAH, pediatric",
    "jumpto": "ENAS5081_7.1.0.0"
}, {
    "name": "PAH, sequential drug combination therapy",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "PAH, treatment algorithm",
    "jumpto": "ENAS5081_6.2.5.0"
}, {
    "name": "PAH, treatment strategy",
    "jumpto": "ENAS5081_6.2.1.0"
}, {
    "name": "PAH, with coincidental defects",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "PAH, with CTD",
    "jumpto": "ENAS5081_7.3.0.0"
}, {
    "name": "PAH, with defect correction",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "PAH, with HIV infection",
    "jumpto": "ENAS5081_7.5.0.0"
}, {
    "name": "PAH, with lung disease",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "PAH, with portal hypertension",
    "jumpto": "ENAS5081_7.4.0.0"
}, {
    "name": "PAH, with small defects",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "PAH, with systemic-to-pulmonary shunts",
    "jumpto": "ENAS5081_4.2.2.0"
}, {
    "name": "palliative care approaches (HF)",
    "jumpto": "ENAS5195_15.2.0.0"
}, {
    "name": "Pansystolic murmur, of tricuspid regurgitation",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "papillary muscle dysfunction",
    "jumpto": "ENAS250_7.2.0.0"
}, {
    "name": "Parasternal lift, symptom of PH",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "paravalvular leak",
    "jumpto": "ENAS248_11.2.10.0"
}, {
    "name": "patent ductus arteriosus",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "patient education in AF",
    "jumpto": "ENAS5194_12.0.0.0"
}, {
    "name": "patient with AHF, initial management",
    "jumpto": "ENAS5195_13.5.0.0"
}, {
    "name": "patterns, AF",
    "jumpto": "ENAS5194_5.2.0.0"
}, {
    "name": "PCI in NSTE-ACS",
    "jumpto": "ENAS5080_5.5.2.0"
}, {
    "name": "PCI related bleeding, management strategies",
    "jumpto": "ENAS5080_5.4.1.0"
}, {
    "name": "PCSK9 inhibitors, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.4.0.0"
}, {
    "name": "peak transvalvular velocity",
    "jumpto": "ENAS248_7.1.0.0"
}, {
    "name": "Pediatric pericardial diseases, regimens",
    "jumpto": "ENAS5082_6.1.2.0"
}, {
    "name": "penetrating aortic ulcer",
    "jumpto": "ENAS264_8.4.0.0"
}, {
    "name": "Penicillin, dental procedure prophylaxis",
    "jumpto": "ENAS5079_3.2.0.0"
}, {
    "name": "percutaneous coronary intervention [CVD Preg]",
    "jumpto": "ENAS255_4.6.0.0"
}, {
    "name": "percutaneous coronary intervention [UDMI]",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "percutaneous coronary intervention, associated MI",
    "jumpto": "ENAS247_5.5.0.0"
}, {
    "name": "percutaneous coronary intervention, tabulation",
    "jumpto": "ENAS247_11.0.0.0"
}, {
    "name": "percutaneous mitral commissurotomy [CVD Preg]",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "percutaneous mitral commissurotomy [VHD]",
    "jumpto": "ENAS248_9.1.0.0"
}, {
    "name": "percutaneous transluminal angioplasty",
    "jumpto": "ENAS256_5.6.6.0"
}, {
    "name": "percutaneous valvulotomy, pregnancy",
    "jumpto": "ENAS255_7.2.0.0"
}, {
    "name": "Perforation, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Perforation, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "peri-operative cardiac monitoring, disturbed glucose metabolism",
    "jumpto": "ENAS261_9.3.0.0"
}, {
    "name": "peri-operative cardiac monitoring, ECG",
    "jumpto": "ENAS261_9.1.0.0"
}, {
    "name": "peri-operative cardiac monitoring, TOE",
    "jumpto": "ENAS261_9.2.0.0"
}, {
    "name": "Pericardial cavity rinsing",
    "jumpto": "ENAS5082_5.2.3.1"
}, {
    "name": "Pericardial cysts",
    "jumpto": "ENAS5082_5.8.6.0"
}, {
    "name": "pericardial disease, cardiotoxicity",
    "jumpto": "ENAS5193_3.9.1.0"
}, {
    "name": "Pericardial disease, diagnostic work-up",
    "jumpto": "ENAS5082_4.1.0.0"
}, {
    "name": "Pericardial disease, general diagnostic workup",
    "jumpto": "ENAS5082_4.2.1.0"
}, {
    "name": "Pericardial disease, high risk patients",
    "jumpto": "ENAS5082_4.2.2.0"
}, {
    "name": "Pericardial disease, infectious cause",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial disease, multimodality imaging",
    "jumpto": "ENAS5082_4.1.0.0"
}, {
    "name": "Pericardial disease, non-infectious cause",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial disease, traumatic and iatrogenic",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial diseases, aetiology",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial diseases, definition",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial diseases, in children",
    "jumpto": "ENAS5082_6.1.1.0"
}, {
    "name": "Pericardial diseases, in pregnancy",
    "jumpto": "ENAS5082_6.2.1.0"
}, {
    "name": "Pericardial diseases, introduction",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Pericardial diseases, surgery",
    "jumpto": "ENAS5082_7.2.1.0"
}, {
    "name": "Pericardial drainage, interventional techniques",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "Pericardial effusion, acute",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, chronic",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, circumferential",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, classification",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, diagnosis",
    "jumpto": "ENAS5082_3.6.4.0"
}, {
    "name": "Pericardial effusion, drug-related",
    "jumpto": "ENAS5082_5.8.3.0"
}, {
    "name": "Pericardial effusion, echocardiographic assessment",
    "jumpto": "ENAS5082_3.6.3.0"
}, {
    "name": "Pericardial effusion, in endocrine disorders",
    "jumpto": "ENAS5082_5.8.4.0"
}, {
    "name": "Pericardial effusion, in metabolic disorders",
    "jumpto": "ENAS5082_5.8.4.0"
}, {
    "name": "Pericardial effusion, in PAH",
    "jumpto": "ENAS5082_5.8.5.0"
}, {
    "name": "Pericardial effusion, initial management",
    "jumpto": "ENAS5082_3.6.6.0"
}, {
    "name": "Pericardial effusion, large",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, loculated",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, management",
    "jumpto": "ENAS5082_3.6.5.0"
}, {
    "name": "Pericardial effusion, mild",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, moderate",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, overview",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, prognosis",
    "jumpto": "ENAS5082_3.6.8.0"
}, {
    "name": "Pericardial effusion, rapid",
    "jumpto": "ENAS5082_3.6.2.0"
}, {
    "name": "Pericardial effusion, slow",
    "jumpto": "ENAS5082_3.6.2.0"
}, {
    "name": "Pericardial effusion, subacute",
    "jumpto": "ENAS5082_3.6.1.0"
}, {
    "name": "Pericardial effusion, therapy",
    "jumpto": "ENAS5082_3.6.7.0"
}, {
    "name": "Pericardial effusion, traumatic",
    "jumpto": "ENAS5082_5.6.0.0"
}, {
    "name": "Pericardial effusion, triage",
    "jumpto": "ENAS5082_3.6.5.0"
}, {
    "name": "Pericardial fluid, analyses",
    "jumpto": "ENAS5082_4.2.5.0"
}, {
    "name": "Pericardial knock",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "Pericardial syndromes, definition",
    "jumpto": "ENAS5082_3.1.0.0"
}, {
    "name": "Pericardial window",
    "jumpto": "ENAS5082_7.2.1.0"
}, {
    "name": "Pericardiectomy, surgery in pericardial diseases",
    "jumpto": "ENAS5082_7.2.2.0"
}, {
    "name": "Pericardiocentesis (Pericard.)",
    "jumpto": "ENAS5082_3.6.5.0"
}, {
    "name": "Pericardiocentesis, complications",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "Pericardiocentesis, interventional techniques",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "Pericarditis during pregnancy, treatment",
    "jumpto": "ENAS5082_6.2.2.0"
}, {
    "name": "Pericarditis, bacterial",
    "jumpto": "ENAS5082_5.2.1.0"
}, {
    "name": "Pericarditis, chronic",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Pericarditis, definition",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Pericarditis, drug-related",
    "jumpto": "ENAS5082_5.8.3.0"
}, {
    "name": "Pericarditis, first level investigations",
    "jumpto": "ENAS5082_4.2.4.0"
}, {
    "name": "Pericarditis, in autoimmune diseases",
    "jumpto": "ENAS5082_5.4.0.0"
}, {
    "name": "Pericarditis, in autoinflammatory diseases",
    "jumpto": "ENAS5082_5.4.0.0"
}, {
    "name": "Pericarditis, in neoplastic disease",
    "jumpto": "ENAS5082_5.7.0.0"
}, {
    "name": "Pericarditis, in renal failure",
    "jumpto": "ENAS5082_5.3.0.0"
}, {
    "name": "Pericarditis, incessant",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Pericarditis, purulent",
    "jumpto": "ENAS5082_5.2.3.1"
}, {
    "name": "Pericarditis, recurrent",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "pericarditis, second level investigations",
    "jumpto": "ENAS5082_4.2.4.0"
}, {
    "name": "Pericarditis, therapeutic algorithm",
    "jumpto": "ENAS5082_3.4.0.0"
}, {
    "name": "Pericarditis, tubercular",
    "jumpto": "ENAS5082_5.2.2.1"
}, {
    "name": "Pericarditis, viral",
    "jumpto": "ENAS5082_5.1.0.0"
}, {
    "name": "Pericarditis, with pericardial involvement",
    "jumpto": "ENAS5082_3.5.0.0"
}, {
    "name": "Perioperative mgmt. in patients requiring CABG",
    "jumpto": "ENAS5080_5.5.3.0"
}, {
    "name": "peripheral arterial disease, dyslipidaemias",
    "jumpto": "ENAS5197_11.10.0.0"
}, {
    "name": "peripheral artery disease",
    "jumpto": "ENAS256_4.1.0.0"
}, {
    "name": "peripheral artery disease (CVD prev)",
    "jumpto": "ENAS5196_13.5.0.0"
}, {
    "name": "peripheral artery disease (PAD), case history [DM]",
    "jumpto": "ENAS257_12.2.2.0"
}, {
    "name": "peripheral artery disease (PAD), CLI mgmt. [DM]",
    "jumpto": "ENAS257_12.2.5.0"
}, {
    "name": "peripheral artery disease (PAD), intermittent claudication treatment algorithm [DM]",
    "jumpto": "ENAS257_12.2.4.0"
}, {
    "name": "peripheral artery disease (PAD), introduction [DM]",
    "jumpto": "ENAS257_12.2.1.0"
}, {
    "name": "peripheral artery disease (PAD), mgmt. in DM",
    "jumpto": "ENAS257_12.1.0.0"
}, {
    "name": "peripheral artery disease (PAD), physical examination [DM]",
    "jumpto": "ENAS257_12.2.3.0"
}, {
    "name": "peripheral artery disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.7.0.0"
}, {
    "name": "peripheral artery disease, assessment",
    "jumpto": "ENAS256_4.3.0.0"
}, {
    "name": "peripheral artery disease, diagnostic tests",
    "jumpto": "ENAS256_4.5.0.0"
}, {
    "name": "peripheral artery disease, history",
    "jumpto": "ENAS256_4.3.0.0"
}, {
    "name": "peripheral artery disease, laboratory",
    "jumpto": "ENAS256_4.4.0.0"
}, {
    "name": "peripheral artery disease, risk factors",
    "jumpto": "ENAS256_4.2.0.0"
}, {
    "name": "peripheral artery disease, treatment",
    "jumpto": "ENAS256_4.6.0.0"
}, {
    "name": "Peripheral oedema (PH)",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "peripheral vascular disease, cardiotoxicity",
    "jumpto": "ENAS5193_3.7.2.0"
}, {
    "name": "peripheral vascular disease, cardiotoxicity",
    "jumpto": "ENAS5193_3.7.1.1"
}, {
    "name": "Persistent atrial fibrillation, group 2 PH",
    "jumpto": "ENAS5081_8.1.0.0"
}, {
    "name": "persistent bradycardia, choice of pacing mode",
    "jumpto": "ENAS259_4.2.2.0"
}, {
    "name": "persistent bradycardia, clinical perspective",
    "jumpto": "ENAS259_4.2.2.0"
}, {
    "name": "persistent bradycardia, indications for pacing",
    "jumpto": "ENAS259_4.2.1.0"
}, {
    "name": "persistent bradycardia, optimal pacing mode",
    "jumpto": "ENAS259_4.2.3.0"
}, {
    "name": "Persistent PH of newborn",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PH diagnostic strategy",
    "jumpto": "ENAS5081_5.9.0.0"
}, {
    "name": "PH due to lung disease, clinical classification",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PH guidelines, new aspects",
    "jumpto": "ENAS5081_3.2.0.0"
}, {
    "name": "PH guidelines, principles",
    "jumpto": "ENAS5081_3.1.0.0"
}, {
    "name": "PH in left heart disease, mgmt.",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "PH referral centre",
    "jumpto": "ENAS5081_11.0.0.0"
}, {
    "name": "PH with unclear mechanisms, clinical classification",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PH, abdominal ultrasound scan",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, blood tests and immunology",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, cardiac magnetic resonance imaging",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, chest radiograph",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, clinical classification",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PH, clinical presentation",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "PH, definition",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "PH, diagnosis",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "PH, diagnostic algorithm",
    "jumpto": "ENAS5081_5.8.0.0"
}, {
    "name": "PH, diagnostic investigations",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, echocardiographic probability",
    "jumpto": "ENAS5081_5.3.0.0"
}, {
    "name": "PH, echocardiographic signs",
    "jumpto": "ENAS5081_5.4.0.0"
}, {
    "name": "PH, echocardiography",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, echocardiography",
    "jumpto": "ENAS5081_5.3.0.0"
}, {
    "name": "PH, electrocardiogram",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, exercise",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "PH, further treatment strategies",
    "jumpto": "ENAS5081_6.2.4.0"
}, {
    "name": "PH, hemodynamic definitions",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "PH, high-resolution computed tomography, contrast enhanced computed tomography",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, physical signs",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "PH, pulmonary angiography",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, pulmonary function tests and arterial blood gases",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, right heart catheterization",
    "jumpto": "ENAS5081_5.6.0.0"
}, {
    "name": "PH, right heart catheterization and vasoreactivity",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "PH, symptoms",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "PH, ventilation\/perfusion lung scan",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "pharmacological cardioversion (HF)",
    "jumpto": "ENAS5195_11.3.0.0"
}, {
    "name": "pharmacological mgmt., side effects, CI and drug-drug interactions [SCAD]",
    "jumpto": "ENAS258_8.4.1.0"
}, {
    "name": "Pharmacological stress testing (VA and SCD)",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "pharmacological treatment in HFrEF",
    "jumpto": "ENAS5195_8.3.0.0"
}, {
    "name": "pharmacological treatment, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.6.0.0"
}, {
    "name": "pharmacotherapy, AHF (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "phenprocoumon, pregnancy",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "phlegmasia cerulea",
    "jumpto": "ENAS256_5.6.11.0"
}, {
    "name": "phosphodiesterase III inhibitors (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "phosphodiesterase type 5 inhibitors (HF)",
    "jumpto": "ENAS5195_12.7.0.0"
}, {
    "name": "Phrenic nerve damage",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "physical activity, population-based approach (CVD prev)",
    "jumpto": "ENAS5196_14.2.0.0"
}, {
    "name": "Physical exercise (PH)",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "plasma homocysteine, PAD",
    "jumpto": "ENAS256_4.2.0.0"
}, {
    "name": "plasma natriuretic peptides (HF)",
    "jumpto": "ENAS5195_5.2.0.0"
}, {
    "name": "pleural effusion, cardiotoxicity",
    "jumpto": "ENAS5193_3.9.2.0"
}, {
    "name": "polygenic AF",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "Polymerase chain reaction (PCR)(Pericard.)",
    "jumpto": "ENAS5082_4.2.5.0"
}, {
    "name": "Polymerase chain reaction, microbiological diagnosis of IE",
    "jumpto": "ENAS5079_5.3.2.0"
}, {
    "name": "popliteal aneurysm thrombosis",
    "jumpto": "ENAS256_5.6.11.0"
}, {
    "name": "positron emission tomography, PET (HF)",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "Post NSTE-ACS, long term management",
    "jumpto": "ENAS5080_5.7.0.0"
}, {
    "name": "Post-capillary PH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "Post-capillary PH, hemodynamic definitions of PH",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "Post-cardiac injury syndrome, definition",
    "jumpto": "ENAS5082_5.5.1.0"
}, {
    "name": "Post-cardiac injury syndrome, diagnosis",
    "jumpto": "ENAS5082_5.5.1.0"
}, {
    "name": "Post-cardiac injury syndrome, management",
    "jumpto": "ENAS5082_5.5.2.0"
}, {
    "name": "Postmyocardial infarction syndrome",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "postoperative AF",
    "jumpto": "ENAS5194_5.3.0.0"
}, {
    "name": "postoperative AF",
    "jumpto": "ENAS5194_11.5.0.0"
}, {
    "name": "Postpericardiotomy syndrome",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Prasugrel (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "prasugrel, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Prasugrel, P2Y12 inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.1.0"
}, {
    "name": "prasugrel, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "prasugrel, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "Pre-capillary PH",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "Pre-capillary PH, hemodynamic definitions of PH",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "pre-eclampsia",
    "jumpto": "ENAS255_11.2.0.0"
}, {
    "name": "pre-eclampsia, pulmonary oedema",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "pre-op cardiac risk evaluation (algorithm)",
    "jumpto": "ENAS261_11.0.0.0"
}, {
    "name": "pre-op cardiac risk evaluation (table)",
    "jumpto": "ENAS261_12.0.0.0"
}, {
    "name": "pre-op cardiac risk, cardiac condition",
    "jumpto": "ENAS261_4.3.0.0"
}, {
    "name": "pre-op cardiac risk, cardiac diagnostic",
    "jumpto": "ENAS261_4.6.0.0"
}, {
    "name": "pre-op cardiac risk, consideration of individual benefit",
    "jumpto": "ENAS261_4.8.0.0"
}, {
    "name": "pre-op cardiac risk, functional capacity",
    "jumpto": "ENAS261_4.5.0.0"
}, {
    "name": "pre-op cardiac risk, further testing",
    "jumpto": "ENAS261_4.7.0.0"
}, {
    "name": "pre-op cardiac risk, surgical risk estimate",
    "jumpto": "ENAS261_4.4.0.0"
}, {
    "name": "pre-op cardiac risk, urgency of surgery",
    "jumpto": "ENAS261_4.2.0.0"
}, {
    "name": "pre-operative cardiac risk assessment, non-cardiac surgery,",
    "jumpto": "ENAS261_4.1.0.0"
}, {
    "name": "pre-operative evaluation, electrocardiography",
    "jumpto": "ENAS261_6.2.0.0"
}, {
    "name": "pre-operative evaluation, invasive coronary angiography",
    "jumpto": "ENAS261_6.4.0.0"
}, {
    "name": "pre-operative evaluation, non-invasive assessment of LV function",
    "jumpto": "ENAS261_6.3.0.0"
}, {
    "name": "pre-operative evaluation, risk indices",
    "jumpto": "ENAS261_6.1.0.0"
}, {
    "name": "Pre-participation evaluation protocol",
    "jumpto": "ENAS5083_13.7.0.0"
}, {
    "name": "pre-test probability (PTP)",
    "jumpto": "ENAS258_7.3.4.0"
}, {
    "name": "pre-test probability, confirmed SCAD",
    "jumpto": "ENAS258_7.5.2.0"
}, {
    "name": "pre-test probability, initial diagnostic mgmt. [SCAD]",
    "jumpto": "ENAS258_7.3.5.0"
}, {
    "name": "pre-test probability, intermediate [SCAD]",
    "jumpto": "ENAS258_7.3.6.0"
}, {
    "name": "pre-test probability, suspected SCAD",
    "jumpto": "ENAS258_7.3.3.0"
}, {
    "name": "precipitating factors (HF)",
    "jumpto": "ENAS5195_11.1.0.0"
}, {
    "name": "preclinical vascular damage measurements (CVD prev)",
    "jumpto": "ENAS5196_9.9.0.0"
}, {
    "name": "Predictors of prognosis, major",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "Predictors of prognosis, minor",
    "jumpto": "ENAS5082_3.2.4.0"
}, {
    "name": "preferred drugs (CVD prev)",
    "jumpto": "ENAS5196_12.3.4.0"
}, {
    "name": "Pregnancy (PH)",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "pregnancy, CVD",
    "jumpto": "ENAS255_8.0.0.0"
}, {
    "name": "pregnancy, CVD diagnosis",
    "jumpto": "ENAS255_4.4.0.0"
}, {
    "name": "pregnancy, drugs: benefit and risk",
    "jumpto": "ENAS255_13.1.0.0"
}, {
    "name": "pregnancy, drugs: FDA classification",
    "jumpto": "ENAS255_13.2.0.0"
}, {
    "name": "pregnancy, drugs: internet reference",
    "jumpto": "ENAS255_13.3.0.0"
}, {
    "name": "pregnancy, drugs: manufactures' instructions",
    "jumpto": "ENAS255_13.4.0.0"
}, {
    "name": "pregnancy, physiological changes",
    "jumpto": "ENAS255_4.2.0.0"
}, {
    "name": "pregnancy, pulmonary embolism [PE]",
    "jumpto": "ENAS262_10.1.0.0"
}, {
    "name": "pregnancy, risk categories",
    "jumpto": "ENAS255_13.2.0.0"
}, {
    "name": "pregnancy, VHD",
    "jumpto": "ENAS248_13.0.0.0"
}, {
    "name": "pregnant women, cardiotoxicity",
    "jumpto": "ENAS5193_3.10.3.0"
}, {
    "name": "pregnany, pacing therapy [Pacing]",
    "jumpto": "ENAS259_6.6.0.0"
}, {
    "name": "Premature ventricular complex (VA and SCD)",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Premature ventricular complexes",
    "jumpto": "ENAS5083_7.3.0.0"
}, {
    "name": "Pressure\/volume curve",
    "jumpto": "ENAS5082_3.6.2.0"
}, {
    "name": "prevention of thromboembolism (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.1.0"
}, {
    "name": "prevention, overt heart failure",
    "jumpto": "ENAS5195_7.0.0.0"
}, {
    "name": "prevention, thromboembolic events, cancer",
    "jumpto": "ENAS5193_4.2.0.0"
}, {
    "name": "primary PCI, anticoagulants",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "primary PCI, indications",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "primary PCI, procedural aspects",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "primary prevention (HF)",
    "jumpto": "ENAS5195_9.1.0.0"
}, {
    "name": "Primary prevention of SCD",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Pro-arrhythmia, drug related",
    "jumpto": "ENAS5083_13.5.0.0"
}, {
    "name": "probe-to-bone test",
    "jumpto": "ENAS256_5.6.9.0"
}, {
    "name": "Prognostic assessment of IE patients",
    "jumpto": "ENAS5079_6.1.0.0"
}, {
    "name": "Programmed ventricular stimulation (PVS)",
    "jumpto": "ENAS5083_6.2.3.0"
}, {
    "name": "Progression of symptoms (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "Propafenone (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "Prophylaxis of IE, cardiac interventions",
    "jumpto": "ENAS5079_3.6.0.0"
}, {
    "name": "Prophylaxis of IE, dental procedures",
    "jumpto": "ENAS5079_3.2.0.0"
}, {
    "name": "Prophylaxis of IE, GI procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, high risk cardiac conditions",
    "jumpto": "ENAS5079_3.3.0.0"
}, {
    "name": "Prophylaxis of IE, high risk dental procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, high risk procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, in TOE",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, respiratory tract procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, skin and soft tissue procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, urogenital procedures",
    "jumpto": "ENAS5079_3.5.0.0"
}, {
    "name": "Prophylaxis of IE, vascular interventions",
    "jumpto": "ENAS5079_3.6.0.0"
}, {
    "name": "prosthesis thrombogenecity",
    "jumpto": "ENAS248_11.2.3.0"
}, {
    "name": "prosthetic dysfunction",
    "jumpto": "ENAS248_11.2.11.0"
}, {
    "name": "Prosthetic valve dehiscence, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Prosthetic valve dehiscence, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Prosthetic valve, dehiscence",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "prosthetic valves, after replacement",
    "jumpto": "ENAS248_11.2.1.0"
}, {
    "name": "prosthetic valves, aortic",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "prosthetic valves, bioprosthesis",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "prosthetic valves, mechanical [CVD Preg]",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "prosthetic valves, mechanical [VHD]",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "prosthetic valves, mitral",
    "jumpto": "ENAS248_11.1.0.0"
}, {
    "name": "proteasome inhibitors, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.7"
}, {
    "name": "proteinuria, pregnancy",
    "jumpto": "ENAS255_11.2.0.0"
}, {
    "name": "proximal isovelocity surface area",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "Pseudoaneurysm, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Pseudoaneurysm, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "psychosocial factors change (CVD prev)",
    "jumpto": "ENAS5196_11.2.0.0"
}, {
    "name": "psychosocial risk factors (CVD prev)",
    "jumpto": "ENAS5196_9.7.0.0"
}, {
    "name": "Psychosocial support (PH)",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "Pulmonary angiography (PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "Pulmonary arterial pressure, PH definition",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "Pulmonary artery wedge pressure, PH definition",
    "jumpto": "ENAS5081_4.1.1.0"
}, {
    "name": "Pulmonary capillary hemangiomatosis (PCH)",
    "jumpto": "ENAS5081_7.6.0.0"
}, {
    "name": "pulmonary disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.8.0.0"
}, {
    "name": "pulmonary embolism, acute phase treatment strategy",
    "jumpto": "ENAS262_7.7.0.0"
}, {
    "name": "pulmonary embolism, anticoagulation in acute phase",
    "jumpto": "ENAS262_7.1.0.0"
}, {
    "name": "pulmonary embolism, biomarkers",
    "jumpto": "ENAS262_6.3.0.0"
}, {
    "name": "pulmonary embolism, cancer",
    "jumpto": "ENAS262_10.2.0.0"
}, {
    "name": "pulmonary embolism, clinical classification",
    "jumpto": "ENAS262_4.4.0.0"
}, {
    "name": "pulmonary embolism, clinical parameters",
    "jumpto": "ENAS262_6.1.0.0"
}, {
    "name": "pulmonary embolism, clinical presentation",
    "jumpto": "ENAS262_5.1.0.0"
}, {
    "name": "pulmonary embolism, clinical probability",
    "jumpto": "ENAS262_5.2.0.0"
}, {
    "name": "pulmonary embolism, diagnostic strategies",
    "jumpto": "ENAS262_5.3.4.0"
}, {
    "name": "pulmonary embolism, duration of anticoagulation",
    "jumpto": "ENAS262_8.0.0.0"
}, {
    "name": "pulmonary embolism, epidemiology",
    "jumpto": "ENAS262_4.1.0.0"
}, {
    "name": "pulmonary embolism, imaging",
    "jumpto": "ENAS262_6.2.0.0"
}, {
    "name": "pulmonary embolism, initial risk stratification",
    "jumpto": "ENAS262_4.4.0.0"
}, {
    "name": "pulmonary embolism, laboratory tests",
    "jumpto": "ENAS262_6.3.0.0"
}, {
    "name": "pulmonary embolism, non-thrombotic",
    "jumpto": "ENAS262_10.3.0.0"
}, {
    "name": "pulmonary embolism, pathophysiology",
    "jumpto": "ENAS262_4.3.0.0"
}, {
    "name": "pulmonary embolism, percutaneous catheter-directed treatment",
    "jumpto": "ENAS262_7.4.0.0"
}, {
    "name": "pulmonary embolism, PESI",
    "jumpto": "ENAS262_6.1.0.0"
}, {
    "name": "pulmonary embolism, predisposing factors",
    "jumpto": "ENAS262_4.2.0.0"
}, {
    "name": "pulmonary embolism, pregnancy",
    "jumpto": "ENAS255_12.2.0.0"
}, {
    "name": "pulmonary embolism, pregnancy",
    "jumpto": "ENAS262_10.1.0.0"
}, {
    "name": "pulmonary embolism, prognostic assessment strategy",
    "jumpto": "ENAS262_6.4.0.0"
}, {
    "name": "pulmonary embolism, revised Geneva score",
    "jumpto": "ENAS262_5.2.0.0"
}, {
    "name": "pulmonary embolism, sPESI",
    "jumpto": "ENAS262_6.1.0.0"
}, {
    "name": "pulmonary embolism, surgical embolectomy",
    "jumpto": "ENAS262_7.3.0.0"
}, {
    "name": "pulmonary embolism, suspected PE with shock\/hypotension",
    "jumpto": "ENAS262_5.3.1.0"
}, {
    "name": "pulmonary embolism, suspected without shock\/hypotension",
    "jumpto": "ENAS262_5.3.2.0"
}, {
    "name": "pulmonary embolism, therapeutic strategies",
    "jumpto": "ENAS262_7.6.0.0"
}, {
    "name": "pulmonary embolism, thrombolytic treatment in acute phase",
    "jumpto": "ENAS262_7.2.0.0"
}, {
    "name": "Pulmonary embolism, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "pulmonary embolism, validated diagnostic criteria",
    "jumpto": "ENAS262_5.3.3.0"
}, {
    "name": "pulmonary embolism, venous filters in acute phase",
    "jumpto": "ENAS262_7.5.0.0"
}, {
    "name": "pulmonary embolism, Wells rule",
    "jumpto": "ENAS262_5.2.0.0"
}, {
    "name": "Pulmonary endarterectomy (PEA)",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "Pulmonary endarterectomy, CTEPH",
    "jumpto": "ENAS5081_10.2.0.0"
}, {
    "name": "pulmonary hypertension mgmt., cardiotoxicity",
    "jumpto": "ENAS5193_3.8.2.0"
}, {
    "name": "pulmonary hypertension, cardiotoxicity",
    "jumpto": "ENAS5193_3.8.1.0"
}, {
    "name": "pulmonary hypertension, pregnancy",
    "jumpto": "ENAS255_5.1.0.0"
}, {
    "name": "pulmonary hypertension, primary MR",
    "jumpto": "ENAS248_8.1.1.0"
}, {
    "name": "pulmonary valve regurg., pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "pulmonary valve replacement, pre-pregnancy",
    "jumpto": "ENAS255_5.4.0.0"
}, {
    "name": "pulmonary valve stenosis, pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "Pulmonary Vascular Resistance (PVR)",
    "jumpto": "ENAS5081_4.1.2.0"
}, {
    "name": "Pulmonary Vascular Resistance (PVR), PAH",
    "jumpto": "ENAS5081_7.2.0.0"
}, {
    "name": "Pulmonary veno-occlusive disease (PVOD)",
    "jumpto": "ENAS5081_7.6.0.0"
}, {
    "name": "Purulent pericarditis, diagnosis",
    "jumpto": "ENAS5082_5.2.3.2"
}, {
    "name": "Purulent pericarditis, overview",
    "jumpto": "ENAS5082_5.2.3.1"
}, {
    "name": "Purulent pericarditis, therapy",
    "jumpto": "ENAS5082_5.2.3.3"
}, {
    "name": "PVOD, heritable",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "PVOD, idiopathic",
    "jumpto": "ENAS5081_4.2.1.0"
}, {
    "name": "Pyrazinamide, in tubercular pericarditis",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "pyrimidine analogues prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.3.3.0"
}, {
    "name": "Q wave changes, MI",
    "jumpto": "ENAS247_7.0.0.0"
}, {
    "name": "QRS complex, MI",
    "jumpto": "ENAS247_7.0.0.0"
}, {
    "name": "QT prolongation risk factors, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.2.1"
}, {
    "name": "QT prolongation, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.2"
}, {
    "name": "qualifiers, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.9.0"
}, {
    "name": "Quinidine, Brugada syndrome",
    "jumpto": "ENAS5083_9.4.2.0"
}, {
    "name": "Quinidine, SQTS management",
    "jumpto": "ENAS5083_9.3.2.0"
}, {
    "name": "R wave changes, MI",
    "jumpto": "ENAS247_7.0.0.0"
}, {
    "name": "Radiation pericarditis",
    "jumpto": "ENAS5082_5.8.1.0"
}, {
    "name": "Radiolabelled leukocytes",
    "jumpto": "ENAS5079_5.4.1.0"
}, {
    "name": "radiotherapy prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.3.5.0"
}, {
    "name": "radiotherapy, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.8"
}, {
    "name": "randomized trials [SCAD]",
    "jumpto": "ENAS258_9.5.0.0"
}, {
    "name": "ranolazine (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "rapid ventricular rate management (HF)",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "rapid ventricular rate management, AFib",
    "jumpto": "ENAS5195_11.2.0.0"
}, {
    "name": "rate control therapy (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "Recurrent pericarditis, anti-inflammatory therapy",
    "jumpto": "ENAS5082_3.3.2.0"
}, {
    "name": "Recurrent pericarditis, biological drugs",
    "jumpto": "ENAS5082_3.3.4.0"
}, {
    "name": "Recurrent pericarditis, corticosteroid tapering",
    "jumpto": "ENAS5082_3.3.3.0"
}, {
    "name": "Recurrent pericarditis, definition",
    "jumpto": "ENAS5082_3.2.1.0"
}, {
    "name": "Recurrent pericarditis, immunosuppresant drugs",
    "jumpto": "ENAS5082_3.3.4.0"
}, {
    "name": "Recurrent pericarditis, management",
    "jumpto": "ENAS5082_3.3.5.0"
}, {
    "name": "Recurrent pericarditis, overview",
    "jumpto": "ENAS5082_3.3.1.0"
}, {
    "name": "Reference centre, recommendations (IE)",
    "jumpto": "ENAS5079_4.2.0.0"
}, {
    "name": "reflex syncope, choice of pacing mode",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "reflex syncope, indications for cardiac pacing",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "regurgitant lesions, pregnancy",
    "jumpto": "ENAS255_7.3.0.0"
}, {
    "name": "reinfarction",
    "jumpto": "ENAS247_10.0.0.0"
}, {
    "name": "relative risk chart for CV mortality, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.4.0"
}, {
    "name": "relevance of CVD prevention",
    "jumpto": "ENAS5196_7.0.0.0"
}, {
    "name": "relief of pain, STEMI",
    "jumpto": "ENAS250_5.2.0.0"
}, {
    "name": "renal artery stenosis, clinical presentation",
    "jumpto": "ENAS256_5.5.1.0"
}, {
    "name": "renal artery stenosis, diagnosis",
    "jumpto": "ENAS256_5.5.2.0"
}, {
    "name": "renal artery stenosis, treatment",
    "jumpto": "ENAS256_5.5.3.0"
}, {
    "name": "renal damage, relationship with BP",
    "jumpto": "ENAS260_4.1.0.0"
}, {
    "name": "renal disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.5.0.0"
}, {
    "name": "renal replacement therapy (HF)",
    "jumpto": "ENAS5195_13.8.3.0"
}, {
    "name": "renin inhibitor, pregnancy",
    "jumpto": "ENAS255_11.8.0.0"
}, {
    "name": "renovascular hypertension, treatment",
    "jumpto": "ENAS260_8.13.0.0"
}, {
    "name": "repeat revascularization\/hybrid procedures (MR)",
    "jumpto": "ENAS265_16.0.0.0"
}, {
    "name": "reperfusion therapy, special subsets",
    "jumpto": "ENAS250_5.5.9.0"
}, {
    "name": "reperfusion therapy, STEMI",
    "jumpto": "ENAS250_5.5.1.0"
}, {
    "name": "reperfusion therapy, strategies",
    "jumpto": "ENAS250_5.4.3.0"
}, {
    "name": "resistant hypertension, treatment",
    "jumpto": "ENAS260_8.11.0.0"
}, {
    "name": "Resting 12-lead ECG (VA and SCD)",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "Restrictive cardiomyopathy (Pericard.)",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "resynchronization therapy, VHD",
    "jumpto": "ENAS248_8.2.2.0"
}, {
    "name": "reteplase",
    "jumpto": "ENAS250_5.5.7.0"
}, {
    "name": "revascularization combined with valve interventions",
    "jumpto": "ENAS265_14.0.0.0"
}, {
    "name": "revascularization for SCAD",
    "jumpto": "ENAS265_8.0.0.0"
}, {
    "name": "revascularization in heart failure\/cardiogenic shock",
    "jumpto": "ENAS265_11.0.0.0"
}, {
    "name": "revascularization in NSTE-ACS",
    "jumpto": "ENAS265_9.0.0.0"
}, {
    "name": "revascularization in patients with CKD",
    "jumpto": "ENAS265_13.0.0.0"
}, {
    "name": "revascularization in patients with diabetes",
    "jumpto": "ENAS265_12.0.0.0"
}, {
    "name": "revascularization in STEMI",
    "jumpto": "ENAS265_10.1.0.0"
}, {
    "name": "revascularization in STEMI, PCI indications",
    "jumpto": "ENAS265_10.2.0.0"
}, {
    "name": "revascularization in STEMI, PCI procedural aspects",
    "jumpto": "ENAS265_10.2.0.0"
}, {
    "name": "revascularization in STEMI, secondary PCI",
    "jumpto": "ENAS265_10.3.0.0"
}, {
    "name": "revascularization, carotid artery",
    "jumpto": "ENAS256_5.7.3.0"
}, {
    "name": "revascularization, CLI",
    "jumpto": "ENAS256_5.6.10.0"
}, {
    "name": "revascularization, endovascular (LEAD)",
    "jumpto": "ENAS256_5.6.6.0"
}, {
    "name": "revascularization, myocardial (prophylactic)",
    "jumpto": "ENAS256_5.7.5.0"
}, {
    "name": "revascularization, myocardial [STEMI]",
    "jumpto": "ENAS250_6.3.0.0"
}, {
    "name": "revascularization, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.6.0.0"
}, {
    "name": "revascularization, surgical (LEAD)",
    "jumpto": "ENAS256_5.6.7.0"
}, {
    "name": "revascularized SCAD, secondary prevention",
    "jumpto": "ENAS258_9.7.0.0"
}, {
    "name": "rhythm control after Tx failure (AFib)",
    "jumpto": "ENAS5194_10.6.0.0"
}, {
    "name": "Rhythm control foll. treat. failure (interactive algorithm)",
    "jumpto": "interactive_0000563"
}, {
    "name": "Rhythm control in sym. pts. (interactive algorithm)",
    "jumpto": "interactive_0000561"
}, {
    "name": "rhythm control management strategy (HF)",
    "jumpto": "ENAS5195_11.3.0.0"
}, {
    "name": "rhythm control mgmt. in AF, algorithm",
    "jumpto": "ENAS5194_10.1.2.0"
}, {
    "name": "Rhythm control of acute AF (interactive algorithm)",
    "jumpto": "interactive_0000560"
}, {
    "name": "rhythm control therapy, AF",
    "jumpto": "ENAS5194_10.3.0.0"
}, {
    "name": "rhythm control, surgical (AFib)",
    "jumpto": "ENAS5194_10.7.2.0"
}, {
    "name": "Rhythm monitoring (NSTE-ACS)",
    "jumpto": "ENAS5080_4.2.0.0"
}, {
    "name": "Rifampicin, in tubercular pericarditis",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "Right heart catherterization (PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "Right Heart Catheterization, group 3 PAH",
    "jumpto": "ENAS5081_9.0.0.0"
}, {
    "name": "Right Heart Catheterization, PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "Right ventricle pseudoaneurism",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "Right ventricle-to-abdomen fistula",
    "jumpto": "ENAS5082_7.1.0.0"
}, {
    "name": "right ventricular outflow tract tachycardia",
    "jumpto": "ENAS255_10.2.0.0"
}, {
    "name": "Riocigaut, Guanylate cyclase stimulators",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Riocigaut, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Riociguat added to bosentan, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Riociguat added to sildenafil, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Riociguat, CTEPH",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "risk age concept Illustration, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.5.0"
}, {
    "name": "risk age, derived from SCORE (CVD prev)",
    "jumpto": "ENAS5196_9.3.4.0"
}, {
    "name": "risk assessment, STEMI",
    "jumpto": "ENAS250_6.2.0.0"
}, {
    "name": "risk based intervention strategies, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.3.0"
}, {
    "name": "risk categories, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.1.0"
}, {
    "name": "risk categories: priorities (CVD prev)",
    "jumpto": "ENAS5196_9.4.0.0"
}, {
    "name": "risk estimation charts (CVD prev)",
    "jumpto": "ENAS5196_9.3.1.0"
}, {
    "name": "risk estimation, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.4.0"
}, {
    "name": "risk factors, AF",
    "jumpto": "ENAS5194_6.1.0.0"
}, {
    "name": "risk factors, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "risk function without HDL-C for men, at high CVD risk (Dyslip)",
    "jumpto": "ENAS5197_4.1.7.0"
}, {
    "name": "risk function without HDL-C for women, at high CVD risk",
    "jumpto": "ENAS5197_4.1.6.0"
}, {
    "name": "risk levels, dyslipidaemias",
    "jumpto": "ENAS5197_4.2.1.0"
}, {
    "name": "risk stratification, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "Rivaroxaban (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "Roth\u2019s spots (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "rupture of aortic aneurysm",
    "jumpto": "ENAS264_8.6.0.0"
}, {
    "name": "Rutherford classification",
    "jumpto": "ENAS256_5.6.1.0"
}, {
    "name": "RV outflow doppler acceleration",
    "jumpto": "ENAS5081_5.4.0.0"
}, {
    "name": "RV outflow doppler acceleration",
    "jumpto": "ENAS5081_5.6.0.0"
}, {
    "name": "RV third heart sound, symptom of PH",
    "jumpto": "ENAS5081_5.1.0.0"
}, {
    "name": "sacubitril (HF)",
    "jumpto": "ENAS5195_11.5.0.0"
}, {
    "name": "SCAD after MI, revascularization",
    "jumpto": "ENAS5083_6.2.3.0"
}, {
    "name": "SCAD after MI, use of antiarrhythmic drugs",
    "jumpto": "ENAS5083_6.2.3.0"
}, {
    "name": "SCAD after MI, with preserved EF",
    "jumpto": "ENAS5083_6.2.3.0"
}, {
    "name": "SCAD mgmt.: blood pressure thresholds",
    "jumpto": "ENAS258_8.3.0.0"
}, {
    "name": "SCAD mgmt.: event prevention",
    "jumpto": "ENAS258_8.4.2.0"
}, {
    "name": "SCAD mgmt.: follow-up after revascularization",
    "jumpto": "ENAS258_9.7.0.0"
}, {
    "name": "SCAD mgmt.: indications for CABG",
    "jumpto": "ENAS258_9.6.0.0"
}, {
    "name": "SCAD mgmt.: indications for PCI",
    "jumpto": "ENAS258_9.6.0.0"
}, {
    "name": "SCAD mgmt.: indications for revascularization",
    "jumpto": "ENAS258_9.4.0.0"
}, {
    "name": "SCAD mgmt.: pharmacological treatment",
    "jumpto": "ENAS258_8.4.4.0"
}, {
    "name": "SCAD mgmt.: revasularization",
    "jumpto": "ENAS258_9.1.0.0"
}, {
    "name": "SCAD mgmt.: side effects, CI and drug-drug interactions",
    "jumpto": "ENAS258_8.4.1.0"
}, {
    "name": "SCAD, basic testing",
    "jumpto": "ENAS258_7.3.2.0"
}, {
    "name": "SCAD, definition and pathophysiology",
    "jumpto": "ENAS258_4.0.0.0"
}, {
    "name": "SCAD, diagnostics in asympt. patients without known CAD",
    "jumpto": "ENAS258_7.6.0.0"
}, {
    "name": "SCAD, epidemiology",
    "jumpto": "ENAS258_5.0.0.0"
}, {
    "name": "SCAD, in diabetes [DM]",
    "jumpto": "ENAS257_9.1.0.0"
}, {
    "name": "SCAD, main features",
    "jumpto": "ENAS258_4.0.0.0"
}, {
    "name": "SCAD, medical mgmt.",
    "jumpto": "ENAS258_8.4.3.0"
}, {
    "name": "SCAD, mgmt.: recommended diet intakes",
    "jumpto": "ENAS258_8.2.0.0"
}, {
    "name": "SCAD, natural history and prognosis",
    "jumpto": "ENAS258_6.0.0.0"
}, {
    "name": "SCAD, reassessment",
    "jumpto": "ENAS258_7.7.0.0"
}, {
    "name": "SCAD, revascularization",
    "jumpto": "ENAS258_8.4.5.0"
}, {
    "name": "SCAD, risk stratification",
    "jumpto": "ENAS258_7.5.3.0"
}, {
    "name": "SCAD, strategy of intervention",
    "jumpto": "ENAS258_9.3.0.0"
}, {
    "name": "SCAD, suspected, diagnostic steps",
    "jumpto": "ENAS258_7.3.3.0"
}, {
    "name": "SCAD, trials",
    "jumpto": "ENAS258_9.5.0.0"
}, {
    "name": "Scar-related VT",
    "jumpto": "ENAS5083_5.4.1.0"
}, {
    "name": "SCD early after MI, risk stratification",
    "jumpto": "ENAS5083_6.2.1.0"
}, {
    "name": "SCD prevention, in congenital heart disease",
    "jumpto": "ENAS5083_10.2.0.0"
}, {
    "name": "SCD with ACS, cardioversion",
    "jumpto": "ENAS5083_6.1.2.2"
}, {
    "name": "SCD with ACS, catheter ablation",
    "jumpto": "ENAS5083_6.1.2.2"
}, {
    "name": "SCD with ACS, defibrillation",
    "jumpto": "ENAS5083_6.1.2.2"
}, {
    "name": "SCD with ACS, drugs",
    "jumpto": "ENAS5083_6.1.2.2"
}, {
    "name": "SCD with ACS, hospital phase",
    "jumpto": "ENAS5083_6.1.2.1"
}, {
    "name": "SCD with ACS, implantable cardioverter defibrillator",
    "jumpto": "ENAS5083_6.1.2.3"
}, {
    "name": "SCD with ACS, indications for revascularization",
    "jumpto": "ENAS5083_6.1.2.1"
}, {
    "name": "SCD with ACS, pacing",
    "jumpto": "ENAS5083_6.1.2.3"
}, {
    "name": "SCD with ACS, pre-hospital phase",
    "jumpto": "ENAS5083_6.1.1.0"
}, {
    "name": "SCD with ACS, prevention and management",
    "jumpto": "ENAS5083_6.1.2.1"
}, {
    "name": "SCD, preventive pharmacotherapy",
    "jumpto": "ENAS5083_5.1.0.0"
}, {
    "name": "SCD, secondary prevention",
    "jumpto": "ENAS5083_4.3.4.0"
}, {
    "name": "SCORE high risk chart, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.2.0"
}, {
    "name": "SCORE in populations at HIGH CV risk",
    "jumpto": "ENAS5196_9.3.2.1"
}, {
    "name": "SCORE in populations at LOW CV risk",
    "jumpto": "ENAS5196_9.3.2.2"
}, {
    "name": "SCORE low risk chart, dyslipidaemias",
    "jumpto": "ENAS5197_4.1.3.0"
}, {
    "name": "SCORE overview (CVD prev)",
    "jumpto": "ENAS5196_9.3.1.0"
}, {
    "name": "SCORE relative risk chart (CVD prev)",
    "jumpto": "ENAS5196_9.3.3.0"
}, {
    "name": "SCORE risks, modifying factors (Dyslip)",
    "jumpto": "ENAS5197_4.1.10.0"
}, {
    "name": "Screening (PH)",
    "jumpto": "ENAS5081_11.0.0.0"
}, {
    "name": "screening, AF",
    "jumpto": "ENAS5194_4.3.0.0"
}, {
    "name": "screening, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.5"
}, {
    "name": "screening, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.2.1"
}, {
    "name": "Screening, PAH",
    "jumpto": "ENAS5081_7.3.0.0"
}, {
    "name": "secondary hypertension, indications and diagnostics",
    "jumpto": "ENAS260_5.9.0.0"
}, {
    "name": "secondary hypertension, signs",
    "jumpto": "ENAS260_5.4.0.0"
}, {
    "name": "secondary prevention (HF)",
    "jumpto": "ENAS5195_9.1.0.0"
}, {
    "name": "Secondary prevention of SCD",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "secondary stroke prevention",
    "jumpto": "ENAS5194_8.9.4.0"
}, {
    "name": "sedentary behaviour and physical activity (CVD prev)",
    "jumpto": "ENAS5196_11.3.0.0"
}, {
    "name": "Selexipag added to ERA and\/or PDE-5i, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Selexipag, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "self-management in AF",
    "jumpto": "ENAS5194_12.0.0.0"
}, {
    "name": "Serum CRP, acute pericarditis therapy",
    "jumpto": "ENAS5082_3.2.7.0"
}, {
    "name": "Short QT syndrome, diagnosis",
    "jumpto": "ENAS5083_9.3.1.0"
}, {
    "name": "Short-coupled torsade de pointes, treatment",
    "jumpto": "ENAS5083_11.4.0.0"
}, {
    "name": "signs (HF)",
    "jumpto": "ENAS5195_5.1.0.0"
}, {
    "name": "Sildenafil added to bosentan, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Sildenafil added to epoprostenol, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Sildenafil, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "single-photon emission computed tomography, SPET (HF)",
    "jumpto": "ENAS5195_6.2.0.0"
}, {
    "name": "sinus arrest [Pacing]",
    "jumpto": "ENAS259_4.3.1.0"
}, {
    "name": "sinus bradycardia, pregnancy",
    "jumpto": "ENAS255_10.5.0.0"
}, {
    "name": "sinus node disease, pacing mode",
    "jumpto": "ENAS259_4.2.3.0"
}, {
    "name": "sinus node dysfunction, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.5"
}, {
    "name": "sinus node dysfunction, pregnancy",
    "jumpto": "ENAS255_10.5.0.0"
}, {
    "name": "Sinus rhythm restoration (AFib)",
    "jumpto": "ENAS5194_10.1.1.0"
}, {
    "name": "SjÃ¶gren syndrome (Pericard.)",
    "jumpto": "ENAS5082_2.0.0.0"
}, {
    "name": "Sleep apnea syndrome",
    "jumpto": "ENAS5083_13.4.0.0"
}, {
    "name": "sleep disturbance (HF)",
    "jumpto": "ENAS5195_12.17.0.0"
}, {
    "name": "sleep-disordered breathing (HF)",
    "jumpto": "ENAS5195_12.17.0.0"
}, {
    "name": "smoking (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "smoking cessation [STEMI]",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "smoking cessation, the five A principles [DM]",
    "jumpto": "ENAS257_8.1.2.0"
}, {
    "name": "smoking intervention (CVD prev)",
    "jumpto": "ENAS5196_11.4.0.0"
}, {
    "name": "smoking, PAD risk factor",
    "jumpto": "ENAS256_4.2.0.0"
}, {
    "name": "smoking, population-based approach (CVD prev)",
    "jumpto": "ENAS5196_14.3.0.0"
}, {
    "name": "Sodium channel blocker, flecainide",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "Sodium channel blocker, mexiletine",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "Sodium channel blocker, ranolazine",
    "jumpto": "ENAS5083_9.2.2.0"
}, {
    "name": "sodium nitroprusside [STEMI]",
    "jumpto": "ENAS250_7.1.1.0"
}, {
    "name": "sotalol, pregnancy",
    "jumpto": "ENAS255_10.1.0.0"
}, {
    "name": "Sotalol, SQTS management",
    "jumpto": "ENAS5083_9.3.2.0"
}, {
    "name": "SQTS, risk stratification and management",
    "jumpto": "ENAS5083_9.3.2.0"
}, {
    "name": "Square root sign",
    "jumpto": "ENAS5082_3.8.2.0"
}, {
    "name": "ST-segment depression [UDMI]",
    "jumpto": "ENAS247_6.2.0.0"
}, {
    "name": "ST-segment elevation [UDMI]",
    "jumpto": "ENAS247_6.1.0.0"
}, {
    "name": "ST-segment elevation MI, acute",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "ST-segment elevation MI, components of delay",
    "jumpto": "ENAS250_5.4.2.0"
}, {
    "name": "ST-segment elevation MI, in-hospital mgmt.",
    "jumpto": "ENAS250_5.4.3.0"
}, {
    "name": "ST-segment elevation MI, long term therapy",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "ST-segment elevation MI, pitfalls",
    "jumpto": "ENAS250_5.5.2.0"
}, {
    "name": "ST-segment elevation MI, prehospital mgmt.",
    "jumpto": "ENAS250_5.4.3.0"
}, {
    "name": "ST-segment elevation MI, prehospital recom.",
    "jumpto": "ENAS250_5.4.4.0"
}, {
    "name": "ST-segment elevation MI, subacute",
    "jumpto": "ENAS250_6.4.2.0"
}, {
    "name": "ST-segment elevation MI, treatment goals",
    "jumpto": "ENAS250_5.5.2.0"
}, {
    "name": "stable angina pectoris, treatment (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "stable coronary artery disease (SCAD), blood tests",
    "jumpto": "ENAS258_7.3.2.0"
}, {
    "name": "stable coronary artery disease (SCAD), initial diagnostic management",
    "jumpto": "ENAS258_7.3.5.0"
}, {
    "name": "stable coronary artery disease, global strategy of intervention",
    "jumpto": "ENAS258_9.3.0.0"
}, {
    "name": "stable coronary artery disease, mgmt. based on risk determination",
    "jumpto": "ENAS258_7.5.2.0"
}, {
    "name": "stable coronary artery disease, predictors of long-term survival",
    "jumpto": "ENAS258_7.5.1.0"
}, {
    "name": "Staphylococcus aureus (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "Staphylococcus spp., infective endocarditis",
    "jumpto": "ENAS5079_7.3.0.0"
}, {
    "name": "statin, hypercholesterolaemia (Dyslip)",
    "jumpto": "ENAS5197_8.1.0.0"
}, {
    "name": "statins, CAD",
    "jumpto": "ENAS256_5.1.5.0"
}, {
    "name": "statins, risk reduction in non-cardiac surgery",
    "jumpto": "ENAS261_7.2.0.0"
}, {
    "name": "Steinert disease",
    "jumpto": "ENAS5083_13.2.1.0"
}, {
    "name": "stent thrombosis",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "stenting and peri-procedural strategies [SCAD]",
    "jumpto": "ENAS258_9.1.0.0"
}, {
    "name": "stents, bare metal [VHD]",
    "jumpto": "ENAS248_11.2.5.0"
}, {
    "name": "stents, bare-metal [STEMI]",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "stents, carotid artery",
    "jumpto": "ENAS256_5.1.5.0"
}, {
    "name": "stents, drug-eluting [STEMI]",
    "jumpto": "ENAS250_5.5.3.0"
}, {
    "name": "stents, drug-eluting [VHD]",
    "jumpto": "ENAS248_11.2.5.0"
}, {
    "name": "stents, infrainguinal",
    "jumpto": "ENAS256_5.6.7.0"
}, {
    "name": "Streptococci oral, infective endocarditis",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "Streptococcus bovis (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "Streptococcus bovis, infective endocarditis",
    "jumpto": "ENAS5079_7.2.0.0"
}, {
    "name": "Streptococcus gallolyticus (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "streptokinase",
    "jumpto": "ENAS250_5.5.7.0"
}, {
    "name": "stress cardiac magnetic resonance [SCAD]",
    "jumpto": "ENAS258_7.3.7.0"
}, {
    "name": "stress echocardiography [SCAD]",
    "jumpto": "ENAS258_7.3.7.0"
}, {
    "name": "Stress imaging (NSTE-ACS)",
    "jumpto": "ENAS5080_3.6.0.0"
}, {
    "name": "stress imaging techniques [SCAD]",
    "jumpto": "ENAS258_7.3.7.0"
}, {
    "name": "stress testing [SCAD]",
    "jumpto": "ENAS258_7.3.7.0"
}, {
    "name": "stress testing [STEMI]",
    "jumpto": "ENAS250_6.2.0.0"
}, {
    "name": "stress testing [VHD]",
    "jumpto": "ENAS248_5.1.5.0"
}, {
    "name": "Stroke prevention in AF",
    "jumpto": "ENAS5194_8.7.0.0"
}, {
    "name": "Stroke prevention in AF, algorithm",
    "jumpto": "ENAS5194_8.3.0.0"
}, {
    "name": "Stroke prevention in AFib (interactive algorithm)",
    "jumpto": "interactive_0000552"
}, {
    "name": "stroke, CABG related",
    "jumpto": "ENAS256_5.7.3.0"
}, {
    "name": "stroke, cardiotoxicity",
    "jumpto": "ENAS5193_3.7.1.2"
}, {
    "name": "stroke, dyslipidaemias",
    "jumpto": "ENAS5197_11.11.0.0"
}, {
    "name": "stroke, ischaemic",
    "jumpto": "ENAS256_5.1.1.0"
}, {
    "name": "stroke, vertebrobasilar",
    "jumpto": "ENAS256_5.2.0.0"
}, {
    "name": "Structural heart disease, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "structured telephone support (HF)",
    "jumpto": "ENAS5195_15.1.4.0"
}, {
    "name": "STS score",
    "jumpto": "ENAS248_5.1.7.0"
}, {
    "name": "subclavian steal syndrome",
    "jumpto": "ENAS256_5.3.0.0"
}, {
    "name": "Subxiphoid pericardiostomy",
    "jumpto": "ENAS5082_5.2.3.1"
}, {
    "name": "Sudden arrhythmic death syndrome (SADS)",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Sudden cardiac death (SCD)",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Sudden cardiac death, in athletes",
    "jumpto": "ENAS5083_13.6.0.0"
}, {
    "name": "Sudden cardiac death, in patients with Afib",
    "jumpto": "ENAS5083_7.2.2.0"
}, {
    "name": "Sudden cardiac death, in patients with mild HF",
    "jumpto": "ENAS5083_7.2.3.0"
}, {
    "name": "Sudden cardiac death, in patients with sinus rhythm",
    "jumpto": "ENAS5083_7.2.1.0"
}, {
    "name": "Sudden cardiac death, indications for autopsy",
    "jumpto": "ENAS5083_4.2.0.0"
}, {
    "name": "Sudden cardiac death, molecular autopsy",
    "jumpto": "ENAS5083_4.2.0.0"
}, {
    "name": "Sudden cardiac death, primary prevention",
    "jumpto": "ENAS5083_7.1.0.0"
}, {
    "name": "Sudden death, definition",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Sudden death, indications for autopsy",
    "jumpto": "ENAS5083_4.2.0.0"
}, {
    "name": "SUDI, definition",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "SUDS, definition",
    "jumpto": "ENAS5083_4.1.0.0"
}, {
    "name": "Summary, antibiotic prophylaxis in IE",
    "jumpto": "ENAS5079_3.7.0.0"
}, {
    "name": "Supervised exercise training, PAH",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "supine hypotensive syndrome",
    "jumpto": "ENAS255_10.5.0.0"
}, {
    "name": "supraventricular arrhythmia, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.3"
}, {
    "name": "Surgery in IE, heart failure",
    "jumpto": "ENAS5079_8.2.0.0"
}, {
    "name": "Surgery in IE, left-sided valve IE",
    "jumpto": "ENAS5079_8.2.0.0"
}, {
    "name": "Surgery in IE, prevention of embolism",
    "jumpto": "ENAS5079_8.2.0.0"
}, {
    "name": "Surgery in IE, uncontrolled infection",
    "jumpto": "ENAS5079_8.2.0.0"
}, {
    "name": "Surgical PEA, CTEPH",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "surgical rhythm control (AFib)",
    "jumpto": "ENAS5194_10.7.2.0"
}, {
    "name": "Surgical rhythm control (interactive algorithm)",
    "jumpto": "interactive_0000562"
}, {
    "name": "Surgical treatment of right-sided IE",
    "jumpto": "ENAS5079_11.0.0.0"
}, {
    "name": "Suspected ACS, initial assessment (NSTE-ACS)",
    "jumpto": "ENAS5080_3.4.0.0"
}, {
    "name": "Suspected NSTE-ACS, diagnosis",
    "jumpto": "ENAS5080_4.3.1.0"
}, {
    "name": "Suspected NSTE-ACS, imaging",
    "jumpto": "ENAS5080_4.3.2.0"
}, {
    "name": "Suspected NSTE-ACS, monitoring",
    "jumpto": "ENAS5080_4.3.3.0"
}, {
    "name": "Suspected NSTE-ACS, risk stratification",
    "jumpto": "ENAS5080_4.3.1.0"
}, {
    "name": "Sustained monomorphic VT, treatment",
    "jumpto": "ENAS5083_5.4.1.0"
}, {
    "name": "Sustained ventricular arrhythmia and ACS, diagnostic workup",
    "jumpto": "ENAS5083_6.1.3.0"
}, {
    "name": "Sustained ventricular arrhythmia, acute treatment",
    "jumpto": "ENAS5083_5.3.0.0"
}, {
    "name": "Sustained ventricular arrhythmia, cardioversion",
    "jumpto": "ENAS5083_5.3.0.0"
}, {
    "name": "Sustained ventricular arrhythmia, defibrillation",
    "jumpto": "ENAS5083_5.3.0.0"
}, {
    "name": "Sustained ventricular tachycardia (VA and SCD)",
    "jumpto": "ENAS5083_4.3.4.0"
}, {
    "name": "SVT, catheter ablation",
    "jumpto": "ENAS5083_7.4.2.0"
}, {
    "name": "SVT, diagnostic workup",
    "jumpto": "ENAS5083_4.3.4.0"
}, {
    "name": "SVT, drug therapy",
    "jumpto": "ENAS5083_7.4.1.0"
}, {
    "name": "symptoms (HF)",
    "jumpto": "ENAS5195_5.1.0.0"
}, {
    "name": "Syncope (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "syncope, carotid sinus",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "syncope, recurrence rate",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "syncope, tilt-induced cardioinhibitory",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "syncope, tilt-induced non-cardioinhibitory",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "syncope, tilt-induced vasovagal",
    "jumpto": "ENAS259_4.4.2.0"
}, {
    "name": "syncope, unexplained [Pacing]",
    "jumpto": "ENAS259_4.4.1.0"
}, {
    "name": "SYNTAX score, myocardial revascularization",
    "jumpto": "ENAS265_5.1.0.0"
}, {
    "name": "Systemic-to-pulmonary shunt (PH)",
    "jumpto": "ENAS5081_7.2.0.0"
}, {
    "name": "T wave changes, MI",
    "jumpto": "ENAS247_6.2.0.0"
}, {
    "name": "T wave changes, prior MI",
    "jumpto": "ENAS247_7.0.0.0"
}, {
    "name": "Tachycardia, bundle branch re-entrant",
    "jumpto": "ENAS5083_7.4.3.0"
}, {
    "name": "tachycardia, supraventricular (pregnancy)",
    "jumpto": "ENAS255_10.6.0.0"
}, {
    "name": "tachycardia, ventricular (pregnancy)",
    "jumpto": "ENAS255_10.2.0.0"
}, {
    "name": "Tadalafil + bosentan, PAH sequential combination therapy",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Tadalafil added to bosentan, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Tadalafil, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "Tako-Tsubo cardiomyopathy, troponin elevation (NSTE-ACS)",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "Targeted medical therapy (PH)",
    "jumpto": "ENAS5081_11.0.0.0"
}, {
    "name": "Targeted medical therapy (PH)",
    "jumpto": "ENAS5081_10.3.0.0"
}, {
    "name": "targeted therapies, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.4"
}, {
    "name": "TASC II classification",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "temporary pacing",
    "jumpto": "ENAS259_8.4.0.0"
}, {
    "name": "tenecteplase",
    "jumpto": "ENAS250_5.5.7.0"
}, {
    "name": "Tetralogy of Fallot",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "Tetralogy of Fallot, risk assessment",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "the main targets (CVD prev)",
    "jumpto": "ENAS5196_5.0.0.0"
}, {
    "name": "therapeutic algorithm, HFrEF",
    "jumpto": "ENAS5195_8.2.0.0"
}, {
    "name": "thiazide diuretic (HF)",
    "jumpto": "ENAS5195_12.11.0.0"
}, {
    "name": "thiazolidinediones (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "thoracic aortic aneurysms",
    "jumpto": "ENAS264_9.2.0.0"
}, {
    "name": "thoracoscopic AF surgery, complications",
    "jumpto": "ENAS5194_10.7.2.0"
}, {
    "name": "thrombembolic disease mgmt., cardiotoxicity",
    "jumpto": "ENAS5193_3.6.2.0"
}, {
    "name": "thrombembolic disease, cardiotoxicity",
    "jumpto": "ENAS5193_3.6.1.1"
}, {
    "name": "thrombo-embolism prophylaxis (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "thromboembolism, risk in pregnancy",
    "jumpto": "ENAS255_12.1.0.0"
}, {
    "name": "thrombus, left atrial (VHD)",
    "jumpto": "ENAS248_9.1.0.0"
}, {
    "name": "thrombus, left ventricular (STEMI)",
    "jumpto": "ENAS250_7.2.0.0"
}, {
    "name": "thrombus, mesenteric artery",
    "jumpto": "ENAS256_5.4.0.0"
}, {
    "name": "Ticagrelor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "ticagrelor, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Ticagrelor, P2Y12 inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.1.0"
}, {
    "name": "ticagrelor, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "ticagrelor, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "time-velocity integral",
    "jumpto": "ENAS248_5.1.3.0"
}, {
    "name": "TIMI risk score (NSTE-ACS)",
    "jumpto": "ENAS5080_4.1.0.0"
}, {
    "name": "tirofiban, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "Tirofiban, glycoprotein IIb\/IIIa inhibitor (NSTE-ACS)",
    "jumpto": "ENAS5080_5.2.2.0"
}, {
    "name": "tirofiban, primary PCI (STEMI)",
    "jumpto": "ENAS250_5.5.4.0"
}, {
    "name": "tirofiban, use in CKD [STEMI]",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "Torsades de pointes",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "total cardiovascular risk estimation (Dyslip)",
    "jumpto": "ENAS5197_4.1.1.0"
}, {
    "name": "total CV risk assessment (CVD prev)",
    "jumpto": "ENAS5196_9.2.0.0"
}, {
    "name": "Trans Atlantic Inter-Society Consensus",
    "jumpto": "ENAS256_5.6.5.0"
}, {
    "name": "transaortic valve implantation, TAVI (HF)",
    "jumpto": "ENAS5195_12.18.0.0"
}, {
    "name": "transcatheter aortic valve implantation",
    "jumpto": "ENAS248_7.3.0.0"
}, {
    "name": "transcatheter aortic valve implantation, pacing",
    "jumpto": "ENAS259_6.2.0.0"
}, {
    "name": "transcatheter closure, PVL",
    "jumpto": "ENAS248_11.2.10.0"
}, {
    "name": "transient ischaemic attack [PAD]",
    "jumpto": "ENAS256_5.1.1.0"
}, {
    "name": "transoesophageal echocardiography, mitral stenosis",
    "jumpto": "ENAS248_9.3.0.0"
}, {
    "name": "transoesophageal echocardiography, pregnancy",
    "jumpto": "ENAS255_4.4.0.0"
}, {
    "name": "transoesophageal echocardiography, TOE (HF)",
    "jumpto": "ENAS5195_11.4.0.0"
}, {
    "name": "transoesophageal echocardiography, VHD",
    "jumpto": "ENAS248_5.1.4.0"
}, {
    "name": "transplantation, dyslipidaemias",
    "jumpto": "ENAS5197_11.9.0.0"
}, {
    "name": "transposition of the great arteries",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "transprosthetic gradient",
    "jumpto": "ENAS248_11.2.1.0"
}, {
    "name": "Transthoracic echocardiography (NSTE-ACS)",
    "jumpto": "ENAS5080_3.6.0.0"
}, {
    "name": "Transthoracic echocardiography (PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "transthoracic echocardiography, VHD",
    "jumpto": "ENAS248_5.1.4.0"
}, {
    "name": "transvenous catheter pace termination",
    "jumpto": "ENAS250_7.1.3.0"
}, {
    "name": "traumatic aortic injury",
    "jumpto": "ENAS264_8.7.0.0"
}, {
    "name": "Travels (PH)",
    "jumpto": "ENAS5081_6.2.2.1"
}, {
    "name": "treadmill testing, LEAD",
    "jumpto": "ENAS256_5.6.4.0"
}, {
    "name": "treatment causing harm (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "Treatment for symptomatic HFrEF (interactive algorithm)",
    "jumpto": "interactive_0000592"
}, {
    "name": "treatment of HFmrEF",
    "jumpto": "ENAS5195_10.0.0.0"
}, {
    "name": "treatment of HFpEF",
    "jumpto": "ENAS5195_10.0.0.0"
}, {
    "name": "treatment of HFrEF, overview",
    "jumpto": "ENAS5195_8.1.0.0"
}, {
    "name": "Treatment of muscular symptoms during statin Rx (interactive algorithm)",
    "jumpto": "interactive_0000594"
}, {
    "name": "treatment options, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.1.0"
}, {
    "name": "treatment recommendations, other co-morbidities (HF)",
    "jumpto": "ENAS5195_12.13.1.0"
}, {
    "name": "treatment, stable angina pectoris (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "treatments not recommended, other co-morbidities (HF)",
    "jumpto": "ENAS5195_12.13.2.0"
}, {
    "name": "Treprostinil inhaled added to sildenafil or bosentan, PH",
    "jumpto": "ENAS5081_6.2.3.4"
}, {
    "name": "Treprostinil, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "tricuspid disease",
    "jumpto": "ENAS248_10.0.0.0"
}, {
    "name": "Tricuspid regurgitant velocity (TRV)(PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "triglycerides and CVD risk (Dyslip)",
    "jumpto": "ENAS5197_9.2.0.0"
}, {
    "name": "trimetazidine (HF)",
    "jumpto": "ENAS5195_12.2.0.0"
}, {
    "name": "triple therapy after ACS (AFib)",
    "jumpto": "ENAS5194_8.11.2.0"
}, {
    "name": "triple therapy after PCI (AFib)",
    "jumpto": "ENAS5194_8.11.3.0"
}, {
    "name": "troponin elevation, cardiotoxicity",
    "jumpto": "ENAS5193_4.1.2.0"
}, {
    "name": "Troponin elevation, non MI conditions",
    "jumpto": "ENAS5080_3.3.0.0"
}, {
    "name": "troponin I, MI",
    "jumpto": "ENAS247_4.1.0.0"
}, {
    "name": "troponin T, MI",
    "jumpto": "ENAS247_4.1.0.0"
}, {
    "name": "troponin, MI defintion",
    "jumpto": "ENAS247_2.0.0.0"
}, {
    "name": "troponin, myocardial injury",
    "jumpto": "ENAS247_4.2.0.0"
}, {
    "name": "Tubercular pericarditis evaluation, emperic chemotherapy",
    "jumpto": "ENAS5082_5.2.2.2"
}, {
    "name": "Tubercular pericarditis evaluation, initial non-invasive",
    "jumpto": "ENAS5082_5.2.2.2"
}, {
    "name": "Tubercular pericarditis evaluation, pericardial biopsy",
    "jumpto": "ENAS5082_5.2.2.2"
}, {
    "name": "Tubercular pericarditis evaluation, pericardiocentesis",
    "jumpto": "ENAS5082_5.2.2.2"
}, {
    "name": "Tubercular pericarditis, evaluation",
    "jumpto": "ENAS5082_5.2.2.2"
}, {
    "name": "Tubercular pericarditis, management",
    "jumpto": "ENAS5082_5.2.2.3"
}, {
    "name": "Turner syndrome",
    "jumpto": "ENAS255_6.2.0.0"
}, {
    "name": "tx goals LDL-cholesterol (Dyslip)",
    "jumpto": "ENAS5197_6.2.0.0"
}, {
    "name": "tx goals secondary targets (Dyslip)",
    "jumpto": "ENAS5197_6.3.0.0"
}, {
    "name": "tx targets (Dyslip)",
    "jumpto": "ENAS5197_6.1.0.0"
}, {
    "name": "Type 1 MI, definition (NSTE-ACS)",
    "jumpto": "ENAS5080_2.0.0.0"
}, {
    "name": "Type 2 MI, definition (NSTE-ACS)",
    "jumpto": "ENAS5080_2.0.0.0"
}, {
    "name": "typical angina, definition [SCAD]",
    "jumpto": "ENAS258_7.2.0.0"
}, {
    "name": "UFH (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "UFH, dosing (NSTE-ACS)",
    "jumpto": "ENAS5080_5.3.1.0"
}, {
    "name": "unexplained syncope, indications for cardiac pacing",
    "jumpto": "ENAS259_4.4.3.0"
}, {
    "name": "unfractionated heparin, CKD (STEMI)",
    "jumpto": "ENAS250_5.5.10.0"
}, {
    "name": "unfractionated heparin, dosage (STEMI)",
    "jumpto": "ENAS250_5.5.8.0"
}, {
    "name": "unfractionated heparin, fibrinolysis",
    "jumpto": "ENAS250_5.5.6.0"
}, {
    "name": "unfractionated heparin, pregnancy",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "unfractionated heparin, valve replacement",
    "jumpto": "ENAS248_11.2.6.0"
}, {
    "name": "Universal definition of myocardial infarction (NSTE-ACS)",
    "jumpto": "ENAS5080_2.0.0.0"
}, {
    "name": "upper extremity artery disease",
    "jumpto": "ENAS256_5.3.0.0"
}, {
    "name": "Uremic pericarditis",
    "jumpto": "ENAS5082_5.3.0.0"
}, {
    "name": "uteroplacental perfusion",
    "jumpto": "ENAS255_11.5.0.0"
}, {
    "name": "VA prevention, in congenital heart disease",
    "jumpto": "ENAS5083_10.2.0.0"
}, {
    "name": "VA screening, invasive evaluation",
    "jumpto": "ENAS5083_4.3.2.0"
}, {
    "name": "VA screening, non-invasive evaluation",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "vaginal delivery",
    "jumpto": "ENAS255_4.7.0.0"
}, {
    "name": "valsartan (HF)",
    "jumpto": "ENAS5195_11.5.0.0"
}, {
    "name": "Valve aneurysm, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Valve aneurysm, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "valve area",
    "jumpto": "ENAS248_5.1.2.0"
}, {
    "name": "valve stenosis",
    "jumpto": "ENAS248_5.1.2.0"
}, {
    "name": "valve thrombosis, pregnancy",
    "jumpto": "ENAS255_7.4.0.0"
}, {
    "name": "valvular disease, cardiotoxicity",
    "jumpto": "ENAS5193_3.3.1.0"
}, {
    "name": "valvular diseases, dyslipidaemias",
    "jumpto": "ENAS5197_11.7.0.0"
}, {
    "name": "valvular heart disease (HF)",
    "jumpto": "ENAS5195_12.18.0.0"
}, {
    "name": "Valvular heart disease in non-cardiac surgery",
    "jumpto": "ENAS261_8.3.0.0"
}, {
    "name": "Vardenafil, PAH monotherapy",
    "jumpto": "ENAS5081_6.2.3.2"
}, {
    "name": "vasodilators (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "vasodilators, aortic regurg.",
    "jumpto": "ENAS248_6.3.0.0"
}, {
    "name": "vasopressors (HF)",
    "jumpto": "ENAS5195_13.8.2.0"
}, {
    "name": "Vasoreactivity testing (PH)",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "Vasoreactivity testing in PH, recommendations",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "Vasoreactivity testing, PAH",
    "jumpto": "ENAS5081_8.2.0.0"
}, {
    "name": "Vasoreactivity testing, positive response",
    "jumpto": "ENAS5081_5.7.0.0"
}, {
    "name": "vasospastic angina, diagnosis [SCAD]",
    "jumpto": "ENAS258_7.8.2.0"
}, {
    "name": "Vaughan Williams Classification",
    "jumpto": "ENAS255_13.5.0.0"
}, {
    "name": "Vegetation, anatomic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "Vegetation, echocardiographic definition",
    "jumpto": "ENAS5079_5.2.4.0"
}, {
    "name": "VEGF inhibitores, cardiotoxicity",
    "jumpto": "ENAS5193_3.1.1.5"
}, {
    "name": "VEGF inhibitors prevention, cardiotoxicity",
    "jumpto": "ENAS5193_4.3.4.0"
}, {
    "name": "velocity ratio",
    "jumpto": "ENAS248_5.1.2.0"
}, {
    "name": "venous thrombosis, cardiotoxicity",
    "jumpto": "ENAS5193_3.6.1.3"
}, {
    "name": "Ventilation\/perfusion lung scan (PH)",
    "jumpto": "ENAS5081_5.2.0.0"
}, {
    "name": "ventilatory support, acute heart failure (HF)",
    "jumpto": "ENAS5195_13.7.0.0"
}, {
    "name": "Ventricular arrhythmia in VHD, management",
    "jumpto": "ENAS5083_12.2.0.0"
}, {
    "name": "Ventricular arrhythmia, bidirectional",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, children with normal heart",
    "jumpto": "ENAS5083_10.1.0.0"
}, {
    "name": "Ventricular arrhythmia, device therapy",
    "jumpto": "ENAS5083_5.2.1.0"
}, {
    "name": "Ventricular arrhythmia, in childern",
    "jumpto": "ENAS5083_10.1.0.0"
}, {
    "name": "Ventricular arrhythmia, in IHD",
    "jumpto": "ENAS5083_12.1.0.0"
}, {
    "name": "Ventricular arrhythmia, in sleep apnea",
    "jumpto": "ENAS5083_13.4.0.0"
}, {
    "name": "Ventricular arrhythmia, in VHD",
    "jumpto": "ENAS5083_12.2.0.0"
}, {
    "name": "Ventricular arrhythmia, interventional therapy",
    "jumpto": "ENAS5083_5.4.1.0"
}, {
    "name": "Ventricular arrhythmia, monomorphic",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, non-sustained",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, pharmacotherapy",
    "jumpto": "ENAS5083_5.1.0.0"
}, {
    "name": "Ventricular arrhythmia, pleomorphic",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, polymorphic",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, screening",
    "jumpto": "ENAS5083_4.3.1.0"
}, {
    "name": "Ventricular arrhythmia, sustained",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular arrhythmia, sustained",
    "jumpto": "ENAS5083_6.1.3.0"
}, {
    "name": "ventricular arrhythmias, cardiotoxicity",
    "jumpto": "ENAS5193_3.4.1.4"
}, {
    "name": "ventricular dyssynchrony (HF)",
    "jumpto": "ENAS5195_11.6.0.0"
}, {
    "name": "Ventricular fibrillation, idiopathic",
    "jumpto": "ENAS5083_11.3.0.0"
}, {
    "name": "Ventricular flutter (VA and SCD)",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "ventricular paced rhythm",
    "jumpto": "ENAS250_5.1.0.0"
}, {
    "name": "ventricular septal defect, pregnancy",
    "jumpto": "ENAS255_5.3.0.0"
}, {
    "name": "ventricular septal defect, risk assessment",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "ventricular septal rupture",
    "jumpto": "ENAS250_7.2.0.0"
}, {
    "name": "Ventricular tachycardia (VA and SCD)",
    "jumpto": "ENAS5083_4.3.3.0"
}, {
    "name": "Ventricular tachycardia, cardioversion (VA and SCD)",
    "jumpto": "ENAS5083_5.3.0.0"
}, {
    "name": "Ventricular tachycardia, idiopathic",
    "jumpto": "ENAS5083_11.2.0.0"
}, {
    "name": "ventricular tachycardia, management (HF)",
    "jumpto": "ENAS5195_11.5.0.0"
}, {
    "name": "Ventricular tachycardia, miscellaneous origin",
    "jumpto": "ENAS5083_11.2.0.0"
}, {
    "name": "Ventricular tachycardia, outflow tract",
    "jumpto": "ENAS5083_11.1.0.0"
}, {
    "name": "ventricular tachycardia, pregnancy",
    "jumpto": "ENAS255_10.6.0.0"
}, {
    "name": "ventricular tachycardia, STEMI",
    "jumpto": "ENAS250_7.1.3.0"
}, {
    "name": "Ventricular tachycardia, surgical ablation",
    "jumpto": "ENAS5083_5.4.2.0"
}, {
    "name": "Verapamil (AFib)",
    "jumpto": "ENAS5194_9.4.0.0"
}, {
    "name": "verapamil (HF)",
    "jumpto": "ENAS5195_8.5.0.0"
}, {
    "name": "Vernakalant (AFib)",
    "jumpto": "ENAS5194_10.1.3.0"
}, {
    "name": "vertebral artery disease",
    "jumpto": "ENAS256_5.2.0.0"
}, {
    "name": "VHD mgmt., cardiotoxicity",
    "jumpto": "ENAS5193_3.3.2.0"
}, {
    "name": "Viridans streptococci (IE)",
    "jumpto": "ENAS5079_5.4.2.0"
}, {
    "name": "vitamin K antagonist, valve replacement",
    "jumpto": "ENAS248_11.2.2.0"
}, {
    "name": "VKA and NOAC in active bleeding (AFib)",
    "jumpto": "ENAS5194_8.10.2.0"
}, {
    "name": "Vorapraxar (NSTE-ACS)",
    "jumpto": "ENAS5080_5.1.0.0"
}, {
    "name": "warfarin, pregnancy",
    "jumpto": "ENAS255_7.5.0.0"
}, {
    "name": "Wearable cardioverter",
    "jumpto": "ENAS5083_5.2.3.0"
}, {
    "name": "Wells criteria for thromboembolism (interactive score)",
    "jumpto": "interactive_0000320"
}, {
    "name": "Wells score (interactive score)",
    "jumpto": "interactive_0000317"
}, {
    "name": "White-coat HTN OR HTN: White-coat (interactive algorithm)",
    "jumpto": "interactive_0000254"
}, {
    "name": "WHO classification, modified",
    "jumpto": "ENAS255_4.9.0.0"
}, {
    "name": "WHO functional class (PH)",
    "jumpto": "ENAS5081_6.1.2.0"
}, {
    "name": "Wolff-Parkinson-White syndrome",
    "jumpto": "ENAS5083_13.8.1.0"
}, {
    "name": "Wolff-Parkinson-White syndrome, ablation",
    "jumpto": "ENAS5083_13.8.1.0"
}, {
    "name": "Wolff-Parkinson-White syndrome, end of life issues",
    "jumpto": "ENAS5083_13.8.2.0"
}, {
    "name": "women, dyslipidaemias",
    "jumpto": "ENAS5197_11.3.0.0"
}, {
    "name": "WPW syndrome (AFib)",
    "jumpto": "ENAS5194_11.2.0.0"
}]